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ABSTRACT 
 
The data presented within this thesis shows the generation and characterisation of a 
complete-, macrophage/granulocyte- and T cell-specific IFNγR2 deficient mouse 
mutant. This mutant mouse is a valuable tool in dissecting the mechanism of action 
of the pleiotrophic cytokine IFNγ. 
 
The global mutant mouse was tested in three models in vivo – DSS induced colitis, 
Trichuris muris infection and EAE. The aim of the DSS-induced colitis model was to 
test the role of IFNγ in the innate immune system and, despite previous reports 
demonstrating IFNγ deficient mice are protected from DSS-colitis, our IFNγR2 
deficient mice displayed equal or more severe colitis than control mice. We 
hypothesise that this discrepancy is due to differences in the gut microbiota. 
 
The Trichuris muris model was utilised as a method of examining the role of IFNγ in 
the adaptive immune system. The complete IFNγR2 mutant was resistant to a low 
dose T. muris infection; however, neither the T cell specific nor the 
macrophage/granulocyte specific mutant duplicated the resistant phenotype observed 
in the global knock-out mice. Analysis of a double conditional T cell and 
macrophage/granulocyte specific IFNγR2 mutant produced inconsistent results. 
Initial experiments suggested that, in combination, these deficiencies are sufficient to 
duplicate the resistant phenotype observed in the global mutant mice, but this was 
not reproducible. 
 
The final in vivo model that we used to analyse IFNγR2 mutant mice was EAE. This 
model was chosen as, for a long time, the mechanism of action and the involvement 
of IFNγ in EAE has been a matter of uncertainty. These results demonstrated that 
global IFNγR2 mutant mice demonstrate an atypical phenotype, with no signs of 
recovery. In contrast, control mice develop classical EAE symptoms with almost 
complete recovery prior to the termination of the experiment. 
 
The IFNγ receptor mutant mouse generated will be of great value to the scientific 
community as IFNγ has been demonstrated to play a role in multiple diseases and 
this tool allows the mechanism of action of this cytokine to be unravelled. 
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This introduction will begin with a review on the generation of conditional knock-out 
mice, followed by an overview of IFNγ and the IFNγ signalling pathways. The 
introduction will culminate with an overview of the three in vivo models employed 
within this thesis to test the conditional knock-out mice: inflammatory bowel disease 
and the model of dextran sodium sulphate-induced colitis; intestinal nematode 
infection and the model Trichuris muris and finally multiple sclerosis and the murine 
model of experimental autoimmune encephalomyelitis. 
 
1.1 GENERATION OF CONDITIONAL KNOCK-OUT MICE 
 
The use of laboratory mice has had a prominent role in studying human diseases, 
initially through naturally occurring mouse mutants and more recently through the 
generation of genetically modified animals (for review see (Austin et al., 2004)). 
Mice are good model organisms for studying human biology and disease as a high 
level of homology has been demonstrated between the mouse and human genomes, 
at the sequence level (Gregory et al., 2002). 
 
The introduction of foreign DNA into the mouse germ-line was first described in 
1980 (Gordon et al., 1980). This was followed by a successful gene transfer 
experiment, inserting the rat growth hormone fused to the mouse metallothionein-I 
promoter into mice. Animals containing this gene grew faster and larger than 
littermate controls, reaching up to twice their normal size demonstrating successful 
expression of the gene (Brinster & Palmiter, 1984). Advances in techniques then led 
to the first mouse gene targeting experiment in 1987. This method allows the 
inactivation of a specific locus within the mouse genome (Thomas & Capecchi, 
1987). In this experiment gene inactivation was achieved by replacing the chosen 
gene segment with a mutant version, through homologous recombination in 
embryonic stem (ES) cells. As homologous recombination is an infrequent event in 
mammalian cells, isolation of mutant ES cells was selected for through the addition 
of the neomycin resistance gene in the targeted locus. This neomycin expression 
allows recombined ES cells to be easily selected at the same time as inactivating the 
target gene (Thomas & Capecchi, 1987).  Microinjection of mutant ES cells into 
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mouse blastocysts was then performed to generate germ-line chimaeras (Bradley et 
al., 1984), and interbreeding of heterozygous siblings then produces mice 
homozygous for the desired mutation. 
 
This conventional gene targeting method, creating a global knock-out, can create an 
embryonic lethal phenotype if the gene is involved in development. Moreover, a 
gene may exert its function in different cell types resulting in complex phenotypes 
where it is difficult to determine cell-autonomous effects from more complex 
interactions (Rajewsky et al., 1996). Recent advances in the genetic manipulation of 
mice and the development of site-specific recombinase systems have allowed the 
conditional inactivation of a gene and have proved a powerful tool in the elucidation 
of gene function (Gu et al., 1994). 
 
The two main recombinase systems that have been use for mouse gene targeting 
experiments are the Cre-loxP system (Gu et al., 1994; Lakso et al., 1992) and the 
Flp-FRT system (Dymecki, 1996). The Cre-loxP system was introduced over 15 
years ago and has become a favoured approach in biomedical and immunological 
research (for review see (Schmidt-Supprian & Rajewsky, 2007)). 
 
1.1.1 The Cre-loxP system 
The site-specific Cre-loxP recombination system was originally isolated from 
bacteriophage P1 where it is important in the viral life cycle (Abremski & Hoess, 
1984). The system consists of two components: the loxP recognition site and the Cre 
protein. The loxP (locus of crossover (x) in P1) recognition site is a 34-bp consensus 
sequence. This sequence consists of two 13-bp inverted repeats flanked by an 8-bp 
nonpalindromic core, which defines the orientation of the recognition site (Kwan, 
2002) (Fig 1.1A). The size of the loxP sites mean it is large enough to be unlikely to 
occur at random within the mouse genome, but it is small enough to not interfere 
with gene expression. The second component is the Cre (causes recombination) 
protein, which carries out the recombination between two loxP sites (Abremski & 
Hoess, 1984) (Fig 1.1B). The relative orientation of the loxP sites is important. A 
DNA fragment between two loxP sites in the same orientation is excised in a circular 
form, whereas, a fragment between two loxP sites in opposing orientations will be 
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inverted with respect to the rest of the DNA. An important characteristic of this 
reaction is it’s autonomy. Cre recombinase has high fidelity, without the need for 
accessory proteins, (Abremski et al., 1983), and this allows the system to be 
manipulated for use in mammalian cells. 
 
The targeting vector used to create the loxP flanked (“floxed”) gene needs to 
incorporate several essential components. This includes two arms of DNA sequence 
homologous to that of the ES cells to be targeted, and a positive selection gene 
cassette (e.g. neomycin), within the two homology arms, allowing for selection of 
integration. The vector can also include a negative selection gene (e.g. thymidine 
kinase or diptheria toxin) outside of the two homology arms, to allow selection 
against random integration (see review of gene targeting strategies by (Cheah & 
Behringer, 2000)). 
 
The addition of a selectable marker e.g. neor into the targeted gene has been 
demonstrated to potentially complicate results. Chen et al. observed that the presence 
of a neor cassette blocked the normal splicing of the target gene. Other experiments 
have shown the insertion of a neor cassette can disrupt the amino acid sequence and 
introduce stop codes in the gene of interest (Hirotsune et al., 1998). This interference 
in the transcription or splicing of the target or neighbouring genes can make the 
Fig 1.1 The Cre-loxP system A. The loxP recognition site – two 13bp inverted repeats 
flanking an 8-bp nonpalindromic core B. The Cre protein carries out recombination 
between 2 loxP sites (represented by ) excising the exon(s) contained within the loxP 
sites. Adapted from (Hoess & Abremski, 1985) and (Kwan, 2002). 
A. 
B. 
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interpretation of a specific phenotype potentially very difficult (Chen et al., 1999; 
Pham et al., 1996). To circumvent this complication, new gene targeting techniques 
have aimed to delete the selectable marker after confirmation of homologous 
recombination. 
 
One of the most popular strategies currently used, in the generation of a conditional 
knock out mouse, to delete the selectable marker, is the 3-loxP approach. The 
targeting vector in this method uses three loxP sites in the same orientation – two 
flanking the selectable marker and the third one positioned to cause the desired 
excision after Cre recombination (Gu et al., 1994) (see Fig 1.2A). In this method, 
once it has been established that the 3-loxP gene construct has successfully targeted 
the gene locus, the selectable marker can be removed by transiently expressing Cre. 
Transient Cre expression produces three possible recombination products and the 
desired clone, containing the floxed gene, can be isolated. 
 
Recently, the 2-loxP 2-Flp recognition target (FRT) method has become increasingly 
popular. This more elegant method eliminates the need to screen for the desired 
clone, by flanking the positive selection marker with FRT sites instead of loxP sites 
(Jung et al., 1993) (see Fig 1.2B). The positive selection marker can be deleted, 
following confirmation of homologous recombination, through the transient 
expression of Flp. Flp is a recombinase enzyme derived from Saccharomyces 
cerevisiae (Dymecki, 1996) and acts in a similar manner to Cre, causing 
recombination between FRT sites (Meyers et al., 1998). This Flp-mediated deletion 
can be performed in vitro or in vivo by breeding mice containing the target gene with 
Flp deleter mice (Meyers et al., 1998) (see Fig 1.2). If the deletion is performed in 
vivo the need to manipulate the ES cells is minimised and therefore the preservation 
of germline competency is enhanced. However, this needs to be weighed up against 
the increased potential for genetic contamination. 
 
Once mice, containing the floxed target gene with deleted selectable marker, have 
been generated, mice with a cell-specific gene deletion can then be created by inter-
crossing with mice expressing Cre in the selected cell lineage (Gu et al., 1994). In  
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Fig 1.2 Gene targeting approaches allowing the deletion of the positive selection 
cassette A. 3-loxP approach. The targeting vector has three loxP sites in the same 
orientation – two flanking the selectable marker and the third one flanking the 
exon(s) to be deleted. Following, transient Cre expression the desired clone, 
containing the floxed gene, can be isolated. B 2-loxP 2- FRT method. The targeting 
vector has two loxP sites flanking the exon(s) to be deleted and 2 FRT sites flanking 
the positive selection marker. The positive selection cassette can be deleted using 
the transient expression of Flp, which causes recombination between FRT sites.  
sites of homologous recombination  loxP sites   FRT sites  positive 
selection cassette  exons. Adapted from (Kwan, 2002) 
A. 
B. 
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these offspring, carrying both the loxP flanked gene and Cre transgene, the target 
gene will be excised in only the tissues expressing Cre recombinase. This a powerful 
system and there is now a large collection of Cre mice which express the Cre 
recombinase under different promoters (Nagy et al., 2009). Therefore, once mice 
containing the floxed target gene have been generated, multiple conditional knock-
out mice can be created through breeding with the appropriate Cre lines.  
 
Despite the wealth of data generated through the use of conditional gene targeted 
mice there are still come drawbacks with this system. For example, some promoters 
are tissue-specific in adults, but can be active in multiple tissues during development, 
resulting in a complicated gene deletion pattern (Castrop et al., 2006). These 
drawbacks have led to the generation of methods allowing the temporal control of 
gene deletions. There are currently two approaches established: the Cre-Estrogen 
receptor system (Metzger et al., 1995) and the tetracycline (tet) – dependent system 
(Gossen & Bujard, 1992).  
The Cre-Estrogen receptor system involves the fusing of the ligand-binding domain 
(LBD) of the hormone receptor to the Cre protein. This takes advantage of the nature 
of hormone receptors, which are located in the cytoplasm, and only upon binding to 
their ligands are they translocated to the nucleus. Therefore, the autonomous nuclear 
translocatory ability of Cre is blocked, and the fusion protein is held in the 
cytoplasm. Upon exposure to the ligand, and after binding to the LBD, nuclear 
localisation occurs and subsequent recombination at loxP sites results in the deletion 
of the gene of interest (Fig 1.3A). Initial fusion proteins were generated using the 
LBD of the estrogen receptor, however, using this system endogenous estrogen could 
cause background levels of Cre-mediated excision. Furthermore, treatment with 
estrogen, to induce the deletion, could have biological consequences independent of 
deletion due to the presence of high levels of the hormone (Metzger et al., 1995). 
This problem has been circumvented through the generation of a mutated estrogen 
receptor LBD fused to the Cre protein (Cre-ERT). This LBD doesn’t bind the 
naturally occurring 17β-estradiol but binds the synthetic ligands tamoxifen and 4-
hydroxytamoxifen  (4-OH-tamoxifen) (Feil et al., 1996).  
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Fig 1.3 Systems for temporal control of gene expression A. The Cre-ERT system. 
Under basal conditions in the absence of tamoxifen the Cre-ERT protein remains in 
the cytoplasm and no recombination occurs between the two loxP sites When 
tamoxifen is given to the mice / introduced into the system it binds the mutated 
estrogen receptor ligand binding domain resulting in the movement of the Cre-ERT 
protein to the nucleus. The Cre protein then induces recombination between the two 
loxP sites. B. The tTA system. Under basal conditions the tTA (tetR-VP16) fusion 
protein can bind to the tetO sequences, resulting in transcriptional activation of Cre 
and therefore recombination at target sites. When tetracycline (or doxycyclin) tTA 
undergoes a conformational change, is unable to bind the tetO sequence and 
therefore no transcription of Cre occurs. TSP, tissue-specific promoter; TATA, 
representing a minimal promoter required for transcription; pA, polyA signal 
sequence (adapted from (Branda & Dymecki, 2004)). 
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The second system, allowing the temporal control of gene deletion, is the tet 
responsive system. This system involves two components (1) a transactivator gene 
which encodes a fusion protein that specifically binds tet (or the tet analogue 
doxycycline) and operator sequences of the tet operon (tetO) and (2) a 
tetO::recombinase transgene, where a minimal promoter e.g. CMV drives expression 
of the Cre recombinase protein (see Fig 1.3B) (Gossen & Bujard, 1992). The fusion 
protein encoded by the transactivator gene is termed tTA and contains a tetracycline 
repressor (from E. Coli) fused to the herpes simplex viral protein 16 (VP16) 
transactivation domain. This fusion protein can be driven either by a cell-specific or 
a globally active promoter. Therefore, in the absence of tet the transactivator gene 
tTA is able to bind to tetO DNA, activating transcription of Cre. After tet 
administration, tet prevents tTA binding to tetO and therefore results in suppression 
of transcription (Gossen & Bujard, 1992) (see Fig 1.3B). A similar system has been 
generated with a ‘reverse’ tTA (rtTA) which only binds tetO in the presence of tet, 
therefore the administration of tet activates transcription. The disadvantage of this 
system is that it involves three genetic manipulations: the floxed allele, the tTA or 
rTA system under the control of a specific promoter and the tet operator driving the 
expression of Cre. This can result in the need for multiple time-consuming breedings 
and therefore, in practice, the Cre-ERT system is more commonly used. 
In summary, the Cre-LoxP system is an extremely powerful method for dissecting 
the cytokine network during homeostasis and disease. The value of this method is 
exemplified in the generation of the gp130 conditional mutant mice. Gpl30 is the 
signal-transducing subunit shared by the receptors for the IL-6 family of cytokines. 
Global inactivation of gp130 in mice results in lethality between day 12.5 post 
coitum and term, due to altered myocardial development and hematopoiesis 
(Yoshida et al., 1996). To circumvent this, a floxed gp130 mouse was created and 
this has allowed several conditional knock-out mice to be generated though breeding 
with various Cre expressing lines (Betz et al., 1998). The first conditional gp130 
mouse generated was the result of a cross to the Mx-Cre line. MxCre mice contain an 
interferon responsive promoter so floxed genes are deleted in all haematopoietic 
stem cells, endothelial cells and liver cells after infection with IFN-α, IFN-β or 
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synthetic double-stranded RNA (Kuhn et al., 1995). These gp130fl/flMxCre 
conditional mutant mice exhibit neurological, cardiac, haematopoietic, 
immunological, hepatic and pulmonary defects. This clearly demonstrated the 
importance of gp130 dependent cytokines, not only during development, but also 
after birth, in the main regulatory functions of the body (Betz et al., 1998). 
Subsequently crosses have been made to various other Cre lines, including lines 
which are specific for the liver e.g. Alfp-Cre (hepatocyte-specific), the heart e.g. 
MLC2vCreKI (Cardiac myocyte-specific), the brain e.g. GFAP-Cre (Astrocyte-
specific) and immune cells e.g. CD4-Cre (T cell-specific) (Drogemuller et al., 2008; 
Fasnacht & Muller, 2008; Hirota et al., 1999; Streetz et al., 2003). These mice have 
revealed the important role of gp130 in counterbalancing apoptotic signals and 
demonstrate that gp130 dependant cytokines have the potential to act over a long 
range (for a review of the gp130 conditional mouse mutants see (Fasnacht & Muller, 
2008)). 
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1.2 INTERFERON-γ  
Interferons were originally described, in 1957, by Issacs and Lindenmann as a 
soluble factor produced by virus-infected cells, that can transfer virus resistance to 
uninfected cultures (Isaacs & Lindenmann, 1957). Since then, the family has grown 
and interferons (IFNs) are now divided into three major groups: IFN type I, II and III 
The IFN-I family includes IFNα, IFNβ, IFNδ, IFNε, IFNχ, IFNτ and IFNω. The 
different family members can promote different biological responses but are all 
structurally related and signal through the same receptor subunits. Interferon-γ 
(IFNγ), was originally identified as ‘macrophage-activation factor’ (Schroder et al., 
2004), and is the sole type II interferon. The IFN-III family is a relatively recent 
addition and includes three proteins, namely IFN-λ1 (IL-29), IFN-λ2 (IL-28A), and 
IFN-λ3 (IL-28B), that all signal through the IFN-λ receptor. The biological role of 
these proteins is not fully understood but appears to be similar to that of the IFN-I 
family (for an overview of the IFN-III family see (Kotenko et al., 2003)). 
 
1.2.1 IFNγ  structure and signalling 
The IFNγ receptor complex is composed of four transmembrane polypeptide chains: 
two ligand-binding chains (IFNγR1) and two accessory chains (IFNγR2) which do 
not bind IFNγ but are required for signal transduction (Hemmi et al., 1994; Krause et 
al., 2006; Platanias, 2005; Regis et al., 2006). It has been demonstrated that in its 
resting state, the receptor chains of the IFNγ complex are a preassembled tetramer on 
the cell membrane held together by an interaction involving Jak1 (Regis et al., 2006). 
Within this complex, IFNγR1 and IFNγR2 are constitutively associated with the 
inactive forms of the tyrosine kinases Jak1 and Jak2, respectively.   
 
IFNγ binding, and subsequent rearrangement and dimerisation of the receptor 
subunits, results in the transactivation of Jak1 and Jak2. This then allows for the 
phosphorylation of Tyr440 on IFNγR1, generating a docking site for STAT1 
(Platanias, 2005). After its recruitment, STAT1 is activated by phosphorylation at 
Tyr701, resulting in its homodimerisation and nuclear translocation. The STAT1 
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dimers interact in the nucleus with specific DNA sequences called IFNγ-activated 
sequences (GAS). GAS are located in the promoter regions of IFNγ-stimulated genes 
(ISGs), and in this way regulate transcription (Fig 1.4) (Regis et al., 2006; Sizemore 
et al., 2004). Active STAT1 in the nucleus is acetylated by histone acetyltranserases 
(HATs), which flags STAT1 for dephosphorylation and therefore deactivation by the 
STAT1 phosphatase TCP45 (Kramer et al., 2009). Dephosphorylated STAT1 
shuttles back to the cytoplasm where histone deacetylases (HDACs) deacetylate 
STAT1, completing the phosphorylation – acetylation cycle (Kramer et al., 2009). 
Although STAT1 is essential for cells to respond fully to IFNγ there is accumulating 
evidence that several supplementary pathways function in parallel with JAK-STAT1 
(Gough et al., 2007; Platanias, 2005; Sizemore et al., 2004). Moreover, the JAK-
STAT pathway alone is not sufficient for the generation of all the biological 
Fig 1.4. IFNγ  signalling pathway. IFNγ binds to the receptor resulting in Jak 1 and 2 
transactivation, phosphorylation of IFNγR1 and STAT1 recruitment. STAT1 
homodimerises and translocates to the nucleus to regulate transcription. Supplementary 
pathways activate PI3K and its effector kinases AKT, MAPK, and PKCδ, which 
phosphorylate STAT1, potentiating its actions. Independent pathways also play a role 
including an IκB Kinase (IKK)-dependent, NFκB-independent pathway and STAT3 
pathway. Adapted from Platanias et al 2005 
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activities of IFNγ (for review see (Platanias, 2005)). Many of these supplementary 
pathways activate kinases, such as PI3K and its effector kinases Akt, MAPK, and 
PKCδ. These kinases are involved in the phosphorylation of serine 727 on STAT1 
(Fig 1.4) (Gough et al., 2007; Platanias, 2005) and potentiates the ability of STAT1 
to activate gene transcription (Leon et al., 2006). 
 
However, ISGs can also be activated independently of STAT1 through various 
pathways, including the activation of an IκB Kinase (IKK)-dependent, NFκB-
independent pathway. This pathway appears to be essential for the induction of a 
subset of ISGs, including inflammatory and antiviral responses, expression of MHC 
class I and growth control (Sizemore et al., 2004). Furthermore, in the absence of 
STAT1, IFNγ can activate STAT3 which is able to drive the expression of some 
genes that normally respond to STAT1 (Qing & Stark, 2004). Nevertheless, the 
analysis of STAT1 deficient mice and cells over-expressing a constitutively active 
STAT1 mutant protein, demonstrate that STAT1 is required for most of the 
responses induced by IFNγ (Lu et al., 1998; Qing & Stark, 2004). 
 
1.2.2. Expression of IFNγ receptors 
It has been demonstrated that the IFNγR1 chain is highly and uniformly expressed on 
T, B and myeloid cells, where as IFNγR2 chain is highly expressed on B cells and 
myeloid cells but has a limited expression on T cells (Bernabei et al., 2001; Regis et 
al., 2006). IFNγR2 levels appear to govern the ability of cells to respond to IFNγ, 
with an increase in IFNγR2 expression resulting in the switch from a proliferative to 
an apoptotic outcome following IFNγ stimulation. This is evident in CD4+ Th1 cells 
where the low IFNγR2 chain expression elicits a response to IFNγ, with enhanced 
MHC class I expression and cell proliferation, but is unable to trigger the apoptotic 
pathway (Bernabei et al., 2001; Lu et al., 1998; Regis et al., 2006). 
 
1.2.3. Effects of IFNγ signalling 
It is now recognised that IFNγ has pleiotropic immunomodulatory, antiviral, anti-
neoplastic and pro-inflammatory activities (Bernabei et al., 2001; Leon et al., 2006; 
Regis et al., 2006; Schroder et al., 2004). 
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Initially thought to be produced exclusively by Th1 CD4+ T cells, CD8+ T cells and 
natural killer (NK) cells, there is now evidence that other cells including B cells, 
NKT cells and professional antigen presenting cells (APCs) may also secrete IFNγ. 
This production is controlled primarily through IL-12 and IL-18 secretion (for a 
review see (Frucht et al., 2001)). 
 
IFNγ has several important effects including up-regulation of cell surface MHC class 
I and class II, skewing of the immune response to a Th1 phenotype, up-regulation of 
adhesion molecules and chemokine expression, induction of key antiviral enzymes 
e.g. PKR, activation of microbicidal effector functions, apoptosis, cell growth 
inhibition and reduction of epithelial barrier function (Adams et al., 1993; Bernabei 
et al., 2001; Gough et al., 2007; Schroder et al., 2004; Steimle et al., 1994). This is 
achieved through the activation of a variety of different ISGs with specificity 
achieved, in part, through the variation in availability of key signalling effectors 
(Rose et al., 2007). IFNγ is also able to promote inflammatory processes through the 
inhibition of the anti-inflammatory cytokines IL-10 and TGFβ e.g. IFNγ induces the 
inhibitory Smad7 which binds to the TGFβ receptor complex, preventing its 
interaction and phosphorylation of Smad3, resulting in the loss of TGFβ signalling in 
the nucleas (Ulloa et al., 1999). The inhibition of these molecules is thought to be an 
important mechanism to ensure effective pathogen clearance (Herrero et al., 2003). 
 
1.2.3.1 Role of IFNγ in Macrophages 
IFNγ is thought to be one of the most important mediators for activating 
macrophages (Hu et al., 2005). Indeed, exposure to IFNγ results in the altered 
expression of 25% of the genome (Ehrt et al., 2001). This has downstream actions, 
which include the promotion of microbial killing, production of inflammatory 
mediators and antigen presentation (see review by (Schroder et al., 2004)). 
Furthermore, IFNγ has the ability to “prime” macrophages for faster and heightened 
responses to LPS, other Toll-like receptor (TLR) ligands and other cytokines such as 
tumour necrosis factor (TNF) (Bundschuh et al., 1997; Pace et al., 1983; Sweet et 
al., 1998). While some genes e.g. CpG -induced iNOS, require IFNγ priming for 
induction (Sweet et al., 1998) in other cases IFNγ priming shifts the dose response 
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curve, so a lower concentration of TLR agonist can have an effect (Costelloe et al., 
1999). It is thought that IFNγ not only achieves this priming effect through the 
enhancement of positive TLR signalling (reviewed by (Schroder et al., 2006)), but 
also by inhibiting TLR-induced negative feedback (Hu et al., 2006). 
1.2.3.2 Role of IFNγ in T cells 
IFNγ is the major effector cytokine of Th1 immunity and is able to reinforce Th1 
development as well as inhibiting Th2 and Th17 differentiation (Gajewski & Fitch, 
1988; Harrington et al., 2005). Initially evidence using the intracellular protozoan 
Leishmania major suggested that IFNγ played an important role in Th1 
differentiation (Scott, 1991; Wang et al., 1994). However, further work demonstrated 
that whilst IFNγ is crucial for the elimination of L. major, IFNγ mediated signals 
were not necessary for the differentiation of cells towards a Th1 phenotype (Swihart 
et al., 1995). It has since been demonstrated that IFNγ enhances responsiveness to 
IL-12 in naïve T cells, thus increasing Th1 development, but is not vital for the 
development of a Th1 response (Wenner et al., 1996). 
Moreover, recently a more complex picture of IFNγ-mediated regulation of Th17 
cells has emerged. Despite the ability of IFNγ to inhibit Th17 differentiation 
(Harrington et al., 2005), it is now apparent that at many inflammatory sites T cells 
can co-express IFNγ and IL-17. This is thought to occur due to plasticity in the Th17 
cell lineage, resulting in Th17 cells evolving to become IFNγ-expressing cells (Lee et 
al., 2009). As well as IFNγ IL-17 double positive cells, it has also been demonstrated 
that IFNγ IL-10 double positive T cells can also be detected and it is proposed than 
these cells are important in governing the extent of APC activation (Anderson et al., 
2007; Jankovic et al., 2007). 
1.2.3.3. IFNγ  homeostatic functions 
As well as its pro-inflammatory effects, IFNγ also possess a number of important 
homeostatic functions, which limit inflammation-associated tissue damage. This is 
achieved, in part, through the attenuation of tissue destructive molecules e.g. matrix 
metalloproteinases (Ho et al., 2008). Another important homeostatic mechanism is 
the attenuation of granulopoiesis and myelopoiesis (Matthys et al., 1999). This has 
Chapter One: Introduction 
 
 - 37 - 
been clearly demonstrated in IFNγ deficient mice which display a large expansion of 
macrophages and granulocytes upon exposure to mycobacteria (Murray et al., 1998). 
This synergises with the IFNγ induced inhibition of chemokine production e.g. 
CXCL6 and suppression of adhesion molecule expression to alter the monocytes 
chemotactic response. These effects of IFNγ result in a decreased infiltration of 
neutrophils and monocytes into tissues (Hu et al., 2008; Kelchtermans et al., 2007). 
1.2.4. IFNγ deficiency 
Mice deficient in IFNγ, IFNγR1 or IFNγR2 develop normally and are fertile but 
demonstrate an increased susceptibly to microbial pathogens and parasites (Huang et 
al., 1993; Lu et al., 1998; Scharton-Kersten et al., 1996). Moreover, IFNγR2 
deficient mice display altered immunoglobulin class switching with B cells unable to 
class switch to IgG2a in response to IFNγ. 
 
Dighe and colleagues created transgenic mice over-expressing a dominant negative 
IFNγR1 chain on either T cells or macrophages. This data suggests that Th1 cell 
development in vivo requires a functional IFNγ receptor on macrophages, but not on 
T cells (Dighe et al., 1995). A similar method was subsequently adopted by Lykens 
and colleagues to create mice with “macrophages insensitive to IFNγ” (MIIG mice). 
These mice express a dominant negative IFNγR1 chain under the CD86 promoter 
and therefore have monocytes, macrophages, dendritic cells and mast cells 
unresponsive to IFNγ. Using this mouse model they were able to demonstrate 
impaired parasitic control and heightened mortality after Trypanosoma cruzi, 
Leishmania major and Toxoplasma gondii infection (Lykens et al., 2010). 
 
Additionally, humans with mutations in components of the IFNγ receptor-signalling 
pathway have been identified. Such individuals have profound immunodeficiency’s, 
especially to intracellular bacterial infections, with some individuals dying in early 
childhood as a result of uncontrolled mycobacterial infections (for review see 
(Filipe-Santos et al., 2006)).  
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1.3 INFLAMMATORY BOWEL DISEASE 
 
Inflammatory Bowel Disease (IBD) is a chronic, relapsing, idiopathic inflammation 
of the gastrointestinal tract that causes significant morbidity. Clinical symptoms 
include weight loss, diarrhoea accompanied by blood, abdominal pain and 
malnutrition (Cho, 2008; Neuman, 2007) all of which can substantially affect a 
patient’s quality of life, largely as a result of the psychosocial implications (Ghosh & 
Mitchell, 2007). An increased incidence of colorectal cancer is the most lethal, long-
term complication of IBD (Jess et al., 2006). This can be attributed to alterations in 
the intestinal epithelium that are initiated and, at least partially, sustained by chronic 
inflammation (Harpaz & Polydorides, 2010). However, recent data suggests that with 
current therapies the risk for developing IBD-related colorectal cancer is limited 
(Baars et al., 2010). 
 
There are estimated to be as many as 2.2 million people in Europe (Loftus, 2004) and 
1 in 400 people in the UK affected by IBD (Butcher, 2007). As the peak onset age is 
early, between 15 and 30 years, IBD commonly requires a lifetime of care (Loftus et 
al., 1998). Patients need to take regular medication, even when well, and make 
considerable lifestyle adaptations to reduce relapses and prevent complications 
(Nightingale, 2007). Current treatment strategies for IBD include corticosteroids, 
immunomodulators e.g. azathioprine and methotrexate and more recently some 
biological therapeutics (Strauch & Scholmerich, 2010). Treatment strategies aim to 
promote mucosal healing and maximise quality of life. However, even anti-TNF 
antibodies, the best biological treatment for IBD, are not effective in all patients, 
with remission only achieved in approximately 50% (Trinder & Lawrance, 2009). 
 
The two main forms of IBD are Crohn’s disease (CD) and ulcerative colitis (UC). 
They share many characteristics and end-stage effector pathways of tissue damage, 
but have distinct morphological, immunological and clinical features (Bouma & 
Strober, 2003; Peluso et al., 2006). CD is characterised by non-caseating 
granulomas, lymphoid aggregates and extension of inflammation through all layers 
of the bowel wall. CD most commonly affects the ileum and colon but can involve 
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any region of the gut. By contrast, UC is characterised by mucosal inflammation and 
extensive ulcers, usually confined to the submucosa. UC always involves the rectum 
and, in some cases, the inflammation extends up to the caecum in a continuous 
pattern (Arihiro et al., 2002; Cho, 2008; Podolsky, 2002). Currently, the 
pathogenesis of inflammatory bowel disease is poorly understood, but it is 
recognised to be complex and multi-factorial. Nevertheless, significant progress and 
insights have been made through the analysis of genetic, environmental and 
immunological factors - the main components thought to be involved in the 
establishment and development of IBD. The current hypothesis is that, both CD and 
UC, are due to an exaggerated or inappropriate response to normal gut bacterial flora 
that is, in part, genetically determined (see review by (Bouma & Strober, 2003; 
Monteleone et al., 2006)).  
 
1.3.1 The role of genetic susceptibility in inflammatory bowel disease 
Epidemiological studies have made it clear that genetic factors play an important role 
in the pathogenesis of IBD, with multiplex IBD families and 5-10% of patients 
reporting a positive family history (Binder, 1998). Indeed, a positive family history is 
still the largest independent risk factor for IBD, with genetic factors playing a more 
Fig 1.5 Inflammatory bowel disease susceptibility loci Susceptibility 
loci which have been identified in genome wide scans. Linkage 
Significance  Confirmed and replicated Other. Adapted from 
(Limbergen et al., 2007) 
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prominent role in CD than UC (Hibi & Ogata, 2006). This has been demonstrated 
through epidemiological studies among affected twins, with a pooled concordance of 
58% for CD and 18% for UC in monozygotic twins compared to 0% and 4% for CD 
and UC respectively in dizygotic twins (Orholm et al., 2000). However, other studies 
have reported slightly different levels of concordance (Thompson et al., 1996). 
Despite this variation UC and CD are both polygenic diseases and genomic wide 
scans have revealed susceptibility regions on several chromosomes (see Fig 1.5). In a 
few cases the gene or genes underlying the different chromosome loci, linked to 
IBD, have been identified. The first such gene to be identified was nucleotide-
binding oligomerisation protein 2 (NOD2), a region on chromosome 16 associated 
with CD (Hugot et al., 1996). Currently, the key candidate genes with which 
susceptibility to IBD is associated are NOD2, the human leukocyte antigen (HLA) 
region, multidrug resistance 1 (MDR-1), IL-23 receptor and autophagy-related 16-
like 1 (ATG16L1), although there are many more putative IBD genes (Limbergen et 
al., 2007). However, these genes still play a minor role in the pathogenesis of the 
disease. Based on the known epidemiology of IBD for every affected patient, 
carrying a single identified polymorphism, approximately 500 individuals with the 
same polymorphism are completely healthy (Marks & Segal, 2008). This clearly 
demonstrates other factors must play a role in the development of IBD. 
 
1.3.2 The role of environmental triggers in inflammatory bowel disease 
The commensal bacterial flora of the gut is the environmental factor most frequently 
implicated in the development of IBD. One hypothesis on the aetiology of IBD is 
that these diseases represent an aberrant, exaggerated immune response by the 
mucosal immune system to the normal constituents of the mucosal microflora 
(Bouma & Strober, 2003; Nieuwenhuis & Blumberg, 2006). In this situation the 
normal symbiotic relationship between commensal gut bacteria and the host is 
disrupted and exposure to luminal microflora triggers an inflammatory response. 
Research in animal models suggests that genetic alterations can result in varied 
responses to the same bacteria e.g. exposure to Bacteriodes vulgatus in IL-10 
deficient mice results in minimal inflammation, whereas, the same bacteria causes 
severe inflammation in another model of IBD (HLA-B27 transgenic rats) (Rath et 
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al., 1996; Sellon et al., 1998). Moreover, some bacteria are more capable of inducing 
gastrointestinal inflammation than others (Rath et al., 2001). Similarly, in humans, it 
is thought that different bacteria may be responsible for the inflammatory effects 
seen in different patients, and it is believed unlikely that colitis development is 
attributable to a single member of the flora. 
 
Despite the inability to identify (a) specific micro-organism(s) there is substantial 
evidence for their role in IBD. A lot of this evidence comes from mouse models 
where experimental colitis is less severe or does not develop when the animals are 
raised in a specific pathogen free (SPF) or a germ free environment respectively 
(Kuhn et al., 1993; Rath et al., 1996; Sellon et al., 1998). Other studies in humans 
have demonstrated that the elimination of gut bacteria, using antibiotics or by 
diverting the fecal stream, is capable of controlling colonic inflammation in specific 
subgroups of patients with active IBD (Winslet et al., 1994) and antibiotics 
attenuates colitis in IL-10 deficient mice (Winslet et al., 1994; Zhang et al., 2005). 
Therefore, when taken together, these experiments clearly highlight the importance 
of the gut microflora in IBD. 
 
There are several other putative environmental risk factors for IBD including sugar 
rich foods and excessive sanitation (Baumgart & Carding, 2007; Hanauer, 2006). 
These risk factors are, in part, supported by epidemiological studies that demonstrate 
a higher incidence of IBD in industrialised countries and a dramatic increase during 
the last century (Hanauer, 2006; Loftus, 2004; Lopez-Serrano et al., 2010). However, 
no clear conclusions have been made as to the role of nutrition, diet and sanitation in 
IBD. Another risk factor is smoking, which has been demonstrated to have 
deleterious effects in CD development but a protective effect in UC, although the 
mechanism for this is unclear (Nightingale, 2007). 
 
1.3.3. The role of immune dysregulation in inflammatory bowel disease 
Despite differences in the underlying genetic and environmental aetiology of IBD, an 
excessive immune response is seen in the gut wall. The traditional view is that IBD is 
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mediated by the adaptive immune system, however, there is increasing evidence 
suggesting that the innate immune system may play an important role. 
 
1.3.3.1 Alterations in the intestinal epithelial barrier in inflammatory bowel 
disease 
The first line of defence in the intestine is the epithelial barrier. Made up of gut 
epithelial cells, mucus producing goblet cells and defensin producing paneth cells, 
the epithelial barrier serves a vital function in the defensive system of gastrointestinal 
mucosal system. This cell layer acts as an immunologically inert barrier to the large 
amount of commensal bacteria found in the external environment, but is also 
required to mount innate and adaptive responses to invading pathogens (Sansonetti, 
2004). In IBD, particularly CD, the epithelial barrier has been demonstrated to be 
leaky with increased permeability of the intestinal epithelium to specific molecular 
probes (Irvine & Marshall, 2000). Permeability fluctuates with disease severity (Miki 
et al., 1998) and an increase in intestinal permeability is able to predict a relapse 
(Hilsden et al., 1999), indicating the importance of epithelial integrity. Nevertheless, 
it remains unclear whether this process is a consequence of mucosal inflammation or 
is an early step in the pathogenesis of CD. Observations of elevated gut permeability 
among unaffected first degree relatives of patients with CD and increased epithelial 
permeability preceding diagnosis of CD suggests that a permeability defect may 
initiate the damage in IBD (Irvine & Marshall, 2000). It has been postulated this is 
mediated through alterations in epithelial tight junctions (Soderholm et al., 2002). 
However, the increased permeability may also be, in part, a result of mucin 
abnormalities evident in both CD and UC patients (Buisine et al., 2001; Smithson et 
al., 1997). These patients appear to have enhanced mucin degradation and therefore 
increased exposure of the epithelium to microorganisms and their products.  
 
As well as acting as a physical barrier, gut epithelial cells are able to recognise 
intestinal bacteria through toll like receptors (TLR) and alterations in TLR 
expression has been associated with IBD (Cario & Podolsky, 2000). TLRs in healthy 
patients play an important role in the innate immune system defence and 
homeostasis, and are involved in the protection of barrier integrity and elimination of 
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invading micro-organisms. However in IBD, TLRs may induce inappropriate 
signalling pathways resulting in an aggressive immune response with subsequent 
tissue injury and inflammation (Cario, 2007). Indeed, a strong up-regulation of TLR4 
and TLR2 (Veres et al., 2007) and a down-regulation of TLR3 expression has been  
demonstrated amongst CD patients. It is unclear whether these alterations are a cause 
or a consequence of the inflammation seen in the IBD gut (Cario & Podolsky, 2000). 
However, the recent observation by Veres and colleagues, that a similar TLR 
expression is seen in the non-inflamed mucosa of children with IBD suggests TLRs 
do not play a primary role in the development of IBD (Veres et al., 2007). 
 
1.3.3.2. Alterations in the cytokine milieu in inflammatory bowel disease 
Activated gut epithelial cells are capable of producing pro-inflammatory cytokines 
which provide chemotactic signals and are able to induce cell adhesion molecule 
expression, aiding the accumulation of leukocytes into the inflamed tissue (Gulubova 
et al., 2007). In IBD, increased levels of endothelial E-selectin (Bhatti et al., 1998), 
P-selectin (Schurmann et al., 1995), mucosal addressin cell adhesion molecule-1 
(MAdCAM-1) (Arihiro et al., 2002), intercellular cell adhesion molecule-1 (ICAM-
1) and vascular cell adhesion molecule-1 (V-CAM1) (Gulubova et al., 2007) have 
been reported together with increased numbers of lymphocyte function-associated 
antigen-1 (LFA-1), Mac-1 and very late antigen-4 (VLA-4) positive leukocytes in the 
inflamed tissue (Gulubova et al., 2007). These changes play an important role in the 
pathogenesis of the disease with a significant correlation between the number of 
LFA-1, Mac-1, VLA-4 and ICAM-1 positive inflammatory cells and the disease 
activity of UC patients (Gulubova et al., 2007). Moreover, neutralisation of 
MAdCAM-1 or its ligand α4β7 integrin has been demonstrated to significantly 
reduce the severity of colonic inflammation in a CD45RBhi transfer model of colitis 
(Picarella et al., 1997; Sydora et al., 2002). However, β7 integrin deficiency in IL-2 
deficient mice (Sydora et al., 2002) and IL-10 deficient mice (W. Müller, personal 
communication) does not alter the development and course of the spontaneous colitis 
seen in these mice. These discrepancies may be a result of the initial differences in 
the number of pathogenic T cells in the colon (Sydora et al., 2002). In the IL-2/ β7-
integrin double deficient mice the local expansion of T cells appears to play a more 
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important role in the development of colitis than influx of T cells, whereas the 
converse is true for the CD45RBhi transfer model of colitis.  
 
Nevertheless, the influx of leukocytes, mostly CD4+ T lymphocytes, into the 
inflamed tissue (Peluso et al., 2006) is believed to be an important step in the 
pathogenesis of IBD, despite the presence of some models of colitis which can occur 
in the absence of T cells e.g. in RAG knock-out mice. In both murine models of 
colitis and in human IBD the blockade of CD4+ T cell activation or activity is able to 
limit inflammation (Fantini et al., 2007). However, the nature of the infiltrating 
leukocytes is different in CD and UC. CD is characterised by a prototypic Th1 
response, associated with an increase in secretion of IL-12 and IFNγ by isolated 
mucosal T cells (Parronchi et al., 1997).  Conversely, UC is often viewed as a Th2 
condition with IL-5 playing a prominent role (Fuss et al., 1996). However, a clear 
association with IL-4, the prototypic Th2 cytokine, has not been established (Fuss et 
al., 1996).  
 
1.3.3.3. The role of IL-23 in driving inflammatory bowel disease 
IL-23 has been shown to play a key role in intestinal inflammation see in both innate 
and T cell mediated chronic colitis in mouse models (Hue et al., 2006; Kullberg et 
al., 2006; Uhlig et al., 2006; Yen et al., 2006) and in human diesease (Duerr et al., 
2006). 
 
Mouse models have revealed that IL-23 plays a key role in driving intestinal 
inflammation mediated by both innate immune cells and T cells (Izcue et al., 2008). 
Studies have demonstrated IL-23 depletion, using monoclonal antibodies specific for 
the p19 subunit of the IL-23 receptor, or by genetic deletion attenuates colitis in T 
cell transfer models (Hue et al., 2006; Kullberg et al., 2006). Depletion also inhibits 
the spontaneous colitis development normally seen in IL-10 deficient mice (Yen et 
al., 2006). As well as its role in the adaptive immune system, IL-23 appears to be 
important in innate mechanisms of intestinal inflammation. This was demonstrated 
with recombination activating gene (RAG) knock-out mice where IL-23 is required 
for development of colitis following infection with Helicobactuer hepaticus (Hue et 
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al., 2006). In various IBD models it has been established that high levels of IL-23 
expression are seen in the inflamed intestine but not in systemic sites and 
accordingly, systemic immune pathology is not altered by IL-23 depletion (Hue et 
al., 2006; Uhlig et al., 2006). The importance of IL-23 in mouse models of IBD is 
reflected in human IBD patients. This has been demonstrated through genome-wide 
association studies of CD patients and healthy controls (Maloy, 2008). These studies 
have uncovered several polymorphisms in the IL-23R gene locus, which are 
associated with either susceptibility or resistance to CD (Consortium, 2007; Duerr et 
al., 2006). 
 
Recently it has been demonstrated that IL-23 orchestrates intestinal inflammation 
through a direct effect on T cells. Using IL-23R-deficient CD4+ T cells it has been 
demonstrated that IL-23 signalling in T cells is crucial for T cell proliferation and 
accumulation in the colon (Ahern et al., 2010). IL-23 is also known to be important 
in the expansion and maintenance a novel subset of CD4+ inflammatory T cells 
known as Th17 cells (Elson et al., 2007; Hue et al., 2006; Maloy, 2008). It is 
becoming clear that this recently identified T cell subset is responsible for many of 
the inflammatory responses once attributed to Th1 cells (Kikly et al., 2006). IL-23 
also promotes the development IL-17A+IFN-γ+ double-producing CD4+ T cells and 
inhibits the induction of Foxp3+ Treg cells (iTregs) in the gut (Ahern et al., 2010; 
Izcue et al., 2008). These IL-17A+IFN-γ+ CD4+ T cells are seen in T cell-dependent 
colitis models (Hue et al., 2006; Kullberg et al., 2006), have been recovered from 
lesions of human CD patients and are thought to be highly pathogenic (Annunziato et 
al., 2007). This, in combination with the inhibition of iTreg induction, results in 
chronic inflammation as the iTreg cells normally help to balance the effects of 
pathogenic effector T cells during inflammation (Izcue et al., 2009).  
 
1.3.4 Mouse models of inflammatory bowel disease 
Mouse models of IBD have contributed to the recent progress in the understanding of 
mechanisms underlying CD and UC. The key characteristics desired for an optimal 
model include similar morphological alterations, inflammation, pathophysiology, 
course and response to treatment as human IBD.  It is also preferential for the model 
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to be on a well-defined genetic background and to have a well-characterised immune 
response (see review by (Jurjus et al., 2004)). Currently there are well over 50 mouse 
models used to study intestinal inflammation (Uhlig & Powrie, 2009) and the 
available models can be broadly divided into four categories: immune cell transfer, 
gene targeting, spontaneously occurring or chemically induced models (as defined by 
(Jurjus et al., 2004; Wirtz & Neurath, 2007)).  
 
The primary immune cell transfer model used to create an IBD-like pathology is the 
CD45RB transfer model. This model transfers CD4+CD45RBHi T cells isolated from 
the spleens of donor mice into severe combined immunodeficient (SCID) or RAG1/2 
knock-out mice. These immunodeficient mice subsequently develop a wasting 
syndrome associated with transmural intestinal inflammation (Morrissey et al., 
1993). 
 
The second category is gene targeted mice and an increasing number of these 
transgenic mice are being developed as IBD models, reflecting the heterogeneous 
nature of human IBD. These mice can be divided into three further categories 
according to the primary cause of disease onset: defect in epithelial integrity e.g. 
keratin 8 deficient mice and IKKγ mice; defects in innate immune cells e.g. STAT3 
deficient mice, A20 deficient mice; or a defect in the adaptive immune response e.g. 
IL-10 deficient mice, TCRα deficient mice (Wirtz & Neurath, 2007). The IL-10 
deficient mice have been extensively studied since initially described by Kuhn and 
colleagues (Kuhn et al., 1993). As the colitis phenotype in the IL-10 deficient mice 
varies with the genetic background of the mice, quantitative trait loci studies of F2 
generations have been performed. This has allowed the identification of colitis-
modifying genes and has aiding in elucidating the complex genetics underlying 
susceptibility to IBD (Farmer et al., 2001). 
 
The third category is mice species which spontaneously develop an IBD-like disease 
without any exogenous manipulation e.g. C3H/HejBir mice (Sundberg et al., 1994). 
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The final catergory are the inducible colitis models. These are some of the most 
commonly used animal models for IBD as the procedures are straightforward and 
onset of inflammation is uniform and immediate. These models include acetic acid-
induced, iodoacetamide-induced, indomethacin-induced, 2,4,6-trinitrobenzene 
sulphonic acid (TNBS)-induced, oxazolone-induced and dextran sodium sulphate 
(DSS)-induced colitis.  
 
1.3.4.1 Dextran sodium sulphate-induced colitis 
Colitis induced by the oral administration of DSS in mice was first described in 1990 
by Okayasu and colleagues (Okayasu et al., 1990). It is now established as a 
reproducible model of acute and chronic colitis with morphological changes 
corresponding well to the clinical signs of human ulcerative colitis (Okayasu et al., 
1990). The acute colitis is characterised by bloody diarrhoea, colonic mucosal 
inflammation with ulcerations, body weight loss, shortening of the intestine and 
infiltration of neutrophils (Jurjus et al., 2004; Melgar et al., 2005). Chronic colitis 
develops several weeks after the cessation of 3-5 cycles of DSS administration and is 
characterised by the infiltration of chronic inflammatory cells into the mucosa and 
regenerative changes in the epithelium (Dieleman et al., 1998; Melgar et al., 2005). 
 
Interestingly, Dieleman and colleagues (Dieleman et al., 1994) demonstrated that 
SCID mice, without T and B cells, were able to develop acute DSS-induced colitis. 
This suggests that adaptive immunity is not essential in the acute phase of this model 
(Melgar et al., 2005) and the colitis is thought to be mediated by neutrophils and 
macrophages.  
  
The mechanism by which DSS induces colitis is unclear, however, several 
mechanisms have been proposed. These include a direct toxic effect on the 
epithelium, increased exposure to luminal antigens by destruction of mucin content 
or altered macrophage function due to ingestion of DSS (Kitajima et al., 1999; Ni et 
al., 1996; Okayasu et al., 1990). A toxic effect on the epithelium was first observed 
by Ni and colleagues, who demonstrated a concentration dependent toxicity of DSS 
on intestinal epithelial cells (Ni et al., 1996). This was supported by experiments 
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demonstrating that the earliest histological feature observed in DSS-induced colitis is 
the loss of crypt followed by a separation of the crypt base from the muscularis 
mucosa (Kitajima et al., 1999). This injury to the colonic epithelium would increase 
permeability of the intestine therefore, allowing the uptake of bacterial products into 
the submucosal tissue (Ito et al., 2006; Okayasu et al., 1990). It has also been shown 
that the DSS is phagocytosed by macrophages in the inflamed mucosa, mesenteric 
lymph node (MLN) and spleen during the chronic phase of DSS-induced colitis 
(Okayasu et al., 1990). This may increase susceptibility to luminal bacterial invasion 
during colitis by preventing the macrophages from ingesting the microbes (Ito et al., 
2006; Kitajima et al., 1999). 
 
Acute DSS induced colitis model is a useful model to study the contribution of the 
innate immune system to colitis development, whereas T cells may play an important 
role in the chronic and regenerative phases (Dieleman et al., 1998). DSS induced 
colitis has also been shown to be a relevant model for the translation of data from 
mice to humans. The therapeutic agents cyclosporine A (CsA), anti-IL-12p40 and 
anti-CD3 ameliorated the inflammatory response seen in DSS colitis in a similar 
manner to effects seen in human IBD patients (Melgar et al., 2008). In light of this 
data it has been suggested the DSS induced colitis model is a useful model for the 
validation of new therapies for the treatment of IBD. 
 
1.3.5 IFNγ  and murine models of colitis 
IFNγ receptor deficient mice have been tested in two models of colitis with differing 
results. In TNBS-induced colitis IFNγR deficient mice appeared pathologically 
similar to wild type mice (Camoglio et al., 2000; Tozawa et al., 2003). However, in a 
DSS-induced model of colitis IFNγR deficient mice and treatment of wild-type with 
anti-IFNγ antibodies attenuated colitis (Ito et al., 2006; Obermeier et al., 1999). This 
suggests IFNγ may play an important role in, at least, the DSS-induced model of 
colitis. 
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1.4 INTESTINAL NEMATODE INFECTION 
Gastrointestinal nematodes (also know as round worms) cause some of the most 
prevalent and chronic human diseases worldwide. Soil-transmitted helminth (STH) 
and shistosome infections account for more than 40% of the global burden of all 
tropical diseases excluding malaria (WHO, 1999). STH infections are caused by 
infection with intestinal nematodes, in particular, Ascaris lumbricoides, the 
whipworm Trichuris trichiura and the hookworms Ancylostoma duodenale and 
Necator americanus. It is estimated that 4.5 billion people are a risk of STH infection 
and that the global burden due to STH infection is between 4.5 and 39 million 
disability-adjusted life years (DALYs) (Keiser & Utzinger, 2008). 
 
There are currently four anthelminthics recommended by the World Health 
Organisation for the treatment of STH infections. However, efficacies against the 
different nematodes vary and there is concern that large-scale administration of 
anthelminthics might result in the development and spread of drug-resistant 
nematodes (Keiser & Utzinger, 2008). Moreover, even when anthelminthic drugs 
effectively clear the parasite patients are often re-infected from the environment. 
Therefore, the development of long-term immunological intervention strategies e.g. 
vaccines are being extensively researched, however, despite progress there is still no 
vaccine available against STH infections (for review see (Loukas et al., 2006)). 
 
1.4.1 Trichuris trichiura 
Trichuris trichiura (T. trichiura) is most common in warm, moist, tropical and 
subtropical countries, where over 90% of children can be infected in some areas 
(Stephenson et al., 2000). It is estimated 1050 million people are infected with T. 
trichiura and it causes morbidity in 220 million (Crompton, 1999). Heavy T. 
trichiura infection can cause Trichuris dysentery syndrome (TDS) resulting in 
chronic dysentery, rectal prolapse, anaemia, poor growth and clubbing of the fingers 
(Stephenson et al., 2000). T. trichuria infection has also been reported to have a 
detrimental impact on a child’s cognitive function (Nokes & Bundy, 1992) and can 
impair locomotor development (Callender et al., 1992). The consequences of these 
symptoms are decreased school attendance and ultimately life long reduced 
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productivity. Indeed, the world bank estimates that intestinal helminth infections 
account for 16.7 million DALYs lost and is the main cause of disease burden in 
children 5-14 years of age in developing economies (Montresor A, 2002; World 
Bank, 1993). 
 
The currently available anthelminthics have a particularly low efficacy when used 
for T. trichiura treatment. After treatment with a single dose of albendazole the risk 
of still being infected is only reduced 28% compared with approximately 90% for A. 
lumbricoides (Keiser & Utzinger, 2008). 
 
1.4.2 Trichuris muris 
The naturally occurring mouse counterpart, Trichuris muris (T. muris), is a powerful 
model for T. trichiura, and research in this area has provided a lot of information on 
the immune response to this parasite (Cliffe et al., 2005; Else et al., 1994; Helmby & 
Grencis, 2003; Liu et al., 2006). 
 
T. muris is transmitted by a faeco-oral route through the ingestion of infective eggs. 
These infective eggs are larvae in the L1 stage where they can remain infective for 
many months or years (deSchoolmeester & Else, 2002; Wakelin, 1969). Once 
ingested, the eggs hatch in the distal ileum, where the bacterial load and temperature 
provides the optimum conditions to trigger egg hatching (Hayes et al., 2010). After 
hatching, the larvae penetrate into the epithelium (Helmby & Grencis, 2003) forming 
syncytical tunnels within which the parasites resides throughout infection (Cliffe et 
al., 2005). The larvae moult through several stages at approximately days 9-11, 20-
21 and 28 post infection (p.i.), before becoming adult by day 35 p.i. (see Fig 1.6) 
(Panesar, 1989; Wakelin, 1969). Adult worms have their anterior end embedded 
within the epithelium and their posterior end free in the intestinal lumen, allowing 
copulation and release of eggs. The eggs are then released into the environment 
within the faeces and take approximately 2 months to embryonate, become infective 
and able to restart the sequence. 
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Fig 1.6 T. muris life cycle. L1 larvae remain infective for months and 
once ingested hatch in the large intestine. The larvae then moult 
through several sages at approximately day 10, 20 and 28 post 
infection (p.i.) before becoming adult at day 35 p.i. Adapted from 
(deSchoolmeester & Else, 2002) 
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T. muris, as observed in humans with variability in susceptibility to T. trichiura, 
causes chronic infections in some mouse strains and is expelled in others (Schopf et 
al., 2002).  
 
1.4.2.1 The role of T cells in T. muris infection 
The importance of T cells in resistance to T. muris infection was initially 
demonstrated in experiments where the transfer of a T cell enriched population from 
infected mice was able to transfer protection to recipient mice (Lee et al., 1983). This 
was then verified in experiments using nude mice where resistance to the parasite 
could be restored through lymphoid cell transfer (Ito, 1991). Further work identified 
the CD4+ T cell compartment as vital for the expulsion of T. muris (Else & Grencis, 
1996). Moreover, the CD4+ cells are important in the larval stages of the infection, as 
transferring cells into an established adult infection in SCID mice was unable to 
restore resistance. 
 
1.4.2.1.1 T helper cell subsets in T. muris infection 
The type of CD4+ T helper cell response, developed to T. muris, is critical to 
infection outcome (Else & deSchoolmeester, 2003; Else et al., 1994; Helmby & 
Grencis, 2003). A Th2 response, with high levels of IL-4, IL-5, IL-9, IL-13 and other 
Th2 cytokines is associated with host protection. In contrast, a Th1 response with the 
induction of IFNγ, IL-18 and IL-12 is associated with susceptibility to infection 
(Cliffe et al., 2005; Else & deSchoolmeester, 2003; Else et al., 1994; Liu et al., 
2006). Hence, resistant strains such as BALB/K, BALB/c and 129, which expel T. 
muris in larval stages between 14 and 21 days post infection, mount a Th2 response 
(Schopf et al., 2002). Conversely, susceptible strains such as AKR mice that are 
unable to expel the parasite and harbour chronic infections, mount an inappropriate 
Th1 response (Artis et al., 1999; Cliffe et al., 2005; Helmby & Grencis, 2003). 
 
T helper 1 subset 
Susceptibility to T. muris is not due to the inability to mount an immune response but 
rather the generation of an inappropriate immune response, with high levels of Th1 
cytokines. The role of type 1 cytokines in susceptibility has been clearly 
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demonstrated, as normally susceptible mice can clear an infection following 
depletion of IFNγ (Else et al., 1994) or IL-12 (Grencis, 2001), with an expansion of 
type 2 responses. Furthermore, the administration of recombinant IL-12 to normally 
resistant mice results in the generation of a type 1 response to T. muris and the 
development of a chronic infection (Bancroft et al., 1997). 
 
Another important cytokine involved in the promotion of a type 1 immune response 
is IL-18 (Okamura et al., 1995). IL-18 has been demonstrated to be important in T. 
muris infection with the appearance of IL-18 mRNA in the intestines of infected 
susceptible mice even before the appearance of IL-12 (Helmby et al., 2001). 
Moreover, IL-18 knock-out mice rapidly expelled their worm burdens (faster than 
IL-12 knock-out mice). However, surprisingly, the IFNγ response in IL-18 KO mice 
corresponds to the IFNγ response seen in wild type mice. Indeed, IL-18, instead of 
functioning as an IFNγ-inducer during T. muris infection, acts as a direct regulator of 
Th2 cytokines such as IL-13 and IL-4 (Helmby et al., 2001). 
 
Recently it has been demonstrated that IL-27, a cytokine with close structural and 
functional activity to IL-12, can also promote a Th1 response. During T. muris 
infection IL-27/WSX-1 interactions are increased in susceptible mice compared to 
resistant mice and WSX-1 deficient mice are resistant to T. muris. This resistance to 
infection is associated with a down-regulation of the type 1 immune response and an 
increased type 2 response (Bancroft et al., 2004). Furthermore, it has been 
demonstrated that IL-27 signalling involves the common IL-6 receptor subunit 
gp130. In IL-10 deficient mice, that are normally highly susceptible to T. muris, the 
conditional inactivation of gp130 on T cells results in rapid worm expulsion. This is 
associated with the up-regulation of regulatory T cells and the development of a 
strong Th2 polarised response, thought be dependent on IL-27 (Fasnacht et al., 
2009). 
 
During T. muris infection, in susceptible animals, IFNγ production is increased and 
this is essential for progression to chronic infection (Cliffe et al., 2005). Indeed, 
attenuated pathology is seen in SCID mice following anti- IFNγ treatment (Artis et 
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al., 1999). IFNγ is known to drive epithelial cell proliferation and induces CXCL10 
production, which, in turn, slows cell movement up the crypt. This promotes crypt 
cell hyperplasia and increases the epithelial niche that the parasite occupies (Artis et 
al., 1999; Cliffe et al., 2005; deSchoolmeester et al., 2006). 
 
The importance of IFNγ in driving susceptibility to T. muris is demonstrated by the 
kinetics of worm expulsion in IFN-γ KO and IFN-γ receptor KO mice. These mice 
display a very early production of type 2 cytokines following infection and more 
rapid worm expulsion than wild type control animals (unpublished observations in 
review by (Grencis, 2001)). 
 
T helper 2 subset 
The type 2 cytokines have been demonstrated to play an important role in the 
expulsion of T. muris. Studies have demonstrated that blockade of the IL-4 receptor, 
in normally resistant mice, results in the production of a type 1 immune response and 
development of a chronic infection. Conversely, the administration of IL-4 to a 
susceptible mouse, early in infection, expands the type 2 response and results in 
clearance of the infection (Else et al., 1994). This phenotype has been confirmed 
using IL-4 knock-out mice, which, dependant on the background strain and sex of 
mouse, don’t generate a type 2 response and are susceptible to infection (Bancroft et 
al., 2000). 
 
However, there is also an important, IL-4 independent, role of IL-13. This was 
identified in female IL-4 KO mice on a BALB/c background, which are still able to 
expel the parasite. However, neutralisation of IL-13 in these mice leads to the 
establishment of a chronic infection (Bancroft et al., 2000). It has since been 
demonstrated that IL-13 is important in enhancing the rate of epithelial cell turnover. 
This can mediate worm expulsion as elevating the rate of epithelial cell turnover is 
sufficient to displace parasites from the intestine (Cliffe et al., 2005). 
 
The precise mechanism through which the Th2 immune response is able to mediate 
the expulsion of T. muris is not fully understood, although the increase in the 
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epithelial escalator by IL-13 is thought to play a key role. It has been demonstrated 
that worm expulsion can occur even in the absence of classical Th2 effector 
mechanisms such as eosinophilia and mastocytosis (Betts & Else, 1999). Recently 
RELMβ, a highly specific Th2 cytokine, has been suggested to have an important 
role in worm expulsion with maximum expression correlating with host protective 
immunity. It is thought that this is mediated through RELMβ disrupting the ability of 
T. muris to sense their environment (Artis et al., 2004). However, RELMβ null mice 
are still able to expel T. muris, which again demonstrates the redundancy of the 
responses mounted against the parasites (Artis & Grencis, 2008). 
 
Regulatory T cells 
It has become clear over recent years that parasites also stimulate suppressive T-cell 
populations, termed regulatory T cells (Tregs). Tregs can produce IL-10 and TGFβ, 
switching off inflammatory immune responses and down regulating effector T cell 
activation. In T. muris it has been demonstrated that there is an association between 
the presence of Foxp3+ Tregs and the survival of the parasite (D'Elia et al., 2009). 
These Foxp3+ cells appear to be involved in the control of pathological immune 
responses as, deletion of these cells results in increased gut pathology following T. 
muris infection (D'Elia et al., 2009). 
 
The importance of IL-10 production during T. muris infection has been demonstrated 
with global IL-10 and IL-10R1 deficient mice. Both of these mutant mice have 
elevated worm burdens, generate a strong Th1 and Th17 response and display 
increased intestinal inflammation following T. muris infection (Pils et al., 2010b). 
This increased inflammatory response eventually results in death of the animals due 
to the breakdown of epithelial barrier function. It has been shown that it is T-cell 
derived IL-10 that has a vital role in infection outcome through the inhibition Th1 
immune responses following infection and the promotion Th2 development 
(Fasnacht, 2008). The important cells responding to IL-10 is not fully known as the T 
cell specific deletion of IL-10R1 displays similar expulsion kinetics to wild type 
mice. Moreover, although deletion of IL-10R1 in monocytes, macrophages and 
neutrophils leads to higher worm burdens at day 21 p.i., the mice are still resistant to 
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the parasite and expel before day 35 p.i.. Thus, IL-10 plays an important role in 
regulation of the Th1 immune response but neither T-cells nor 
monocytes/macrophages and neutrophils alone are the crucial targets of IL-10 (Pils 
et al., 2010b). 
 
1.4.2.2 The role of B cells in T. muris infection 
The role of B cells and antibodies in the expulsion of T. muris has been thoroughly 
investigated, however the data is somewhat contradictory. Initial experiments 
demonstrated that serum from previously infected mice can transfer some degree of 
immunity to recipient animals (Selby & Wakelin, 1973). Moreover, parasite specific 
IgA is capable of transferring immunity (Roach et al., 1991). Further experiments 
utilising µMT mice, which are deficient in functional B cells, have reinforced the 
role of B cells in protection against T. muris infection. These mice are highly 
susceptible to infection and the administration of T. muris specific IgG1 antibodies 
from resistant mice is sufficient to prevent worm establishment (Blackwell & Else, 
2001). However, there is a wealth contradictory data, which suggests that antibody 
production isn’t important in worm expulsion. Indeed, the transfer of a B cell 
enriched population from infected mice is insufficient to alter worm expulsion (Lee 
et al., 1983). Moreover, FcγR deficient mice, which are incapable of binding IgE or 
IgG and therefore can’t generate antibody dependent mediated cytotoxicity (ADCC), 
are resistant to infection and display similar expulsion kinetics to wild type mice 
(Betts & Else, 1999). Currently, the general consensus is, that while B cells and 
antibody responses aren’t vital for T. muris resistance they play an important role in 
the protection again secondary infections. It is worth noting that whilst laboratory 
infections look predominantly at primary infections naturally infected animals are 
like to be infected multiple times and therefore protection against secondary 
infections is extremely important. 
 
1.4.2.3 The role of macrophages in T. muris infection 
The vital role of macrophages in nematode infections has been demonstrated in other 
models of helminth infection. Experiments using clodronate-loaded liposomes to 
deplete macrophages in vivo has demonstrated a central role for macrophages during 
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N. brasiliensis (Zhao et al., 2008) and secondary H. polygyrus infections (Anthony et 
al., 2006). Parasite clearance in these models, like in T. muris, is dependent on the 
generation of a Th2 response and the depletion of macrophages prevents worm 
expulsion. 
 
In T. muris infection it has been demonstrated that large numbers of macrophages are 
found in the intestines of mice infected with T. muris (Little et al., 2005) and there is 
a larger accumulation of macrophages in the lamina propria of resistant mice than 
susceptible mice (deSchoolmeester et al., 2003). It has been proposed that 
macrophages may play an important role in the phagocytosis of dead or dying cells 
and foreign material during infection and the decreased numbers of macrophages in 
the intestine of susceptible mice may lead to a more chronic inflammatory response 
due to the decreased phagocytosis.  A second role proposed for macrophages during 
T. muris infection is the stimulation of antigen specific T cells in the draining lymph 
nodes of infected mice (deSchoolmeester et al., 2003). Recent data has demonstrated 
that macrophage depletion doesn’t alter parasite survival but has a profound 
influence of inflammation in the intestine with no inflammation observed in 
macrophage-depleted mice (M. Little, personal communication). 
 
1.4.2.4. The role of goblet cells in T. muris infection 
Goblet cells secrete mucus into the intestinal environment protecting the intestinal 
epithelium. A marked goblet cell hyperplasia is seen during T. muris infection 
regardless of susceptibility to the parasite but an increase in Muc2 expression in the 
caecum correlates with worm expulsion. Indeed, Muc2-deficient mice demonstrate a 
significant delay in worm expulsion despite unaltered adaptive immune responses 
(Hasnain et al., 2010). This demonstrates that the mucus barrier is an important 
component of the immune response in the gut to T. muris and appears to act 
independently of the adaptive immune system. 
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1.4.2.5 The importance of parasite burden and parasite-derived factors in T. 
muris infection 
An important factor in determining the susceptibility to T. muris is the level of 
infection. Mice which are normally resistant, and able to expel a high level infection, 
if subjected instead to a low level infection become susceptible and chronic 
infections are established (Wakelin, 1973). Furthermore, once a mouse has expelled 
the parasite it is resistant to subsequent challenges whether they are high or low level 
infection. Conversely, if you are susceptible to a primary infection, either through the 
administration of a high or low dose infection, you are primed for susceptibility on 
further challenges (Bancroft et al., 2001). 
 
As well as the level of infection the parasite genetics have an important role in the 
outcome of infection. There are currently 3 isolates of T. muris, which are used in the 
laboratory. The E isolate obtained from house mice in Edinburgh in 1954 (Wakelin, 
1967), the E-J or J isolate (a subculture of the E isolate maintained in Japan since 
1969, (Ito, 1991)) and the S isolate obtained from house mice in Sobreda, Portugal in 
1992 (Bellaby et al., 1995). These 3 isolates show different expulsion kinetics in 
mice with B10.BR mice harbouring chronic infections with the S strain and expelling 
the E-J isolate before the E isolate (Koyama & Ito, 1996). These differences in 
expulsion kinetics are thought to be due to the different immune responses provoked 
by the different isolates. The S isolate excretory/secretory (E/S) proteins have been 
demonstrated to induce higher levels of IL-12, IL-10 and IL-6 by antigen presenting 
cells than the E-J or E isolate E/S proteins (D'Elia & Else, 2009; Johnston et al., 
2005). Indeed, the E/S proteins of T. muris are being investigated and it has been 
demonstrated that these secreted proteins can interact with the host immune 
response. One protein that has been isolated from the T. muris E/S proteins is a 
43kDa T. muris-derived protein that shares epitopes with IFNγ. This protein has been 
demonstrated to be capable of binding IFNγ receptors on host cells and inducing 
cellular changes similar to those induced by IFNγ. This has been proposed to enable 
the parasite to drive the host immune response to mount an inappropriate Th1 
response and promote it’s own survival (Grencis & Entwistle, 1997).  
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Given the clear association between expulsion of the parasite and the generation of a 
Th2-skewed immune response, the T. muris model is a powerful model for 
investigation alterations in the host’s adaptive immune response. It has previously be 
demonstrated that IFNγ or IFNγR1 deficient mice demonstrate accelerated expulsion 
kinetics following the administration of a high dose T. muris infection (unpublished 
observations in review by (Grencis, 2001)). However, it remains to be determined if 
they are capable of expelling a low dose infection and which cells are the key in 
responding to IFNγ and altering susceptibility to T. muris infection. 
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1.5 MULTIPLE SCLEROSIS 
Multiple sclerosis (MS) is a devastating chronic neurological disease which affects 
approximately 2 million people worldwide (Zivadinov et al., 2003) including 
approximately 85,000 in the United Kingdom (Leary et al., 2005) and is the leading 
cause of disability in young adults. The disease also has a considerable social and 
economic impact, despite its relatively limited prevalence, due to its long duration 
and high incidence among young adults. It is estimated that the annual cost in the 
United Kingdom of MS is £1.34 billion, with costs per person increasing in 
proportion to the disability they suffer (Kobelt et al., 2000). Globally and in the 
United Kingdom there is a north-south discrepancy in prevalence rates, with 
prevalence in south-east Scotland over twice the rates seen in England and Wales, 
and female:male ratio of between 2.2 and 2.8 (Pugliatti et al., 2006)  
 
MS has been identified as an autoimmune inflammatory disorder in which T cells 
play a pivotal role. MS results in characteristic areas of demyelination within the 
central nervous system (Kerstetter et al.; Tyas et al., 2007). The accumulation of 
these MS lesions over time results in progressive neurological deficits such as pain, 
cognitive impairment, visual and sensory disturbances, limb weakness, gait 
problems, bladder and bowel symptoms and ultimately failure of axonal conduction 
and permanent disability in patients (Bjartmar & Trapp, 2003; Kerstetter et al.). 
 
The aetiology of the disease is unknown, but the key event in the development of MS 
is thought to be the breakdown of immune tolerance to central nervous system (CNS) 
self-antigens in genetically susceptible individuals (David et al., 2005; Frohman et 
al., 2006; Hafler et al., 2005; Zozulya & Wiendl, 2008). The importance of genetics 
has been demonstrated through the concordance of the occurrence of disease of 30% 
in monozygotic twins and 3% in siblings of patients with MS (Sadovnick et al., 
1996). These genetic studies have demonstrated the human leukocyte antigen (HLA) 
region as the only major gene locus associated with MS. HLA-DR1501 and HLA-
DQ0601 are both associated with 2-4 fold increased risk of developing MS (Olerup 
& Hillert, 1991).  
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1.5.1 Types of MS 
MS presents with a wide variety of symptoms, which can be broadly classified into 4 
groups according to their disease course (see Fig 1.7) 
(i) relapsing remitting MS (RRMS): the most common type of MS affecting 
85% of MS patients (Leary et al., 2005). RRMS presents with the acute 
onset of symptoms from which people recover partially or fully and then 
relapses occur at irregular intervals. When recovery from relapses is 
incomplete people can accumulate a neurological deficit and disability. 
(ii) Secondary progressive MS (SPMS): over time (normally approximately 
15 years) a large proportion of people with RRMS enter a secondary 
progressive stage with the gradual accumulation of irreversible 
neurological deficit and disability. During this phase they can continue to 
have relapses. 
(iii) Primary progressive MS (PPMS): characterised by a progressive disease 
from the onset with no relapses and accounts for 10-15% of MS patients 
(Leary et al., 2005). The average age of onset appears to be later than 
RRMS – approximately 40 years old with an more equal male:female 
ratio (Thompson et al., 1997) 
(iv) Progressive relapsing MS (PRMS): a progressive disease from the onset 
with superimposed relapses, although the progressive disease is 
predominant. Largely similar to PPMS with 10-15% of PPMS patients 
showing superimposed relapses 
1.5.2 MS therapy  
Although a lot of progress has been made in MS research, there are still no optimal 
therapies available to slow or halt disease progression (Hemmer et al., 2006). NICE 
guidelines recommend that acute relapses are treated with corticosteroids as there is 
evidence that it accelerates the recovery from a relapse, although the mechanism of 
action is unknown (Leary et al., 2005). Several immunoprophylactic therapies are 
available, however, their efficacy at modifying disease course is limited and they are 
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often accompanied by severe side effects (Pugliatti et al., 2006) 
1.5.3 Experiment autoimmune encephalomyelitis 
Experimental autoimmune encephalomyelitis (EAE) is an inflammatory disease of 
the CNS and is currently the most commonly used animal model for the study of MS 
(Peiris et al., 2007). This model causes clinical symptoms (spontaneous relapses and 
remissions) and histological manifestations, which closely parallel the human disease 
(Espejo et al., 2001; Kerstetter et al.; Swanborg, 1995).  
 
Active EAE is induced in susceptible animals through immunisation by the 
subcutaneous injection of an encephalitogenic peptide, normally myelin 
oligodendrocyte glycoprotein (MOG)35-55 or proteolipid protein (PLP)139-151 
emulsified in complete Freund’s adjuvant (CFA), followed by the intraperitoneal 
injection of pertussis toxin. The other widely used model of EAE is adoptive transfer 
EAE. Adoptive transfer EAE is induced through the adoptive transfer of activated 
myelin specific T cells into naïve animals (Goverman, 2009; Steinman & Zamvil, 
Fig 1.7 Types of multiple sclerosis. A. Relapsing remitting MS with acute 
onset of symptoms and recovery at irregular intervals B. Secondary 
progressive MS with a gradual accumulation of disability C. Primary 
progressive MS a progressive disease with no relapses D. Progressive 
relapsing MS a progressive disease with superimposed relapses. Adapted 
from (Lublin & Reingold, 1996) 
 
Chapter One: Introduction 
 
 - 63 - 
2006).  Different mouse strains and methods of immunisation can result in different 
disease courses, mimicking some of the different disease progressions seen in MS. 
For example, immunisation of SJL mice with MOG (with or without the pertussis 
adjuvant) induces a relapsing remitting EAE whereas MOG immunisation of A.SW 
mice induces a primary progressive disease course, if immunised without pertussis, 
or a secondary progressive disease course if pertussis is used (Tsunoda et al., 2000).  
 
1.5.3.1 Pathogenic CD4+ T cells in EAE 
The widespread demyelination seen in EAE is the result of a CD4+ T-cell-mediated 
immune response directed at the myelin sheath within the CNS. Upon activation, 
CD4+ T cells can differentiate into different effector cells, dependent on the priming 
immune synapse and cytokines present (Gutcher & Becher, 2007). For many years, 
IFNγ-secreting Th1 cells were believed to be the pathogenic population central to the 
autoimmune pathogenesis of EAE and MS (Steinman et al., 2002). Indeed, several 
observations supported these proposals including experiments demonstrating that 
cells invading the central nervous system (CNS) during EAE produced IFNγ and 
other Th1 cytokines (Renno et al., 1995). Moreover, EAE can be induced by the 
adoptive transfer of encephalitogenic Th1 cells (Gutcher & Becher, 2007; Pettinelli 
& McFarlin, 1981). Furthermore, the administration of IFNγ to MS patients 
exacerbates symptoms (Panitch et al., 1987) and levels of IFNγ produced in MS 
patients in response to PLP and MBP (putative MS autoantigens) correlates with 
worsening of disease symptoms (Moldovan et al., 2003). 
 
However, the role of IFNγ and other Th1 cytokines has been challenged by the 
observation that, contrary to expectations, the loss of the major Th1 cytokines, IFNγ, 
IL-12, and IL-18 does not protect against disease development (Becher et al., 2002; 
Gutcher et al., 2006; Willenborg et al., 1996). In fact, IFNγ and IL-12 deficiency 
leads to more severe inflammation in EAE (Becher et al., 2002; Ferber et al., 1996; 
Willenborg et al., 1996). Therefore, the notion that Th1 cells and Th1 associated 
cytokines are the instigators of autoimmunity has been re-examined (Haak et al., 
2009). 
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More recently, Th17 cells have been highlighted to have an increased 
encephalitogenic potential compared to Th1 cells (Langrish et al., 2005). This was 
demonstrated through IL-23 deficient mice that are completely resistant to EAE, and 
IL-23 is crucial for Th17 cell development (Cua et al., 2003). However, despite 
increased levels of IL-17 transcripts in chronic MS lesions (Lock et al., 2002) and 
the ability of transferred Th17 cells to induce EAE, IL-17a and IL-17f deficient mice 
remain susceptible to EAE (Haak et al., 2009). Indeed, even anti–IL-17A–treated Il-
17f–/– mice appear to be fully susceptible to EAE. This suggests that while Th17 cells 
are associated with an encephalitogenic state, neither IL-17A nor IL-17F appear to 
have a substantial pathogenic function in vivo (Haak et al., 2009). 
 
It is now apparent that both Th1 and Th17 cells can play a pathogenic role in EAE. 
Indeed, in has been demonstrated that Th1 cells can promote inflammation in the 
CNS, modifying the conditions to make it more attractive and accessible for Th17 
cells to infiltrate the EAE lesions (O'Connor et al., 2008). Adoptive transfer of Th1 
or Th17 polarised MOG-specific T cells are both capable of mediating similar 
clinical symptoms. However, they display a different composition and positioning of 
infiltrating leukocytes, as Th17 cells home preferentially to the brain resulting in 
atypical EAE and Th1 cells home preferentially to the spinal cord resulting in 
classical EAE symptoms (Kroenke et al., 2008; Stromnes et al., 2008). Moreover, 
Th1-mediated disease is characterised by an infiltration composed primarily of 
macrophages, whereas in Th17-mediated disease the infiltrate is primarily 
neutrophils (Kroenke et al., 2008). 
 
To add another layer of complexity to the role of these populations it has now been 
demonstrated that IFNγ+ IL-17+ dual producing cells are significantly increased in 
MS patients in acute relapse, but not during remission. Moreover, these double 
producers can preferentially cross the blood brain barrier (BBB) due to the 
synergistic effect of IFNγ up-regulating the expression of ICAM-1 on BBB-
endothelial cells and IL-17 disrupting the BBB (Kebir et al., 2009). 
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1.5.3.2. The role of IFNγ  in EAE 
The role of IFNγ in the pathogenesis of CNS inflammation has been extremely 
controversial. It’s function as a pro-inflammatory cytokine is clear in some cases, as 
treatment of MS with IFNγ leads to significant disease worsening (Panitch et al., 
1987). Furthermore, the direct injection of IFNγ into normal rat CNS produces 
inflammation (Sethna & Lampson, 1991; Simmons & Willenborg, 1990). However, 
i.v. injection of IFNγ can inhibits EAE in rats (Voorthuis et al., 1990) and 
administration of anti-IFNγ antibodies exacerbates EAE in mice (Billiau et al., 1988; 
Duong et al., 1994). 
 
These experiments have led to the hypothesis that IFNγ may have different CNS and 
peripheral actions. In particular it was proposed that peripheral circulating IFNγ may 
act to inhibit antigen triggered T cell proliferation but induces inflammation in 
tissues (Krakowski & Owens, 1996). This is supported by experiments which have 
demonstrated elevated T cell proliferation in IFNγ knock-out mice suggesting a 
reduced ability to down regulate T cell responses (Dalton et al., 1993). Furthermore, 
IFNγ has been shown to have several pro-inflammatory actions in the CNS including 
activation of resident microglia and infiltrating macrophage cells. As well as, the 
ability to induce MHC class II and co-stimulatory molecule expression in astrocytes 
(Nikcevich et al., 1997), which all culminate in increased tissue injury (Goverman, 
2009; Krakowski & Owens, 1996). Moreover, IFNγ expression in the mature CNS 
under the control of an oligodendrocyte-specific promoter resulted in the 
development of demyeliniation, gliosis and inflammation (Horwitz et al., 1997). 
 
However, more recent studies using the adoptive transfer EAE model have provided 
slightly contradictory results as, the transfer of encephalitogenic cells into WT mice 
results in spinal cord inflammation but the transfer of the same cells into IFNγR 
deficient mice led to inflammation specifically in the brain (Lees et al., 2008). The 
conclusion drawn from this data was that IFNγ activation in the spinal cord results in 
inflammation but IFNγR signalling in brain resident cells leads to an inhibition of 
inflammation (Lees et al., 2008).  
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Therefore, there are still a lot of discrepancies in the literature about the role of IFNγ 
and Th17 cells in EAE and MS that need further investigation. 
 
1.6 THE AIMS AND STRUCTURE OF THIS THESIS: FUNCTIONAL 
ANALYSIS OF THE ROLE OF IFNγ  IN DSS-INDUCED COLITIS, T. MURIS 
AND EAE 
 
The importance of IFNγ in many mouse models is well established, primarily 
through the use of IFNγ or IFNγR mutant mice. However, little is known about the 
specific cells, which are responsible for the pleiotropic effects of this cytokine. The 
generation of a conditional knockout IFNγR2 mouse will allow the dissection of the 
IFNγ network and clarification of the role of IFNγ in these in vivo models. 
 
The DSS-induced colitis system is a well-defined acute colitis model that has been 
shown to be IFNγ-dependent and driven by innate immunity. This will provide a 
good model to investigate the role of IFNγ in innate-cell driven intestinal 
inflammatory responses. In contrast, the T. muris model is known to rely on the 
adaptive immune system with the generation of a Th2-biased immune response vital 
for resistance to the parasite. This model will allow the investigation of IFNγ 
responding cells in adaptive intestinal immunity. Finally, the role of IFNγ in EAE 
has been widely investigated but with somewhat contradictory results, therefore this 
system is a good mechanism to finally dissect the role of IFNγ in EAE. 
 
My hypotheses are stated in the introduction of each chapter and the overall aims of 
my thesis are: 
1. To generate a global-, T cell- and macrophage-specific knockout of IFNγR2. 
The results of chapter 3 describe the breeding and genotyping performed to 
generate these mice and the in vitro functional confirmation of abrogation of 
IFNγ signalling. Finally, the phenotype of unchallenged complete IFNγR2 
deficient mice is assessed 
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2. To examine the role of IFNγ in the innate-driven model of DSS-induced 
colitis. The results of chapter 4 describe in vivo studies using the IFNγR2 
deficient mice subject to DSS-induced colitis. 
3. To investigate the role of IFNγ in T. muris infection and to dissect the cells 
responsible for the effects of IFNγ during infection. The results of chapter 5 
describe in vivo studies using the IFNγR2Δ/Δ, IFNγR2fl/fl, IFNγR2fl/flCD4Cre+, 
IFNγR2fl/flLysMCre+ and IFNγR2fl/flCD4Cre+LysMCre+ mice during low 
dose T. muris infection. 
4. To investigate the role of IFNγ during EAE and to try and elucidate the 
mechanisms behind the different EAE phenotypes seen in the IFNγR2-
deficient animals. The results in chapter 6 describe studies performed during 
time at a collaborators laboratory in Zurich examining the IFNγR2 knock-out 
mice in EAE. 
 
The results of this thesis demonstrate the successful characterisation of an IFNγR2 
global and conditional knock-out mouse mutant and the phenotype of these animals 
in several in vivo models. Some of the data obtained during this work contradicts 
existing published data. The novel discoveries and their implications will be analysed 
in the following chapters. 
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2.1 ANIMALS 
An overview of the mice strains and abbreviations used in this thesis is given in 
Table 2.1. All mice were imported from the Helmholtz Centre for Infection 
Research, Braunschweig, Germany. Imported mice were colonised with the Charles 
River altered Schaedler flora (CRASF®) which has been demonstrated to remain 
stable for years when mice are housed in individually ventilated cages (Stehr et al., 
2009). At the University of Manchester mice were kept in the Biological Services 
Unit in individually ventilated cages. The mice were sacrificed by schedule 1 
methods in accordance with the animals (scientific procedures) act 1986. All 
experiments were performed under Project Licence (4032/17) and all breeding under 
Project Licence (4031/67) granted by the Home Office (U.K.) and conducted in 
accordance with University of Manchester guidelines. 
 
For all EAE experiments mice were exported to the University of Zurich where mice 
were maintained in individually ventilated cages and treated according to 
institutional guidelines for animal care and use. Animal experiments undertaken at 
the University of Zurich were approved by the Swiss Veterinary Office. 
 
Sex-matched mice 6-9 weeks old were used for all experiments. 
 
Complete Designation Abbreviation Functional abberation Reference 
C57BL/6J B6 wildtype - 
C57BL/6J;129-Ifngr2tm1HZI IFNγR2fl/fl IFNγR2 flox unpublished 
C57BL/6J;129-Ifngr2tm2HZI IFNγR2Δ/Δ IFNγR2 knock-out unpublished 
C57BL/6J-Tg(CD4-cre)1Cwi/J CD4-Cre T cell Cre expression (Lee et al., 2001) 
C57BL/6JP2-Lzm-s2tm1(cre)Cgn LysM-Cre Macrophage/neutrophils 
Cre expression 
(Clausen et al., 1999) 
C57BL/6J-Tg(KRT14-cre)1Cgn K14-Cre Oocytes, keratinocytes 
Cre expression 
(Hafner et al., 2004) 
 
Table 2.1 Mouse strains used for breeding and experiments. All mice were imported from 
the Helmholtz Centre for Infection Research, Braunschweig, Germany and maintained at the 
University of Manchester in accordance with the animals (scientific procedures) act of 1986. 
Chapter Two: Materials and Methods 
 
 - 70 - 
2.1.1 Genotyping 
 
2.1.1.1. Isolation of genomic DNA 
A portion of a mouse tail or mouse ear punches were digested at 54°C overnight in 
200µl tail-lysis buffer (appendix A) and 2µl proteinase K (Promega, 10mg/ml). Cell 
debris and fur were separated by centrifugation at 12,000g for 10min. The 
supernatant was transferred into a new tube and stored at 4°C.  
 
2.1.1.2. Genotyping using PCR 
To genotype IFNγR2 mice and the different Cre mouse strains the following PCR 
protocols were applied. The genotype was confirmed by a duplicate PCR from a 
second genomic DNA isolate, performed post-autopsy, for all mice that were used 
experimentally. Primers were ordered from Eurofins-MWG Operon (0.01µmol scale 
HPSF purification) and made up to a concentration of 10pmol/µl. All primers are 
represented in the 5’ to 3’ orientation. Subsequent to PCR, the products were 
subjected to gel electrophoresis on ethidium bromide (Sigma-Aldrich) or SafeView 
(NBS Biologicals) stained 2% agarose gels (Lonza). 
 
Mastermix A: Bio-X-Act short acting DNA polymerase: 
2.5µl  10xPCR Buffer, 15mM MgCl2 (Bioline)  
0.5µl  10mM dNTPs (Bioline) 
1.0µl  50mM MgCl2 (Bioline) 
1.0µl  Primer A, 10pmol/µl 
1.0µl  Primer B, 10pmol/µl  
0.25µl  Bio-X-Act Polymerase (Bioline) 
17.75µl  Nuclease free water (Ambion)   
1µl  template DNA  
 
PCR-Programme A: 
 1. 95°C   5min  
 2. 95°C   60sec  
 3. annealing temperature 60sec  
 4. 68°C   40sec  
           5. go to 2:   34x 
 6. 68°C   5min  
 7. 4°C             for ever 
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Mastermix B: AmpliTaq Gold polymerase 
2.5µl 10xPCR Buffer, 15mM MgCl2 (Applied Biosystems) 
0.5µl 10mM dNTPs (Bioline) 
0.5µl 50mM MgCl2 (Applied Biosystems) 
0.5µl Primer A, 10pmol/µl 
0.5µl Primer B, 10pmol/µl  
0.5µl AmpliTaq Gold Polymerase (Applied Biosystems) 
19µl  Nuclease free water (Ambion) 
1µl template DNA  
    
PCR-Programme B: 
 1. 94°C   1min  
 2. 94°C   30sec  
 3. annealing temperature 30sec  
 4. 72°C   30sec  
           5. go to 2:   34x 
 6. 72°C   5min  
 7. 4°C             for ever 
 
Detection of the IFNγR2 flox allele 
To differentiate between IFNγR2fl/fl, IFNγR2fl/wt and IFNγR2wt/wt mice a PCR 
was performed using the Bio-X-Act polymerase (mastermix A) and the following 3-
primer approach 
  
Primers:  LoxP1  5’ – TGA GTT CCA AGC AAG ACA GA – 3’ 
  LoxPsite 5’ – AAG TTA TGG TCT GAG CTC GC – 3’ 
  LoxP2  5’ – CAG GGT AGA AAA GAT GTG CA – 3’ 
 
Product:  IFNγR2 flox allele: 392bp and 191 bp 
  IFNγR2 WT allele: 358 bp 
 
All other PCRs were performed using a standard 2-primer approach as detailed 
below: 
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Gene Primers Polymerase Product 
size  
Annealing 
temperature 
Neomycin 
resistance 
cassette 
neo-1 5`- CTG TCC GGT GCC CTG AAT GA-3` 
neo-2 5`- TGG TCG AAT GGG CAG GTA GC -3` 
Amplitaq 
gold 
248bp 61.8°C 
IFNγR2 
Delta 
allele 
delta-1 5`- TGA GTT CCA AGC AAG ACA GAG 
CC -3` 
delta-2 5`- GTA GAA TGC GGC CGC GTT TA -
3` 
Amplitaq 
gold 
278bp 55°C 
IFNγR2 
wild-type 
allele 
wt-1 5’- CCC ATC TGT CCC TCT GCT TGT -3’ 
wt-2 5’- AGA GCC CAT GTG GTC GGA TT -3’ 
Amplitaq 
gold 
198bp 52°C 
Non 
specific 
Cre 
cretot-1 5`- CTG TCC GGT GCC CTG AAT GA -
3` 
cretot-2 5`- CTC GAC CAG TTT AGT TAC CC-
3` 
Amplitaq 
gold 
350bp 60°C 
CD4 
specific 
Cre 
cd4cre-1 5`-ACC AAC AAG AGC TCA AGG 
AGA CCA-3` 
cd4ccre-2 5`-GAT GAG TTG CTT CAA AAA 
TCC CTT CCA-3` 
Bio-X-Act 900bp 60°C 
LysM 
specific 
Cre 
lysM-1 5`-GTA TGC TTA TTC TTG GGC TGC 
CAG A-3` 
lysM-2 5`-CCC AGA AAT GCC AGA TTA CG-3` 
Bio-X-Act 800bp 60°C 
 
2.2 EXPERIMENTAL MODELS 
 
2.2.1. Infection with Trichuris muris 
Infections with T. muris were carried out at the University of Manchester. 20-25 
viable E isolate T. muris eggs (provided by Prof. Else, University of Manchester) 
were counted into a volume of 200µl and give to mice by oral gavage using a metal 
20 gauge needle. At specified days post infection (p.i.) the mice were sacrificed by 
carbon dioxide (CO2) asphyxiation. At autopsy serum was harvested, mesenteric 
lymph nodes excised, a snip of the proximal colon removed and fixed in paraffin, 
and the remaining caecum and colon frozen for worm counts. 
 
2.2.2. Induction of colitis using DSS 
Induction of DSS-colitis was carried out at the University of Manchester. A solution 
Table 2.2 Paired primers used in genotyping PCRs. Product lengths given in base pairs. All 
primers were purchased from MWG. IFNγR and neo PCRs were designed using Vector NTi 
software. Cre primer sequences were provided by previous members of W. Müller’s lab 
(Braunschweig, Germany) or by A. Roers (Dresden, Germany). 
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containing DSS (MP Biomedicals, MW: 36,000-50,000) in sterilized water was used 
to induce colitis in mice. Drinking water containing the specified percentage of DSS 
was given for 7 days (unless specified) ad libitum. The DSS treatment period was 
followed by 3 days of normal drinking water. During the entire period, bodyweight 
and clinical symptoms for each mouse were assessed daily. If any mouse lost more 
than 20% body weight, compared to untreated mice, they were euthanised. At day 
10, mice were sacrificed by CO2 asphyxiation. Serum was harvested, the entire 
colon was excised, measured and rolled up in a “Swiss roll” for histology. The ‘swiss 
roll’ was an adaptation of the method described by Moolenbeek and Ruitenberg. In 
contrast to the small intestine they describe, we did not divide the colon into sections 
and rolled up the entire length of the colon without opening it longitudinally and 
cleaning (Moolenbeek & Ruitenberg, 1981). 
 
2.2.2.1. Clinical scoring for colitis 
Clinical scoring was used to monitor the health of DSS-treated mice for animal 
welfare reasons. The following symptoms were assessed: diarrhoea, occult blood in 
the faeces and behaviour. Diarrhoea was graded from 1 to 3 for mild, moderate and 
severe. Low amounts of blood visible in faeces resulted in a grade of 1, moderate 
amounts were graded as 2 and if blood was visible around the anus the resulting 
score was 3. The behaviour of the animal was graded as 1 if piloerection was visible. 
Mild apathy and a hunchback position resulted in a behaviour score of 2. Moderate 
to severe apathy was graded as 3. Macroscopically visible inflammation of the 
intestine was graded upon autopsy. A grade of 1 was assigned if faeces were not well 
formed, 2 if swelling was present or 3 if swelling and hyperaemia were present. 
 
2.2.3. Induction of EAE 
The induction of EAE was performed at the University of Zurich. Mice were 
immunised subcutaneously with 200 g of MOG (35–55) 
(MEVGWYRSPFSRVVHLYRNGK, GenScript) emulsified in complete Freund’s 
adjuvant (CFA, Difco). Mice received 200ng pertussis toxin (Sigma-Aldrich) intra-
peritoneally at the time of immunisation and 48 hours later. During the entire period 
clinical symptoms for each mouse were assessed daily (see Table 2.3). Any mouse 
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scoring 3 or more for 7 days, 3.5 or more for 3 days or a score of 4 was euthanised. 
Additionally, once a score of 1.5 was achieved food and drink was provided inside 
the cage. At day 21-25 post immunisation, mice were sacrificed by CO2 
asphyxiation. Mice were perfused with PBS through the heart before the brain and 
spinal cord were excised. 
 
2.2.3.1. Clinical scoring for EAE 
Classical EAE scoring system 
 
Score Clinical symptoms Assessment 
0 No detectable signs of EAE  
0.5 Distal limp tail  
1.0 Complete limp tail  
1.5 Limp tail and hind limb weakness One leg occasionally falls through the grid 
2.0 Unilateral partial hind limb paralysis One leg consistently falls through the grid 
2.5 Bilateral partial hind limb paralysis Cage grid test bilaterally positive 
3.0 Complete bilateral hind limb paralysis  
3.5 Complete bilateral hind limb paralysis and partial forelimb paralysis  
4.0 Moribund (mouse completely paralyzed)  
5.0 Dead  
 
Mice displaying atypical EAE were scored according to the following system. A 
score of 0.5 was assigned when, upon suspension by the tail, an asymmetrical 
rotation of the body was observed. A score of 1.0 was given when a clear tilting of 
the head was observed when mice were placed onto a flat surface, this increased to a 
score of 2.0 when the head and body were both tilted. Finally, a score of 3.0 was 
assigned when the mice displayed evidence of vertigo and were incapable of walking 
in a straight line. 
 
Table 2.3 Clinical Scoring system used to assess the severity of EAE. Mice were 
assessed daily for the development of clinical symptoms of EAE.  
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2.2.4. Serum analysis 
Blood samples were harvested directly from the heart upon necropsy. The blood was 
left for a minimum of 1 hour at 37°C to clot and serum isolated by centrifugation at 
5,000xg for 8min twice. The serum was then isolated and stored at -80°C.  
 
2.3 HISTOLOGY 
Caecum sections and/or colon sections, whole colon or brain and spinal cord were 
removed and fixed with 4% formalin or, if specified, adapted neutral buffered 
formalin (NBF) fixative (see Appendix A) for 24-48 hrs. Fixed tissues were 
dehydrated through a graded series of ethanol, cleared in xylol and infiltrated with 
paraffin in a dehydration automat (Citadel 2000, Shandon) using a standard protocol. 
Specimens were embedded in paraffin (Histocentre2, Shandon), sectioned on a 
microtome (5µm sections) and allowed to dry for a minimum of 4 hours at 37°C. 
Prior to staining slides were deparaffinised with citroclear and rehydrated through 
alcohol (100% to 50%) to PBS or water. 
 
2.3.1. Hematoxylin-eosin (H&E) staining 
H&E staining was performed by placing slides in harris hematoxylin (Sigma-
Aldrich) for 3min. After washing in tap water and differentiation in acidified alcohol 
(1% HCl (Sigma-Aldrich) in 70% ethanol) for 10 secs, sections were counterstained 
with eosin (Merck) for 4min. The sections were washed in tap water and dehydrated 
in ethanol, followed by citroclear and mounted using Depex mountant (BDH 
Laboratory Supplies). 
 
2.3.1.1. Histological score – longitudinal colon 
Histological scoring was used to evaluate the severity of colitis in DSS-treated mice 
microscopically using H&E stained sections. The method was adapted in the lab of 
Werner Muller (HZI, Braunschweig) from the TJL-score, developed for scoring 
colitis in mice by The Jackson Laboratory (Bleich et al., 2004). The colon was 
divided into a proximal (oral), middle and distal (aboral) section, each of 
approximately the same size. The three sections were scored for the general criteria: 
severity, degree of ulceration, degree of oedema and percentage of area involved. 
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The grading was performed blinded to the genetic status of the animals. Grades 
applied for severity were 0 = no alterations, 1 = mild, 2 = moderate, 3 = severe 
alterations. Focally small or widely separated multi-focal areas of inflammation 
limited to the lamina propria were graded as mild lesions (1). Multi-focal or locally 
extensive areas of inflammation extending to the submucosa were graded as 
moderate lesions (2). If the inflammation extended to all layers of the intestinal wall 
or the entire intestinal epithelium was destroyed, lesions were graded as severe (3). 
Ulceration was graded as: 0 = no ulcer, 1 = 1-2 ulcers (involving up to a total of 20 
crypts), 2 = 1-4 ulcers (involving a total of 20-40 crypts) and 3 = any ulcers that 
exceed the previous. Oedema was graded as 1 if only mild epithelial or submucosal 
oedema (less than the muscular layer in thickness) was present. Mild epithelial 
oedema associated with mild submucosal oedema or more moderate submucosal 
oedema (1 to 2 times as thick as the muscular layer) was graded as 2. Every oedema 
more extensive than the previous was graded as 3. 
 
A 10% scale was used to estimate the area involved into the inflammatory process. 0 
= 0%, 1 = 30%, 2 = 40% -70%, 3 = > 70%. The scores were added up to a total of up 
to 12 per section and the scores of the three sections to a total of up to 36 per colon 
sample.  
 
2.3.1.2. Histological score – transverse colon 
Sections were scored from 0-3 for each of the following parameters – severity of 
inflammation, degree of ulceration, degree of oedema and percentage of area 
involved. Each parameter was defined as above (Section 2.3.1.1) 
 
2.3.1.3. Colon measurements 
The measurement of crypt depth was performed on digital photomicrographs of 
H&E stained sections taken at 100 × magnification. A minimum of 20 measurements 
of crypt depth were taken, from 3 sections evenly distributed across the specimen, 
using ImageJ software (http://rsb.info.nih.gov/ij). 
2.3.2. Goblet cell staining 
Mucins in goblet cells were stained with 1% alcian blue (Sigma-Aldrich) in 3% 
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acetic acid (Sigma-Aldrich, pH 2.5) for 5 mins. Sections were washed in distilled 
water and treated with 1% periodic acid, 5mins (Sigma-Aldrich). Following washes 
in distilled water, tap water (5mins) and a rinse in distilled water sections were 
treated with Schiff’s reagent (Vicker’s Laboratories) for 15mins. Slides were again 
washed in distilled water, tap water (5 mins) and rinsed in distilled water before 
counterstaining in Mayer's haematoxylin (Sigma-Aldrich). Slides were blued in tap 
water, dehydrated and mounted in depex mounting medium (BDH Laboratory 
Supplies). Goblet cells were stained blue (acid mucins), magenta (neutral mucins) or 
purple (acid / neutral mixed mucins) with grey/blue nuclei. For enumeration of 
goblet cell staining, the average number of cells from 20 crypts was taken from three 
different sections per mouse. 
2.3.3. Arginase 1 immunohistochemistry 
Endogenous peroxidase activity was blocked for 20 min with methanol containing 
0.005% hydrogen peroxide (Sigma-Aldrich) at 4°C. Sections were then washed in 
PBS, incubated in pepsin digest-allTM 3 (Zymed Laboratories) at 37°C for 10mins to 
unmask antigens, washed in PBS and endogenous avidin and biotin biding sites 
blocked using a commercial kit according to the manufacturer’s instructions (Vector 
Laboratories). The sections were incubated at room temperature for 1 h with mouse 
Ig blocking reagent from Vector mouse-on-mouse (M.O.M.) Basic Immunodetection 
kit according to the manufacturer’s instructions (Vector Laboratories). Sections were 
washed in PBS and incubated for 10 mins in M.O.M. diluent before incubation for 
30mins with anti mouse Arginase-1 (BD biosciences, 1:500). Sections were washed 
in PBS and incubated for 10mins in M.O.M. biotinylated anti-mouse IgG reagent. A 
Vectastain Elite avidin-biotin-peroxidase complex kit, followed by a 3,3'-
diaminobenzidine (DAB) chromagen kit, were then used according to the 
manufacturer’s instructions (Vector Laboratories). The sections were counterstained 
in Hematoxylin QS (Vector Laboratires), dehydrated and mounted. Slides were 
blinded and positive cells counted in a minimum of 20 crypts from 3 sections evenly 
distributed across the specimen. 
 
2.3.4. CD3, F4/80, CD45 and IBA-1 immunohistochemistry 
Endogenous peroxidase activity was blocked for 20 min with methanol containing 
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0.005% hydrogen peroxide at 4°C. Sections were then washed in PBS, incubated in 
pepsin digest-allTM 3 (Zymed Laboratories) at 37°C for 10mins to unmask antigens 
for CD3 and F4/80 staining or were boiled in citrate buffer (see Appendix A) for 2 
mins and left to cool for 10 mins in the case of CD45 and IBA-1 staining. Slides 
were then washed in PBS and endogenous avidin and biotin binding sites blocked 
using a commercial kit according to the manufacturer’s instructions (Vector 
Laboratories). The sections were incubated at room temperature for 1 h in 7% goat 
serum (Vecor Laboratories; for CD3 and IBA-1) or 7% rat serum (Sigma-Aldrich; 
for F4/80 and CD45), washed and incubated overnight at 4°C with primary antibody 
(CD45 (1:1400, AbD serotec), IBA-1 (1:1000, Wako), CD3 (1:100, DAKO), biotin-
F4/80 (1:25, AbD serotec)). Sections were washed and incubated with goat anti-rat 
(for CD45) or goat anti-rabbit (for CD3, IBA-1) secondary antibodies (Jackson 
ImmunoResearch) for 1 hour at room temperature (no secondary antibody was 
applied to the biotin-F4/80 antibody). A Vectastain Elite avidin-biotin-peroxidase 
complex kit, followed by a DAB chromagen kit, were then used according to the 
manufacturer’s instructions (Vector Laboratories). The sections were counterstained 
in Hematoxylin QS (Vector Laboratires), dehydrated and mounted. Slides were 
blinded and positive cells counted in a minimum of 20 crypts from 3 sections evenly 
distributed across the specimen. 
 
2.3.5. Scoring of microglial activation 
Microglial activation was scored on IBA-1 stained sections in ten x1000 fields of 
view based on a morphological criteria adapted from (Sanchez-Guajardo et al., 
2010). Four cellular profiles were defined as: Score 1: cells with no visible 
cytoplasm, a round dense nucleus and long thin processes with little branching – 
deemed ‘resting’ microglia. Score 2: cells with a visible thin cytoplasm surrounding 
a dense nucleus and long, mainly thin processes with many branches. Score 3: 
enlarged and irregular body with less defined nucleus and shorter processes of 
increased thickness with little branching. Score 4: large cell body, predominately 
occupied by the cell nucleus with only a few thick and short processes. 
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2.4 ISOLATION OF CELLS 
 
2.4.1 Isolation of cells from the spleen 
The spleen was excised from mice and placed in complete RPMI (see Appendix A). 
The spleen was then homogenized by passing through a 100µm cell strainer (BD 
Biosciences). After centrifugation at 250xg for 5mins, the cell pellet was incubated 
for 10min at room temperature with 3ml lysing buffer (BD Pharm Lyse™, BD 
Biosciences) for erythrolysis. The suspension was then washed and resuspended in 
complete RPMI. 
 
2.4.2 Isolation of cells from lymph nodes 
The lymph nodes were excised from mice and placed in complete RPMI. The lymph 
nodes were homogenized by passing through a 100µm cell strainer. After 
centrifugation at 250xg for 5 mins, the cell pellet was washed twice and resuspended 
in complete RPMI. 
 
2.4.3 Isolation of T cells 
To isolate T cells the pan T cell isolation kit (Miltenyi Biotec) was used. Cells were 
isolated from spleen and/or lymph nodes (see sections 2.4.1 and 2.4.2) and 
resuspended in 40µl MACS buffer (Appendix A) per 107 cells. 10µl of Biotin-
Antibody cocktail was added per 107 cells and incubated for 10 minutes at 4°C. 30µl 
MACS buffer and 20 µl of anti-biotin microbeads were added per 107 total cells and 
incubated for a further 15 minutes at 4°C. Cells were washed with MACS buffer and 
resuspended in 500 µl of MACS buffer per 108 cells. LS columns were prepared by 
rinsing with 3ml MACS buffer before adding the cells. The unlabelled T cell 
enriched effluent was collected and the column washed three times with 3ml of 
MACS buffer. The labelled non T-cells were then eluted by removing the column 
from the magnetic field and flushing out the cells using 5ml of MACS buffer.  The T 
cell purity was assessed before and after isolation by FACS analysis.  
 
2.4.4 Isolation of Peritoneal Lavage Cells 
Peritoneal lavage cells were isolated by injecting 5ml of complete RPMI into the 
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mouse peritoneal cavity, gently agitating the fluid and aspirating. This was 
performed twice. Cells were then centrifuged, at 250xg for 5mins, resuspended in red 
blood cell lysis buffer (BD Pharm Lyse™, BD Biosciences) for 5mins before 
washing, counting and plating out at 2 x106cells/ml. Cells were left for a minimum of 
2 hours to adhere before removing the supernatant (and non-adherent contaminating 
cells). Cells were and stimulated with IFNγ (eBioscience, 0 or 100ng/ml, 20mins) to 
analyse STAT1 phosphorylation or ± LPS (Sigma-Aldrich; 100ng/ml) ± IFNγ 
(eBioscience, 50ng/ml) ± IL-4 (Peprotech, 50ng/ml), for 24 hours at 37°C, 5% CO2 
to analyse macrophage activation. 
 
2.5 RE-STIMULATION OF MESENTERIC LYMPH NODE CELLS 
Mesenteric lymph nodes were isolated (see section 2.4.2), plated at 5x106 cells/ml 
and re-stimulated with 50 µg/ml parasite E/S antigen (provided by Prof. Else, 
University of Manchester) at 37°C, 5% CO2 for 48 hrs. Supernatants were harvested 
and stored at –20°C until use. 
 
2.6 RNA EXTRACTION AND RT-PCR 
Upon sacrifice mice colon sections were place in tubes containing 1ml of Trizol 
(Invitrogen) and immersed in liquid nitrogen before storing at -80°C. Tissue samples 
homogenised using a FastPrep homogeniser (MP biologicals) and cell debris pelleted 
by centrifuging at 8500xg for 10min at 4°C. The resulting tissue homogenate 
supernatant was added to 0.2ml chloroform (Sigma-Aldrich) and vigorously shaken 
for 15 seconds. Samples were left for 3mins at room temperature before centrifuging 
at 8500xg for 15mins at 4°C. The RNA containing aqueous phase was the 
precipitated using 0.5ml isopropanol (Sigma-Aldrich) and incubated at room 
temperature for 10mins. RNA was pelleted by centrifuging at 8500xg for 10mins at 
4°C. RNA pellets were washed in 75% ethanol (Sigma-Aldrich), air-dried, 
resuspended in 40µl RNAse/DNAse free water (Ambion) and stored at -80°C. The 
concentration of total RNA was measured by absorbance at 260 nm on a Nanodrop 
ND-1000 spectrophotometer (Labtech International). 1µg of total RNA was reverse 
transcribed using SuperScript 2 (Invitrogen) in a final volume of 40 µl according to 
the manufacturer's instructions and stored at −20° until used. 
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2.7 QUANTITATIVE PCR  
Quantitative PCR was performed using SYBR green (Quantace) on an OPTICON 
DNA engine with OPTICON monitor software version 2·03 (Real-Time systems; MJ 
Research). Amplification of mRNA encoding Hprt1, 18S or β-actin was performed 
to control for the starting amount of cDNA. Expression levels of genes of interest are 
shown as fold change over that seen in naïve animals after normalization to 
housekeeping gene levels using the ΔΔCt method. 
 
Primers used: 
 
Gene Sense Primer Anti sense primer Tm (°C) 
Hprt1 GTAATGATCAGTCAACGGGGGAC CCAGCAAGCTTGCAACCTTAACCA 60 
18S AGTCCCTGCCTTTGTACACA GATCCGAGGGCCTCACTAAC 60 
β-actin GTGGGCCGCTCTAGGCACCAA CTCTTTGATGTCACGCACGATTTC 60 
SOCS1 TCCGTTCGCACGCCGATTAC TCAAATCTGGAAGGGGAAGG 60 
Ifi205 ATATCCCAGGTCTCATCTTCGG TGTGATTTTTGGTTCTTAGCCG 60 
IP-10 GCTTGAAATCATCCCTGCGA GGCAATGATCTCAACACGTGG 60 
IFNγ AAGACTGTGATTGCGGGGTTG GAGCGAGTTATTTGTCATTCGGG 60 
iNOS CCCTTCCGAAGTTTCTGGCAGC GGCTGTCAGAGCCTCGTGGCTTTGG 60 
 
2.8 FLOW CYTOMETRY 
 
2.8.1 Nine Fluorescence Parameter Flow Cytometry 
As described by (Frischmann & Müller, 2006). Antibodies were titrated to determine 
the optimum concentration of use; importantly CD4 and CD8 (PE-Cy5) antibodies 
were titrated to ensure non-overlapping antibody intensity. After washing in FACS 
buffer (Appendix A) nucleated cells were incubated on ice for 30 min with the 
following directly coupled fluorochrome-labeled antibodies in FACS staining buffer 
(Appendix A): 
 
Table 2.4 Paired primers used in quantitative PCRs. All sequences are shown in 
the  5'–3' direction. All primers were purchased from Eurofins-MWG. 
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Antibody Clone Supplier Concentration 
CD4 PE-Cy5 GK1.5 eBioscience 2.5µg/ml 
CD8 PE-Cy5 53-6.7 BD Biosciences  0.64µg/ml 
CD19 APC 1B3 BD Biosciences  0.1µg/ml 
IgM PE eB121-15F9 eBioscience 0.1µg/ml 
IgD FITC 11-26c eBioscience 0.1µg/ml 
F4/80 PE CI:A3-1 Serotec 0.3µg/ml 
CD49b FITC DX5 BD Bioscience  0.5µg/ml 
Gr-1 PE RB6-8C5 eBioscience 0.1µg/ml 
Gr-1 FITC RB6-8C5 eBioscience 0.1µg/ml 
PI - Sigma-Aldrich 0.5µg/ml 
 
After washing with FACS buffer, cells were re-suspended in FACS buffer and 
measured on a FacsCalibur (BD Biosciences) using Cell Quest software (BD 
Biosciences). Samples were acquired through a live gate without compensation until 
at least 10,000 events were recorded. PI positive cells were excluded from the 
analysis by gating. Using FlowJo software (Tree star), the data was compensated and 
Figure 2.1 Gating strategy used to separate the different leukocyte populations. 
Leukocytes were separated and differentiated into T cells (CD4+ and CD8+), B cells, and 
non-B/non-T cells using CD19-APC (FL4) to select B cells and PE-Cy5-CD4/8 (FL3) to 
select T cells and all FL4-FL3- cells were designated non-B/non-T cells. Non-B/non-T 
cells were differentiated in NK cells (FITC-CD49b+), macrophages/ monocytes (PE-
F4/80+), and neutrophils (FITC-Gr1+ PE-Gr-1+). B cells were then differentiated into 
immature (PE-IgM+) and mature B cells (PE-IgM+ FITC-IgD+).  
 
Table 2.5 Anitbodies used for nine-parameter FACS analysis All antibodies were 
titrated to determine optimum concentration of use. 
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analyzed (Fig 2.1). First, leukocytes were separated and differentiated into T cells 
(CD4+ and CD8+), B cells, and non-B/non-T cells using APC for B cells and PE-Cy5 
for T cells. B cells were then differentiated into immature (PE-IgM+) and mature B 
cells (PE-IgM+, FITC-IgD+). Non-B/non-T cells were differentiated in NK cells 
(FITC-CD49b+), macrophages/ monocytes (PE-F4/80+), and neutrophils (FITC-Gr1+ 
PE-Gr-1+). The percentage of every cell type was calculated by FlowJo software. 
 
2.8.2 Brain FACS analysis 
Brain and spinal cord were cut into small pieces and incubated in complete RPMI 
containing collagenase (Gibco, 0.2mg/ml) and DNase (Gibco). Cells were 
homogenised and strained through a 100µm nylon filter.  After centrifugation at 
400xg for 10mins at 4°C, the cell suspension was resuspended in 30% Percoll 
(Pharmacia) and centrifuged at 8500xg for 30 minutes at 4°C. The inter-phase cells 
were collected and washed in PBS prior to staining. The cells were stained with 
primary antibodies for 30 minutes at 4°C, washed, and incubated with streptavidin-
conjugated APC or PerCP antibodies (BD Biosciences) for 15 minutes. The cells 
were washed and analyzed with a FACSCanto II flow cytometer using BD 
FACSDiva software (BD Biosciences).  
 
2.8.3 Phosphorylated STAT1 FACS analysis 
Cells were re-suspended in PBS and 4% formaldehyde added to a final concentration 
of 3% formaldehye. Cells were fixed for 10mins at 37°C and then chilled on ice for 1 
min. Extra-cellular staining (APC-F4/80 (AbD Serotec), PE-CD11b (BD 
Biosciences)) was performed at 4°C for 30mins. Cells were washed, re-suspended in 
PBS and permeabilised through the addition of ice-cold methanol whilst gently 
vortexing to a final concentration of 90% methanol, then incubated at 4°C for 
30mins. Cells were washed twice in FACS buffer, resuspended in 50µl of staining 
buffer for 10mins at room temperature before the pSTAT1 antibody (Cell Signaling 
Technologies) was added to the samples for 1 hour at room temperature. Cells were 
washed in FACS buffer before re-suspending in PBS and analysed using an LSR II 
flow cytometer with FACSDiva software (Becton Dickenson). 
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2.9 WESTERN BLOTTING 
Spleen cells (5 x 106 cells/ml) were cultured for 20 mins in media alone or in the 
presence of 10 ng/ml IFNγ or IL-6 (eBioscience, UK) or 104-106 U/ml IFNα (W. 
Müller, HZI, Braunschweig). Cells were lysed in Western blot lying buffer (see 
Appendix A) and stored at -20°C until use. Laemelli buffer (Appendix A) was added 
to protein samples and heated at 100°C for 3 min. Samples were subjected to sodium 
dodecyl sulfate polyacrylamide gel electrophoresis on 10% acrylamide gels 
(Appendix A) at 100V through the stacking gel and 150V through the resolving gel 
until the tracking dye reached the bottom of the gel. Gels were positioned on PVDF 
membranes (BioRad) activated in methanol (BDH) for 1min and placed in a BioRad 
semi-dry blot cell above three sheets of Whatman paper (Whatman) soaked in buffer 
API (Appendix A) and two sheets of Whatman paper soaked in buffer APII 
(Appendix A) and below 4 sheets of Whatman paper soaked in CP buffer (Appendix 
A). Blotting was performed for 30mins at 200mA. Blots were stained with Ponceau 
S (Appendix A) and divided into two sections at approximately 75kDa ensuring all 
major bands were avoided. Blots were incubated with blocking solution (5% w/v 
milk in Tween TBS (TwTBS, see Appendix A)) for 90mins at room temperature 
before incubation with rat anti-mouse phosphorylated STAT1 or Jak1 (Cell 
Signalling Technologies; 1:1000 in 4% w/v BSA (Sigma-Aldrich) in TwTBS) and 
mouse anti-mouse β-actin (Sigma-Aldrich; 1:1000 in 4% w/v BSA (Sigma-Aldrich) 
in TwTBS) overnight at 4°C with rocking. The blots were washed 3 times with 
TwTBS for 15mins before incubation with secondary antibody (Stratech Scientific; 
horseradish-peroxidase-conjugated goat anti-mouse or anti-rabbit; 1:10,000 in 0.5% 
milk TwTBS) for 90 min. The blots were washed 3 times with TwTBS for 30mins, 
10mins, 10mins and signals were visualised by using an enhanced 
chemiluminescence (ECL) system (Amersham). After visualising, the section of the 
membrane containing the larger fragments was washed in TwTBS for 15mins prior 
to being placed in strip buffer (see Appendix A) at 80°C for 30-40mins. The 
membrane was then rinsed with dH2O and washed for at least 15mins in TwTBS. 
The membrane was incubated with rat anti-mouse STAT1 overnight (Santa Cruz; 
1:1000 in 4% w/v BSA (Sigma Aldrich) in TwTBS), secondary antibody applied as 
before and ECL used to develop. 
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2.9 TRICHURIS MURIS SPECIFIC IgG1 AND IgG2A/C ELISA.  
To analyse T. muris specific antibody responses in the serum of infected mice 
ELISAs were performed. ELISA plates were coated overnight at 4°C with 5µg/ml T. 
muris overnight E/S (provided by Prof. Else, University of Manchester) in 0.05M 
carbonate bicarbonate buffer (see Appendix A). Following coating, plates were 
washed (5 times) in PBS-Tw and non-specific binding blocked using 3% BSA 
(Sigma-Aldrich) in PBS for 1hr at 37°C. Plates were washed (5 x in PBS-Tw) and 
diluted serum (1:20 – 1:2560) added to the plate and incubated for 1hr at 37°C. After 
washing (5x in PBS-Tw), biotinylated rat anti-mouse IgG1 (BD Biosciences, 1:500) 
or IgG2a/c (BD Biosciences, 1:1000) was added to the plate for 1hr at room 
temperature. The plates were washed (5 x with PBS-Tw) and incubated with 
streptavidin - β - peroxidase (SA-POD, Roche, 1:1000) for 1hr at room temperature. 
Finally plates were washed (5x with PBS-Tw) and developed with 3,3', 5,5' 
tetramethylbenzidine (TMB substrate reagent kit, BD), colour development was 
stopped using sulphuric acid (Sigma-Aldrich). Plates were then read using a Dynex 
MRX11 plate reader (Dynex Technologies) at 405nm with a reference of 490nm. 
 
2.10 DETERMINATION OF NITRITE CONCENTRATION 
To determine classical macrophage activation nitrite production was determined by 
mixing 50µl of culture medium with 50µl of Griess reagent (1 part 0.1% N-(1-
napthyl)ethyldiamine dihydrochloride / 60% ethanoic acid plus 1 part 1% 
sulfanilamide / 30% ethanoic acid (all Sigma-Aldrich)) in a 96 well plate. The 
absorbance was measured using a Dynex MRX11 plate reader (Dynex Technologies) 
at 570nm with background absorbance at 630nm subtracted. 
 
2.11 DETERMINATION OF ARGNIASE ACTIVITY 
To determine alternative macrophage activation argniase activity was evaluated. 
50µl of 0.1% Triton X-100 (Sigma-Aldrich) containing 5µg pepstatin, 5µg aprotinin 
and 5µg antipain as protease inhibitors (all Sigma-Aldrich) were added to cells. The 
mixture was then incubated for 30mins at room temperature with agitation. After the 
cells were lysed 50µl of 10mM MnCl2, 50mM Tris-HCl, pH7.5 (Sigma-Aldrich) was 
added, to activate the enzyme, for 10mins at 55°C. Arginine hydrolysis was initiated 
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by the addition of 25µl of 0.5M arginine (Sigma-Aldrich), pH9.7 to a 25µl aliquot of 
the activated lysate. Incubation was performed at 37°C for 60min and the reaction 
stopped by the addition of 400µl stop solution containing H2SO4, H3PO4, H2O (1:3:7 
v/v; Sigma-Aldrich). The urea formed was colourimetrically quantified at 540nm 
after the addition of 25µl 9% iso-nitrosopropiophenone (ISPF; dissolved in 100% 
ethanol, Sigma-Aldrich) and heating at 95°C for 45min. After 10min in the dark the 
OD at 540nm was determined with a Dynex MRX11 plate reader (Dynex 
Technologies) using 200µl aliquots. A calibration curved was prepared with 
increasing amounts of urea (Sigma-Aldrich) between 1.5mg and 30µg. In this case 
100µl of urea solution at the appropriate concentrations, 400µl stop solution and 
25µl ISPF were added and the procedure followed as described above. 
 
2.12 CYTOKINE BEAD ARRAY (CBA) 
To analyse cytokine levels in the serum and re-stimulated lymph node supernatant of 
mice IL-4, IL-6, IL-10, IL-13, IL-17, IFNγ, TNFα and MCP-1 were measured using 
a BD CBA mouse soluble protein flex set (BD Biosciences) using the manufacturers 
instructions. Briefly, supernatants are incubated with capture beads of a distinct 
fluorescence intensity and coated with capture antibodies specific to one of the 
mentioned cytokines. Bound cytokine is then detected via the addition of PE-
conjugated detection reagents and compared to known standard concentrations on a 
FACSArray using FCAPArray software (BD Biosciences). 
 
2.13 STATISTICAL ANALYSIS 
Statistical analyses were performed with Graphpad Prism version 5. For comparisons 
between 2 groups a t-test or Mann Whitney U test (for non-parametric data) was 
used. A One Way ANOVA with a Tukey’s or Dunnett’s post test was applied for 
parametric data containing more than two groups. In addition, where appropriate, a 
Two Way ANOVA with Bonferroni post test was applied. For all non-parametric 
analyses containing more than two groups a Kruskal-Wallis test and Dunn’s post test 
were applied. Differences were considered significant at p<0.05 and marked with *. 
** designates p<0.005 and *** p<0.001. 
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CHAPTER THREE 
 
Characterisation of IFNγ  conditional 
knock-out mice 
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3.1 INTRODUCTION 
 
The role of IFNγ in a myriad of diseases, as well as during homeostasis, is well 
documented. However, as several cell types are capable of responding to IFNγ it isn’t 
clear in vivo which cells are responsible for the different actions of the cytokine. 
 
The ability to generate conditional knock-out mice, where a gene is ablated in a 
specific cell type or organ, has come to the forefront in the last decade. There is now 
the existence of a Cre ‘zoo’ database containing over 100 different Cre expressing 
lines (Nagy et al., 2009). Therefore, once created, a mouse containing a ‘floxed’ 
target gene enables the conditional deletion of the gene, in almost any cell type, by 
crossing the floxed mouse to the appropriate Cre mouse. This method allows the 
intricate dissection in vivo of the role of the gene of interest. 
 
The creation of a conditionally expressed IFNγ receptor will allow the investigation 
of the cells responsible for the downstream actions of IFNγ signalling. This project 
was instigated by a previous member of Werner Muller’s lab (at the Helmholtz 
Institute for Infection Research, Braunschweig) who generated the IFNγR2 targeting 
vector, transfected the plasmid into embryonic stem cells, injected the clones which 
had undergone homologous recombination into blastocysts and selected mice which 
had undergone germline transmission (Fleige, 2006). The work described in this 
thesis continues on from this work which generated IFNγR2fl/wtneo+ and IFNγR2Δ/wt 
mice. 
 
Aims 
Therefore, the aims of this chapter are as follows: 
1. Generate and characterise an IFNγR2fl/fl mouse 
2. Cross this IFNγR2fl/fl mouse to a deleter Cre line to generate a complete 
knock-out mouse as well as crossing to the CD4-Cre and LysM-Cre mice to 
create T cell and macrophage/granulocyte conditional knock-out mice. 
3. Confirm in each IFNγR2fl/fl x Cre line that the mice are unresponsive to IFNγ 
in the appropriate cell(s). 
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4. Characterise the phenotype of the IFNγR2Δ/Δ mice. 
 
3.2 RESULTS 
 
3.2.1 Breeding of conditional IFNγR2 mutant mice 
The generation of the IFNγR2 conditional knock-out mouse was initiated at Prof 
Muller’s lab at the Helmholtz Institute for Infection Research, Braunschweig, 
Germany (Fleige, 2006).  
 
In order to obtain mice with a ubiquitous deletion of IFNγR2 an IFNγR2fl/wt male 
was mated with a K14-Cre+ female. Breeding with K14-Cre induces deletion of 
floxed sequences in the epidermis, tongue and thymic epithelium when Cre is 
inherited from the father. However, when the Cre is inherited from the mother 
ubiquitous deletion of loxP flanked target sequences occurs due to activity of Cre in 
murine oocytes (Hafner et al., 2004). This cross was performed at the Helmholtz 
Centre for Infection Research prior to transfer of the animals to the facility at the 
University of Manchester. However, the genotyping of these mice was performed at 
the University of Manchester on tail samples sent from Braunschweig. The mice 
were genotyped using two PCRs, designed as part of the work contained within this 
thesis – one to detect the IFNγR2 delta allele (Fig 3.2A) and one to detect the 
presence of a wild type IFNγR2 allele (Fig 3.2B). IFNγR2fl/wtneo- and IFNγR2Δ/wt 
mice were shipped from Braunschweig and subsequently breed to become 
homozygous at the University of Manchester. 
 
In order to remove any complications that have been shown to arise from the 
presence of a selectable marker, in this case the neomycin resistance cassette, 
IFNγR2fl/flneo+ mice were breed with FLP deleter mice to remove the FRT – flanked 
neomycin cassette (see Fig1.2B for overview of the 2loxP 2FRT method). Mice 
having successfully under gone recombination between the two FRT sites, and 
therefore deletion of the cassette, were screened by a PCR designed to recognise a 
section of the neomycin resistance gene (Fig 3.2C). These IFNγR2fl/wtneo- mice were 
subsequently crossed to obtain homozygous IFNγR2fl/fl mice. The detection of the 
floxed gene was determined using a three primer PCR strategy. This PCR allows the  
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easy detection of the insertion of the 23bp loxP fragment. One primer spans the loxP 
site creating 3 bands in the presence of both a floxed allele and a wild-type allele, 2 
bands in the presence of only floxed alleles and only 1 band in the presence of only 
wild-type alleles (Fig3.2D).  
 
In order to obtain mice with a specific deletion of IFNγR2 in T-cells or myeloid cells 
the IFNγR2fl/fl mice were mated with CD4-Cre+ (Lee et al., 2001) or LysM-Cre+ 
(Clausen et al., 1999) mice and the IFNγR2fl/wtCre+ offspring detected by PCR. 
These IFNγR2fl/wtCre+ mice were then crossed again to IFNγR2fl/fl mice and the 
resultant IFNγR2fl/flCre+ mice used for experiments and further breeding as shown in 
the breeding scheme (Fig 3.1). Cre genotyping was performed using primers specific 
for either CD4-Cre or LysM-Cre (sequences courtesy of A. Roers). 
IFNγR2fl/flLysMCre+ mice were subsequently crossed to the IFNγR2fl/flCD4Cre+ 
mice to give double conditional knock-out - IFNγR2fl/flLysMCre+CD4Cre+ mice. 
 
As all the mutant mice used during this thesis were all on a mixed B6 and 129 
background, Cre- littermates were used as controls in every experiment. 
Backcrossing of the IFNγR2fl/fl mice to B6 was conducted simultaneously and mice 
on a predominantly B6 background, which have undergone a minimum of 8 
backcrosses, are now available. 
 
3.2.2 Confirmation of abrogation of responsiveness to IFNγ  
 
To verify the efficiency of IFNγR2 deletion we initially analysed the complete 
knock-out mice. Whole splenocytes were harvested from IFNγR2Δ/Δ, IFNγR2fl/fl 
control mice and B6 mice and stimulated with IFNγ or IL-6 for 20mins. Cell lysates 
were run on a gel, blotted onto PVDF membrane and probed for the presence of 
phosphorylated STAT1, total STAT1 and β-actin protein. IFNγR2fl/fl mice remain 
responsive to IFNγ, as evident through the STAT1 phosphorylation observed after 
stimulation with either IFNγ or IL-6 (Fig 3.3). In contrast, IFNγR2Δ/Δ mice were not 
responsive to IFNγ with no STAT1 phosphorylation detected (Fig 3.3). The 
IFNγR2Δ/Δ mice did not have a defect in the STAT1 phosphorylation pathway as 
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stimulation with IL-6 still resulted in the phosphorylation of STAT1 (Fig 3.3). This 
data demonstrates that the IFNγR2fl/fl mice have normal IFNγ signalling whereas in 
the IFNγR2Δ/Δ mice IFNγ responsiveness has successfully been abrogated. 
 
To verify that deletion of IFNγR2 in IFNγR2fl/flCD4Cre+ and IFNγR2fl/flLysMCre+ 
mice occurs efficiently and is cell-specific, isolated cell populations were analysed. T 
cells were isolated using magnetic cell sorting from a mixed population of 
splenocytes and peripheral lymph node cells. The sorted T cell and non-T cell 
populations were then stimulated with IFNγ and cell lysates analysed by western blot 
for STAT1 phosphorylation. The T cell populations from both the 
IFNγR2fl/flCD4Cre+ (boxed population in Fig 3.4) and IFNγR2Δ/Δ mice were 
unresponsive to IFNγ with no STAT1 phosphorylation detected (Fig 3.4). In contrast, 
the non-T cell population in the IFNγR2fl/flCD4Cre+ mice (second boxed population) 
was responsive to IFNγ and able to phosphorylate STAT1 (Fig 3.4). This 
demonstrated the successful and specific abrogation of IFNγ signalling in T cells in 
these mice. Moreover, both the T cell and non-T cell populations in the 
IFNγR2fl/flLysMCre+ mice were responsive to IFNγ (Fig 3.4). However, the non-T 
cell population, containing the macrophages and granulocytes, had lower STAT1 
phosphorylation levels than the IFNγR2fl/fl control mice following stimulation with 
IFNγ (Fig 3.4). The lower phosphorylation is consistent with these mice having 
deleted IFNγR2 on their macrophages / granulocytes. 
 
Bone-marrow derived macrophages from IFNγR2fl/flLysMCre+ mice were analysed 
by Western Blot for STAT1 phosphorylation following IFNγ stimulation. However, 
we were unable to get a macrophage purity of more than 80% therefore, we decided 
to analyse STAT1 phosphorylation at a single cell level by FACS using a 
phosphorylated-STAT1 antibody. Peritoneal macrophages isolated from mutant mice 
were stimulated with IFNγ and analysed gated on CD11b+F4/80+ double positive 
cells. In the IFNγR2fl/flLysMCre+ positive and IFNγR2Δ/Δ mice this population was 
unresponsive to IFNγ, with no STAT1 phosphorylation. Control IFNγR2fl/fl mice did 
respond to IFNγ stimulation with an increase in STAT1 phosphorylation (Fig 3.5). 
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Furthermore, the non-macrophage population (F4/80-CD11b-) from both the 
IFNγR2fl/fl and IFNγR2fl/flLysMCre+ mice was responsive to IFNγ. In contrast, as 
expected, the non-macrophage population in IFNγR2Δ/Δ mice was unresponsive to 
IFNγ stimulation (Fig 3.5) 
 
Thus the inactivation of the IFNγR2 gene in IFNγR2Δ/Δ, IFNγR2fl/flLysMCre+ and 
IFNγR2fl/flCD4Cre+ mice appears to be occurring in the expected cell-types. 
  
3.2.3. Complete deletion of IFNγR2 does not alter the leukocyte percentages in 
lymph nodes or spleen 
 
Previous work has identified a decrease in CD4:CD8 T cell ratio and a slight increase 
in B cell proportions in the blood of IFNγR1 deficient mice (Frischmann & Müller, 
2006). To determine if the same is true in our IFNγR2Δ/Δ mice we analysed the 
composition of leukocytes in blood, mesenteric lymph nodes, peripheral lymph 
nodes and the spleen. In the IFNγR2Δ/Δ mice we saw no significant changes in the 
CD4:CD8 ratio in the blood, peripheral lymph nodes, mesenteric lymph nodes or 
spleen compared to IFNγR2fl/fl mice (Fig 3.6). In contrast, similarly to in the study by 
Frischmann and Müller, we observed an increase in B cells in the IFNγR2Δ/Δ mice 
compared to the IFNγR2fl/fl mice (Fig 3.7). However, this was only statistically 
significant in the peripheral lymph nodes isolated from female mice (Fig 3.7B), and 
there was no increase in comparison to B6 mice suggesting this may be a product of 
the mixed genetic background of these mice. Moreover, there were no other 
alterations in leukocyte composition analysed (mature and immature B cells, 
monocytes, neutrophils or NK cell percentage) from blood, peripheral lymph nodes, 
mesenteric lymph nodes or spleen between the different genotypes or sexes (Table 
3.1). 
 
3.2.4 Abrogation of IFNγ  signalling through the IFNγR2 chain alters 
responsiveness to IFNα  
 
It has previously been described that the deletion of IFNαR2 can decrease  
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Mesenteric Lymph Node 
  
IgM+ B 
cells 
Igm+IgD+ 
B cells Monocytes Neutrophils NK cells 
IFNγR2 KO M 2.9 ± 0.5 14.8 ± 0.9 8.6 ± 2.3 1.7 ± 0.2 0.3 ± 0.0 
IFNγR2 KO F 2.0 ± 0.1 14.6 ± 0.6 6.0 ± 1.4 1.1 ± 0.1 0.3 ± 0.0 
IFNγR2 floxed M 2.1 ± 0.2 13.7 ± 2.0 6.6 ± 1.4 1.1 ± 0.1 0.3 ± 0.1 
IFNγR2 floxed F 2.6 ± 0.5 13.7 ± 1.9 6.2 ± 0.2 0.9 ± 0.2 0.3 ± 0.0 
B6 M 2.7 ± 0.0 19.5 ± 0.9 5.0 ± 0.0 1.6 ± 0.1 0.4 ± 0.0 
B6 F 3.0 ± 0.9 15.4 ± 2.5 10.9 ± 1.0 1.4 ± 0.7 0.6 ± 0.1 
      
Peripheral Lymph Node 
  
IgM+ B 
cells 
Igm+IgD+ 
B cells Monocytes Neutrophils NK cells 
IFNγR2 KO M 3.0 ± 0.1 22.2 ± 1.7 10.8 ± 0.8 1.4 ± 0.1 0.3 ± 0.0 
IFNγR2 KO F 2.9 ± 0.1 20.0 ± 0.8 10.0 ± 1.1 1.2 ± 0.0 0.3 ± 0.0 
IFNγR2 floxed M 2.2 ± 0.2 15.1 ± 4.2 15.1 ± 0.4 1.5 ± 0.3 0.5 ± 0.0 
IFNγR2 floxed F 2.0 ± 0.2 12.3 ± 1.4 14.6 ± 0.4 0.7 ± 0.2 0.4 ± 0.1 
B6 M 3.1 ± 0.1 23.8 ± 4.7 12.2 ± 2.2 1.8 ± 0.2 0.7 ± 0.0 
B6 F 4.0 ± 0.1 33.1 ± 4.3 15.3 ± 5.8 1.2 ± 0.2 0.5 ± 0.1 
      
Blood 
  
IgM+ B 
cells 
Igm+IgD+ 
B cells Monocytes Neutrophils NK cells 
IFNγR2 KO M 8.6 ± 0.5 26.6 ± 0.5 12.4 ± 2.3 1.1 ± 0.1 4.3 ± 0.1 
IFNγR2 KO F 6.6 ± 2.0 24.1 ± 0.5 2.4 ± 1.2 1.1 ± 0.0 7.9 ± 1.2 
IFNγR2 floxed M 9.3 ± 2.0 30.2 ± 5.6 2.9 ± 0.2 0.7 ± 0.4 
13.1 ± 
1.5 
IFNγR2 floxed F 
10.2 ± 
0.8 27.6 ± 1.4 1.7 ± 0.9 0.8 ± 0.1 9.3 ± 1.6 
B6 M 9.1 ± 1.5 31.5 ± 5.1 2.4 ± 0.3 1.0 ± 0.2 6.7 ± 0.6 
B6 F 
10.1 ± 
0.5 24.3 ± 5.3 3.5 ± 1.0 4.2 ± 2.2 9.5 ± 0.0 
      
Spleen 
  
IgM+ B 
cells 
Igm+IgD+ 
B cells Monocytes Neutrophils NK cells 
IFNγR2 KO M 8.3 ± 0.3 28.8 ± 0.6 23.5 ± 0.3 0.8 ± 0.1 2.0 ± 0.3 
IFNγR2 KO F 9.6 ± 0.7 26.9 ± 2.2 22.3 ± 0.0 0.6 ± 0.1 2.2 ± 0.6 
IFNγR2 floxed M 7.5 ± 0.3 23.8 ± 1.2 20.7 ± 0.3 0.9 ± 0.1 3.1 ± 0.2 
IFNγR2 floxed F 
11.0 ± 
0.3 26.7 ± 1.0 18.4 ± 1.2 0.8 ± 0.2 2.0 ± 0.1 
B6 M 7.2 ± 1.2 30.7 ± 1.6 17.5 ± 0.2 0.6 ± 0.2 2.5 ± 0.1 
B6 F 7.8 ± 0.6 26.7 ± 0.3 18.9 ± 0.7 1.3 ± 0.1 3.4 ± 0.2 
Table 2.1 Analysis of IgM+, IgM+IgD+ B cell, monocyte, neutrophil and NK cell 
percentage in MLN cells, PLN cells, spleen cells and blood. Cells were isolated from 
IFNγR2Δ/Δ (KO), IFNγR2fl/fl (floxed) or B6 mice as indicated and stained with CD4 Pe-Cy5, CD8 
PE-Cy5, CD19 APC, IgM PE, IgD FITC, F4/80 PE, CD49b FITC, Gr-1 PE, Gr-1 FITC and PI. Cells 
were acquired on a FACS Calibur and data analysed using FlowJo. Monocytes were defined 
as CD19-CD4-CD8-F4/80+ neutrophils as CD19-CD4-CD8-Gr1+ and NK cells as CD19-CD4-CD8-
CD49b+. Data shown as mean ± standard error n=2. 
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responsiveness to IFNγ (Takaoka et al., 2000); therefore, we set out to determine if  
the converse is true. Splenocytes from IFNγR2Δ/Δ mice were stimulated with IFNα 
and STAT1 phosphorylation analysed. This demonstrated that upon stimulation with 
104 U/ml of IFNα there was a decrease in STAT1 phosphorylation in IFNγR2Δ/Δ 
mice compared to IFNγR2fl/fl mice (Fig 3.8). At higher levels of IFNα stimulation 
(105 or 106 U/ml) in IFNγR2fl/fl mice there was a decrease in total STAT1 levels 
which wasn’t seen in the IFNγR2Δ/Δ mice. This was mirrored by a decrease in Jak1 
levels in IFNγR2fl/fl mice at 105 or 106 U/ml IFNα that was only observed at 106 
U/ml IFNα in IFNγR2Δ/Δ mice (Fig 3.8). 
 
The changes observed in IFNα responsiveness are relatively minor compared to the 
changes previously demonstrated in response to IFNγ in IFNαR2 deficient mice 
(Takaoka et al., 2000). Nevertheless, we have demonstrated a clear difference in 
IFNα responses, which needs to be further investigated. 
 
3.2.5. Macrophage activation in complete IFNγR2 knock-out mice 
  
Macrophages can be broadly classified into classical and alternatively activated 
macrophages. Classically activated macrophages require IFNγ for activation and are 
characterised by the production of nitric oxide. In contrast, alternatively activated 
macrophages can be activated by other stimuli including IL-4 and are characterised 
by the production of arginase-1 (Gordon, 2003). 
 
Simulation of peritoneal macrophages from IFNγR2Δ/Δ or IFNγR2fl/fl mice with IFNγ 
+ LPS (classical activation) or IL-4 + LPS (alternative activation) allowed the 
analysis of the potential to generate the two classes of macrophages. IFNγR2fl/fl mice 
stimulated with IFNγ or LPS produced nitric oxide and the combination of IFNγ + 
LPS resulted in a synergistic increase in nitric oxide production (Fig 3.9A). In 
contrast IFNγR2Δ/Δ mice produced significantly more nitric oxide than IFNγR2fl/fl 
mice when stimulated with LPS but, as expected, produced no nitric oxide in 
response to IFNγ. Additionally, IFNγR2Δ/Δ mice produced significantly less nitric 
oxide in comparison to IFNγR2fl/fl mice following stimulation with IFNγ + LPS, with 
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no elevation in nitric oxide production compared to stimulation with LPS alone (Fig 
3.9A). In contrast, IFNγR2Δ/Δ mice produced significantly higher levels of arginase-1, 
than IFNγR2fl/fl mice, under baseline conditions. Moreover, when stimulated with 
either LPS or IL-4 IFNγR2Δ/Δ mice had significantly increased arginase-1 activity 
compared to IFNγR2fl/fl mice (Fig 3.9B). In both IFNγR2Δ/Δ and IFNγR2fl/fl mice 
arginase-1 production was increased following the combined stimulation of LPS + 
IL-4 but there was no difference between the IFNγR2fl/fl and IFNγR2Δ/Δ mice (Fig 
3.9B). 
 
This data demonstrates that the deletion of IFNγR2 alters the in vitro activated 
macrophage phenotype, with decreased nitric oxide production and increased 
arginase activity, suggesting a shift towards an alternatively activated phenotype. 
 
As well as the changes reported in this chapter other important phenotypes have been 
demonstrated in the IFNγ, IFNγR1 or IFNγR2 deficient mice. This includes the 
inability of B cells to switch from antibody production of IgM to IgG2a/c (Finkelman 
et al., 1988; Huang et al., 1993) and an impaired T helper 1 development (Dighe et 
al., 1995; Lu et al., 1998). These characteristics will be analysed in our IFNγR2Δ/Δ 
mice in Chapter 5 using the in vivo model of Trichuris muris. The phenotypes 
described in this results chapter will be further dissected in the following discussion. 
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3.3 DISCUSSION 
 
3.3.1 The Cre-loxP system of conditional gene inactivation 
The Cre-loxP system of conditional gene inactivation has been widely used since it 
was first described over 15 years ago. The main complication that needs to be 
monitored, when using this system, is variability in recombination efficiency. This 
variability can be due to certain tissue-specific promoters not expressing the Cre 
proteins at high enough levels to guarantee efficient deletion or problems with 
accessibility of loxP sites. Indeed, some areas of genomic DNA yield low 
recombination efficiency even with high levels of Cre expression and this may be 
due to the local chromatin structure (Castrop, 2010; Vooijs et al., 2001). Therefore, 
even if a specific Cre line has been reported to result in efficient deletion, this has to 
be re-analysed with each cross performed. 
 
In our mice we saw efficient recombination in macrophages and T cells, following 
the cross of the floxed mice to the LysM cre or CD4 cre lines respectively. Although 
we analysed the deletion of the floxed gene in macrophages from LysM Cre+ mice, 
Cre is expressed in all cells of a myeloid lineage. Indeed, it has previously been 
reported that deletion is seen in neutrophils and monocytes/macrophages, but does 
not occur in the majority of peripheral dendritic cells (Clausen et al., 1999). 
Therefore, although the IFNγR2fl/flLysMCre+ mice are referred to as a macrophage 
conditional mutant, for ease in this thesis, further experiments need to be performed 
to examine deletion in other cells types including granulocytes and dendritic cells. 
 
The Cre-loxP system is particularly valuable as, using the same floxed mouse, it is 
now possible to investigate the role of IFNγR2 in other cells types through crossing 
with other Cre lines. It is also possible to analyse the importance of temporal 
inactivation of a gene, through crossing with Cre-ERT mice. The Cre-ERT inducible 
system allows the expression of Cre to be switched on in a specific cell type: by 
giving the mice tamoxifen (Feil et al., 1996). To further investigate a phenotype seen 
using the conditional inactivation of IFNγR2, the floxed mice could be crossed to an 
inducible Cre line. The receptor can then be inactivated at different time points 
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throughout the course of infection or treatment to analyse the role of IFNγ signalling 
in disease onset, maintenance or recovery. 
 
As IFNγ has been demonstrated to have an important role in multiple diseases and 
organs, the use of the IFNγR2 conditional knock-out mouse is an important tool 
which will enable the elucidation of the cytokine network and clarify the role of 
IFNγ in multiple systems. 
 
3.3.2. Analysis of the phenotype of unchallenged IFNγR2 deficient mice 
The IFNγR2 complete knock-out mice develop normally and are fertile, as was 
expected from reports with IFNγ deficient mice (Huang et al., 1993). We therefore 
analysed other parameters previously investigated in IFNγR1 or IFNγ deficient mice 
including the make-up of the resting lymphocyte population, responsiveness to IFNα 
and the macrophage phenotype. 
 
3.3.2.1. Analysis of lymphocyte population in unchallenged IFNγR2 deficient 
mice 
Previous work suggested that IFNγR1 deficient mice have altered lymphocyte 
proportions in the blood. The most striking difference observed was an elevated 
proportion of CD8+ cells, changing the CD8:CD4 ratio from approximately 1:2 in B6 
mice to 1:1 in the IFNγR1 deficient mice. These changes are accompanied by a lower 
percentage of neutrophils than B6 control mice and a higher levels of B cells in 
males than females (Frischmann & Müller, 2006). In contrast, our analysis of the 
complete IFNγR2 deficient mice showed no changes in CD8:CD4 ratio in the blood, 
mesenteric lymph nodes, peripheral lymph nodes or spleen compared to IFNγR2fl/fl 
or B6 control mice. Moreover, the ratio of CD8:CD4 cells in the blood, 
independently of genotype, was comparable to that seen in B6 mice in the previous 
experiment. Similarly, no major changes in B cell or neutrophil percentage was seen 
in comparison to the control mice, except for a slight, statistically significant increase 
in B cell percentage in the peripheral lymph nodes of female IFNγR2Δ/Δ mice 
compared to female IFNγR2fl/fl mice. As both experiments were performed using the 
same method and the control mice display similar characteristics experimental 
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differences are unlikely to be the cause of these discrepancies. Our data is consistent 
with other reports which show no alterations in monocytes/macrophages, neutrophils 
or lymphocyte populations in the spleens of IFNγR1 deficient mice, although 
CD4:CD8 ratios were not analysed (Matthys et al., 1999). A subsequent experiment 
with IFNγ deficient mice analysed the ratio of CD4:CD8 cells in lymph nodes but, 
similarly to our data, saw no change compared to control mice (Cornish et al., 2003). 
Interestingly, in the study by Cornish and colleagues an equal ratio of CD4:CD8 cells 
was observed in IFNγ-/-SOCS1-/- mice, similar to the ratio reported by Frischmann 
and Müller in IFNγR1 deficient mice. In the double IFNγ and SOCS1 knock-out 
mice the altered T cell ratio is attributed to altered responses to cytokines such as IL-
12, IL-7 and IL-15. It will therefore be interesting to analyse the CD4:CD8 ratio and 
cytokine levels during inflammation, to determine if there is an altered cytokine 
response and/or preferential expansion of the CD8+ T cell subset during 
inflammation. 
 
Although this data suggests there are no clear changes in the leukocyte population 
this experiment was performed with very few mice and used mice of a mixed genetic 
background. To be confident that this data is robust, it will be important to repeat the 
experiment with a larger group size and with mice that have been backcrossed onto a 
B6 background. 
 
3.3.2.2. Analysis of IFNα responsiveness in IFNγR2 deficient mice 
Takaoka and colleagues have previously demonstrated that mice deficient in 
IFNαR1 display a decreased sensitivity to IFNγ. They also performed the converse 
study with IFNγR1 deficient mice and demonstrated these mice display equal 
sensitivity to IFNα compared to wild type mice (Takaoka et al., 2000). As the 
proposed mechanism for the cross-talk between the IFNγ and IFNα signalling 
pathways is through an association between IFNαR1 and IFNγR2 (Takaoka et al., 
2000), we analysed the impact of IFNγR2 deficiency on IFNα signalling. In contrast 
to IFNγR1 deficiency, IFNγR2 deficiency results in a decreased sensitivity to IFNα. 
It is thought that a constitutive sub-threshold level of IFNα signalling strengthens the 
association of IFNαR1 and IFNγR2 and maintains the docking site for STAT1 on 
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IFNαR1. These associations are proposed to aid the clustering of receptors in the 
caveolar membrane fractions, to increase the efficiency of signalling (Takaoka et al., 
2000). It will be of interest to verify if the deletion of IFNγR2 alters the clustering of 
receptors seen in wild-type mice and if this is responsible for the reduction in IFNα 
responsiveness seen in the IFNγR2 deficient mice. 
 
Our experiments also demonstrated a decrease in STAT1 and Jak1 protein at high 
levels of IFNα stimulation in IFNγR2fl/fl but not IFNγR2Δ/Δ mice. This could be part 
of a negative feedback loop, as IFNα stimulation is known to cause a state of 
refractoriness following stimulation (Larner et al., 1986). One potential method for 
decreasing the levels of Jak1 and STAT1 protein could be through the ubiquitin-
proteasome pathway, which has previously been implicated in Jak-STAT signalling 
pathways (for review see (Shuai & Liu, 2003)). The ubiquitin-proteasome pathway 
controls the degradation of regulatory proteins, through the conjugation of ubiquitin 
to the substrate. Polyubiquitinated proteins are then recognised by the 19S complex 
of the 26S proteasomes and are degraded into short peptides (for a more detailed 
overview of the pathway see (Nandi et al., 2006)). For example, following IFNγ 
signalling it has been demonstrated that Jak2 (Ungureanu et al., 2002) and STAT1 
(Kim & Maniatis, 1996) undergoes ubiquitin-proteasome-mediated degradation. 
Moreover, it has been demonstrated that IFNα induces the expression of ubiquitin 
cross-reactive protein and ubiquitin-conjugating enzymes which are both involved in 
protein degradation by the ubiquitin system (Nyman et al., 2000). The increased 
protein degradation seen following higher concentrations of the IFNα stimulation 
may be due to the increased levels of phosphorylated protein, as both STAT and Jak 
ubiquitination occurs following protein phosphorylation (Kim & Maniatis, 1996; 
Ungureanu et al., 2002). 
 
Our data demonstrates a slight decrease in STAT1 phosphorylation in IFNγR2Δ/Δ 
mice with a clear decrease in total STAT1 and Jak1 protein levels. The effect of the 
decreased sensitivity to IFNα needs to be investigation to determine if this has any 
functional significance. It will also be of interest to determine if the decreased 
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protein degradation seen in the IFNγR2Δ/Δ mice has an impact on the refractory 
period normally observed following IFNα signalling (Larner et al., 1986) 
 
3.3.2.3. Analysis of macrophage phenotype in IFNγR2 deficient mice 
Macrophages display heterogeneity in their cell surface markers, location, and 
function and have been classified into two broad subtypes – classically activated or 
M1 and alternatively activated or M2. Classically activated M1 macrophages are 
induced by IFNγ alone or in combination with microbial stimuli (e.g. LPS) or 
cytokines (e.g. TNF). Alternatively activated or M2 macrophages are induced by IL-
4 or IL-13, but can also be induced by exposure to immune complexes, IL-10 or 
hormones (Gordon, 2003; Mantovani et al., 2004; Martinez et al., 2008). It has 
previously been reported that IFNγ andd IFNγR deficient mice have an elevation in 
the number of alternatively activated macrophages following infection (Arora et al., 
2005; Gangadharan et al., 2008). However, to our knowledge, there are no studies 
investigating the potential of macrophages to differentiate into alternatively activated 
macrophages in IFNγ or IFNγR-deficient naïve mice. In contrast, as expected with 
the role of IFNγ in classical macrophage activation, it has been demonstrated that 
IFNγ unresponsiveness reduces classical macrophage effector function as measured 
by nitric oxide production (Dighe et al., 1995). 
 
Our data corroborates the previous results by Dighe and colleagues with decreased 
nitric oxide production following activation of macrophages with LPS + IFNγ. 
Interestingly, unstimulated macrophages from naïve IFNγR2 deficient mice display 
an increased Arginase 1 activity, which is also seen following stimulation with IL-4. 
This suggests these mice not only have a decrease in the classical M1 effector 
function, but also demonstrate a shift towards the macrophage M2 phenotype 
following in vitro stimulation. 
 
Classically activated macrophages are thought to play a key role in cellular immunity 
and immunodeficiency. It has recently been demonstrated that macrophages from 
mice with “macrophages insensitive to interferon-γ” (MIIG mice) are, as we have 
demonstrated, unable to produce nitric oxide. These mice also have an impaired 
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ability to control pathogens with an intracellular phase in their life cycle, due to the 
inability to generate classically activated macrophages (Lykens et al., 2010). In 
contrast, alternatively activated macrophages are thought to be involved in allergic, 
cellular, and humoral responses to parasitic and extracellular pathogens. It will be 
interesting to investigate if complete IFNγR2 deficient or IFNγR2fl/flLysMCre+ mice 
are more resistant to these challenges. 
 
3.4 CONCLUSION 
 
The results present in this chapter demonstrate: 
1. The generation and characterisation of a complete IFNγR2 deficient mice and 
IFNγR2fl/fl mice 
2. The generation and confirmation of the abrogation of IFNγ signalling, in the 
appropriate cell type, in T cell and macrophage specific IFNγR2 deficient 
mice 
3. IFNγR2fl/fl mice will allow for subsequent crosses with different Cre 
expressing lines to enable the analysis of the role of IFNγ signalling in further 
cell types 
4. The complete IFNγR2 deficient mice display no clear alterations in leukocyte 
populations but have a decreased responsiveness to IFNα and demonstrate a 
shift towards an alternatively activated (M2) macrophage phenotype 
following in vitro stimulation. 
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4.1 INTRODUCTION 
 
The induction of colitis using dextran sodium sulphate is a well-established, 
reproducible model which has been used for over 20 years (Okayasu et al., 1990). In 
the acute phase of colitis it is thought that inflammation is driven by the innate 
immune system, as experiments with SCID mice suggest that adaptive immunity is 
dispensable (Dieleman et al., 1994; Melgar et al., 2005). Importantly, DSS induced 
colitis has also been shown to be a relevant model for the translation of data from 
mice to humans (Melgar et al., 2008). Therefore, understanding the mechanisms 
underlying DSS induced colitis may aid in understanding the mechanisms underlying 
IBD in humans. 
 
It has previously been demonstrated that the ablation of IFNγ results in protection 
from DSS induced intestinal inflammation (Ito et al., 2006; Xu et al., 2008). 
However, the mechanism through which this protection is achieved is largely 
unknown. It has been proposed that IFNγ-induced chemokines aids the accumulation 
of leukocytes in the intestine and therefore, blockade of IFNγ reduces this influx (Ito 
et al., 2006). The availability of conditional IFNγ receptor deficient mice should help 
to elucidate whether this is an important mechanism and, if so, which are the key 
IFNγ-responding cells that produce these chemokines. 
 
Aims 
Therefore, the aims are as follows: 
1. Establish the dose of DSS which induces colitis in wild type mice 
2. Confirm the previously published phenotype in which the abrogation of IFNγ 
signalling is protective in DSS-induced colitis 
3. Using the conditional IFNγ knock-out mice determine which cell type(s) play 
a role in protection from DSS-induced colitis 
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4.2 RESULTS 
 
4.2.1. Induction of colitis with dextran sodium sulphate 
 
It has previously been demonstrated that the gut microflora plays an important role in 
the development of intestinal inflammation and DSS-induced colitis (Tlaskalova-
Hogenova et al 2005). The mice in our animal facility were imported from the 
Helmholtz Centre of Infection Research, Braunschweig, where all mice are 
maintained with a Charles River altered Schaedler flora (CRASF). This gut flora is 
composed of eight ‘altered Schaedler flora’ strains and has been demonstrated to 
remain stable in mice maintained in individually ventilated cages for several years, 
therefore, we are confident that the mice used in our experiments maintain this flora 
(Stehr et al., 2009). This CRASF microflora is more restricted than gut flora found 
in conventional animal units and, as a result, the dose of DSS needed to induce 
colitis may be different to other facilities. To determine the optimum DSS 
concentration for colitis induction, prior to the initiation of studies with the mutant 
mice, we titrated the level of DSS needed to induce colitis in B6 mice.  
 
Initially, we treated B6 mice with 0%, 2%, 2.5% or 3% DSS in their drinking water 
for 7 days followed by 2 days of normal water. During the entire experiment, 
bodyweight and clinical symptoms were assessed daily. Until day 3 no clinical 
symptoms of colitis were observed. From day 4 onwards loss of body weight was 
observed in the groups being treated with 2.5% and 3% DSS, with a significant loss 
of weight, compared to the 0% DSS group, observed on day 5 in the 3% DSS group 
and day 6 in the 2.5% DSS group. The mice treated with 2% DSS subsequently 
started to lose weight at day 5, reaching significance at day 8 (Fig 4.1A). 
 
By day 8, the mice treated with 3% DSS were showing severe signs of colitis 
including apathy, diarrhoea and evidence of blood in their stools (Fig 4.1B). 
Moreover, the mice and had lost approximately 20% of their bodyweight compared 
to their initial starting weight (Fig 4.1A). Therefore, these mice were euthanised, in 
accordance with the guidelines in our Home Office project licence. Mice in all other 
groups were euthanised at day 9. At the time of autopsy, colitis was evident in all 
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groups of mice treated with DSS with a dose dependent shortening of colon length 
observed. This change in colon length reached significance in the 3% DSS treatment 
group compared to 0% DSS treated controls (Fig 4.1C). Furthermore, all treated 
mice were demonstrating clinical manifestations of colitis with diarrhoea and blood 
present in the faeces of all mice. In some animals behavioural alterations including 
piloerection, hunching and apathy was also observed, although this was not 
significantly different to the control animals (Fig 4.1B). 
 
Histologically, severe ulceration and crypt ablation was observed throughout the 
colon of mice treated with 3% DSS (Fig 4.2). Less severe inflammation and 
ulceration was observed in the 2.5% DSS treatment group with the proximal colon 
relatively unaffected but severe ulceration still evident in the distal colon. Finally, 
treatment with 2% DSS resulted in milder inflammation with only occasional areas 
of complete ulceration, all located in the distal colon (Fig 4.2). 
 
Analysis of the systemic cytokine profile was performed in all groups except the 3% 
DSS treatment group. This group wasn’t analysed due to the unplanned euthanasia 
prior to the end of the experiment. Serum was analysed using the CBA multiplex 
analysis and demonstrated evidence of systemic inflammation in all DSS treated 
animals, with elevated levels of the cytokine IL-6 and chemokine MCP-1 (CCL-2) 
(Fig 4.1D,E). This appears to be a dose-dependent increase, with higher levels seen 
in the 2.5% DSS treatment group than the 2% DSS group. 
 
A dose of 2.5% DSS was chosen for subsequent experiments as an unambiguous 
colitic phenotype developed, providing a clear window in which to analyse the 
expected protective effect of IFNγR2 deficiency. 
 
4.2.2. Comparison of IFNγR2fl/fl and IFNγR2Δ/Δ mice – 2.5% DSS colitis 
To determine the role of IFNγR2 in the development of DSS induced colitis 
IFNγR2Δ/Δ and IFNγR2fl/fl mice were treated with 0% or 2.5% DSS in their drinking 
water for 7 days, followed by a 3 day period of drinking water with no additives. 
Surprisingly, at day 3 the IFNγR2Δ/Δ mice treated with DSS had an increased  
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Fig 4.2 DSS-induced histological inflammation in wild-type (B6) mice. Colitis 
was induced through the addition of varying concentrations of DSS in drinking water 
for 7 days. On day 7 water with no additives was given to the mice. Histological 
changes were analysed from longitudinal H&E stained sections. Sections displayed 
are representative of each group, n=2 per group 
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bodyweight compared to the untreated IFNγR2Δ/Δ mice. However, by day 6 the 
bodyweight of DSS treated IFNγR2Δ/Δ mice had significantly decreased in 
comparison to the untreated IFNγR2Δ/Δ mice (Fig 4.3A). Similarly, the DSS treated 
IFNγR2fl/fl mice demonstrated a significantly decreased bodyweight compared to 
untreated IFNγR2fl/fl control mice from day 5 onwards (Fig 4.3A). Unexpectedly, by 
day 7 the IFNγR2Δ/Δ mice treated with DSS were showing very severe signs colitis 
including diarrhoea, piloerection and up to 20% bodyweight loss compared to day 0 
(Fig 4.3A,B). As the control IFNγR2fl/fl mice treated with DSS were also displaying 
10-15% bodyweight loss compared to their starting weight (Fig 4.3A) the experiment 
was terminated early, at day 7. 
 
Upon necropsy it was apparent that both groups treated with DSS showed a 
significant shortening of the colon (Fig 4.3C), a typical sign of acute intestinal 
inflammation. Furthermore, a significant decrease in colon length was seen in the 
IFNγR2Δ/Δ DSS treated mice compared to the IFNγR2fl/fl treated animals, despite 
similar colon lengths in untreated mice (Fig 4.3C). Moreover, both the DSS treated 
groups displayed swelling of the colon wall with an absence of faecal pellets evident 
through visual inspection of the colon. 
 
To determine the pathological basis of the clinical symptoms of colitis, we examined 
the histology in the intestinal tract of DSS-treated and control animals. There were 
prominent changes following DSS treatment with severe ulceration, loss of 
morphology and crypt architecture, loss of the epithelial layer and inflammatory cell 
infiltration. These changes were statistically significant and observed throughout all 
sections of the colon in IFNγR2Δ/Δ DSS treated mice (Fig 4.4A,B). By contrast, 
although DSS treated IFNγR2fl/fl mice also showed severe ulceration, loss of 
morphology and inflammatory cell infiltration in the distal colon, other areas of the 
colon were less severely affected (Fig 4.4A). In the mid colon there were patches of 
ulceration, but this was not continual with some areas of intact epithelium and the 
proximal colon had mild – medium inflammation with less ulceration than seen in 
the other sections of the colon and areas of normal crypt architecture. However, none 
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of the changes observed in the IFNγR2fl/fl mice, when scored, were significantly 
different to IFNγR2fl/fl untreated animals (Fig 4.4A,B). 
 
Systemically there were no significant changes in cytokine levels with no IL-10, IL-
17A, IL-4, TNF or IL-13 detected in the serum. In both IFNγR2fl/fl and IFNγR2Δ/Δ 
DSS treated mice there was an elevation in systemic IL-6 levels (Fig 4.4C), however 
this didn’t reach significance. Moreover, systemic IFNγ was detected in 2 of the 
IFNγR2fl/fl mice treated with DSS but in no other treatment groups. However, in both 
mice the levels of IFNγ were very low (below 5pg/ml) and this wasn’t statistically 
significant (Fig 4.4E). 
 
Differences in clinical scores and histological changes, particularly in the proximal 
colon, between the IFNγR2Δ/Δ and IFNγR2fl/fl mice suggest that the IFNγR2Δ/Δ 
animals appear more susceptible to DSS than control animals. However, there was 
not a clear difference, between the genotypes, and therefore the experiment was 
repeated with a milder DSS treatment to allow the experiment to run to completion. 
 
4.2.3. Comparison of IFNγR2fl/fl and IFNγR2Δ/Δ mice – 2% DSS colitis 
Similarly to the previous experiment (2.5% DSS), IFNγR2Δ/Δ and IFNγR2fl/fl mice 
were treated with 0% or 2.0% DSS in their drinking water for 7 days, followed by a 
3 day period of drinking water with no additives. Despite the milder DSS regime 
weight loss was evident in both groups treated with DSS by day 5. In both the 
IFNγR2Δ/Δ and IFNγR2fl/fl DSS treated mice the weight loss was significant in 
comparison to untreated controls of the same genotype by day 7 (Fig 4.5A). 
Furthermore, the experiment was ended early, on day 9, due to the significant weight 
loss and clinical manifestations of colitis evident in the mice. The clinical symptoms 
were significantly worse in the DSS treated IFNγR2Δ/Δ mice compared to the DSS 
treated IFNγR2fl/fl mice, although both groups had significantly increased clinical 
scores compared to untreated mice (Fig 4.5B). This was mirrored with the 
bodyweight data as an increased weight loss was observed in the DSS treated 
IFNγR2Δ/Δ mice compared to the DSS treated IFNγR2fl/fl mice, although this didn’t 
reach significance (Fig 4.5A). 
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Upon necropsy DSS treated animals had macroscopically evident colitis, 
characterised by significantly shortened colons with a lack of visible faecal pellets 
(Fig 4.5C), although there were no differences between the genotypes. To enable 
more detailed investigation, instead of using the whole colon for longitudinal 
histological analysis, transverse gut samples were taken from the caecum, proximal, 
mid and distal colon. Sections were also taken from the distal colon for RNA 
analysis. 
 
Upon histological analysis only sections of the proximal colon and caecum could be 
analysed for crypt length. This was due to a complete ablation of all crypt 
architecture in both the mid and distal colon of DSS treated animals (Fig 4.6). In the 
proximal colon there was evidence of a trend towards crypt hyperplasia in the DSS-
treated IFNγR2Δ/Δ mice with no changes evident in the IFNγR2fl/fl mice, however, this 
did not achieve significance (Fig 4.7B). Conversely, in the caecum significant crypt 
hyperplasia was observed in the IFNγR2fl/fl DSS treated mice compared to untreated 
IFNγR2fl/fl animals. However, no clear changes in crypt architecture was evident in 
the caecum of the IFNγR2Δ/Δ DSS treated mice (Fig 4.7C). As well as measurements 
of crypt length evidence of ulceration, inflammation and oedema was scored for each 
section. This revealed significantly increased histological alterations in the DSS 
treated IFNγR2Δ/Δ mice in all sections of the colon and the caecum with the largest 
changes evident in the distal colon. Similarly, significant changes were seen in the 
DSS treated IFNγR2fl/fl mice in the mid and distal colon and the caecum but there 
were no significant differences between the genotypes in any area (Fig 4.7A). 
 
Systemically, low levels of the cytokines IL-17A, IL-4 and TNF were detectable in 
the serum of IFNγR2Δ/Δ DSS treated mice, but not in any of the other treatment 
groups, however none of these increases were significant (Fig 4.8A,C,F). Systemic 
levels of IFNγ and MCP-1 were also detected, however, they were present across all 
groups, including untreated animals, and showed no clear trends (Fig 4.8B,E). The 
only other cytokine tested that was detected systemically was IL-6. This displayed a 
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trend towards increased levels in both IFNγR2fl/fl and IFNγR2Δ/Δ DSS treated 
animals, however, in neither genotype did this reach significance (Fig 4.8D) 
 
Analysis of mRNA transcripts from the colons of treated mice demonstrated no 
increase of IFNγ message in IFNγR2fl/fl or IFNγR2Δ/Δ mice following DSS treatment 
(Fig 4.9D). Furthermore, there were no changes in IFNγ-responsive genes including 
iNOS, IP-10 and ifi205 (Gough et al., 2007) (Fig 4.9A-C). Interestingly, there 
appears to be a trend towards an increase in IFNγ-responsive gene (iNOS, IP-10, 
ifi205) message in untreated IFNγR2Δ/Δ mice, compared to untreated IFNγR2fl/fl mice. 
Furthermore, levels of IL-10 transcript was slightly, but not significantly, increased 
in IFNγR2Δ/Δ mice compared to IFNγR2fl/fl mice independently of DSS treatment. 
The most significant difference in mRNA levels was seen in SOCS1 message which 
was significantly elevated upon DSS treatment, with a 40-fold and 80-fold increase 
seen in DSS treated IFNγR2fl/fl and IFNγR2Δ/Δ mice respectively. There is also an 
approximately 7-fold increase in resting levels of SOCS1 transcript in IFNγR2Δ/Δ 
mice compared to IFNγR2fl/fl mice (Fig 4.9F). 
 
4.2.4. Comparison of IFNγR2fl/fl and IFNγR2Δ/Δ mice – 1.5% DSS colitis 
To confirm the reason we were unable to see a clear phenotype was not due to the 
severity of the colitis a further experiment was performed, this time with a DSS 
concentration of 1.5%. 
 
As with the previous experiments, IFNγR2Δ/Δ and IFNγR2fl/fl mice were treated with 
0% or 1.5% DSS in their drinking water, this time for 5 days followed by a period of 
drinking water with no additives. Unexpectedly, despite the decrease in DSS 
percentage, both IFNγR2fl/fl and IFNγR2Δ/Δ treated mice displayed a significant 
decrease in bodyweight on day 6. By day 7 this had reached a 15-20% loss of 
bodyweight (Fig 4.10A), and was significantly greater in IFNγR2fl/fl mice compared 
to IFNγR2Δ/Δ mice. The animals were euthanised on day 7 to prevent any more 
suffering as there was already a statistically significant increase in clinical symptoms 
of colitis including diarrhoea and bloody stools in both DSS treated groups (Fig 
4.10B). Upon necropsy DSS treated animals had macroscopically evident colitis  
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Fig 4.6 DSS-induced histological inflammation in IFNγR2fl/fl and IFNγR2Δ/Δ 
mice treated with 0 or 2% DSS. Colitis was induced through the addition of 2% 
DSS in drinking water for 7 days. On day 7 water with no additives was given to 
the mice. Histological changes were analysed from transverse H&E stained 
sections. Sections displayed are representative of each group. 
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exemplified by significantly shortened colons. DSS treated IFNγR2Δ/Δ mice had 
shorter, but not significantly so, colons than the DSS treated IFNγR2fl/fl mice (Fig 
4.10C). 
 
Upon histological analysis IFNγR2Δ/Δ mice displayed a complete ulceration of the 
distal and mid section of the colon, which was statistically significant. Less severe 
ulceration was evident in the proximal section but this didn’t reach significance, in 
comparison to untreated IFNγR2Δ/Δ mice (Fig 4.11A, B). Similarly, IFNγR2fl/fl mice 
displayed increasing ulceration when moving up from the distal to the proximal 
colon sections. These histological alterations were significantly increased compared 
to the IFNγR2fl/fl untreated mice in the distal and mid colon but did not reach 
significance over the total colon (Fig 4.11A,B). 
 
Similar systemic inflammation as the previous DSS experiments, was observed with 
a trend towards increased IL-6 levels in the DSS treated animals, independently of 
genotype (Fig 4.11F). Detectable levels of circulating MCP-1 and TNF were 
observed but displayed no clear trends (Fig 4.11E,G) and elevated IL-17A and IFNγ 
levels were seen in DSS treated IFNγR2Δ/Δ or IFNγR2Δ/Δ and IFNγR2fl/fl mice 
respectively (Fig 4.11C,D).  
 
These results demonstrate that the phenotype of IFNγR2Δ/Δ mice in the DSS-induced 
colitis appears to be slightly more severe than the colitis observed in the DSS treated 
IFNγR2fl/fl mice. This is evident through the increased weight loss and severity of 
histological alterations when subjected to 2.5% or 2.0% DSS. However, these 
changes are not all statistically significant. Nevertheless, it can be conclusively stated 
that our IFNγR2Δ/Δ mice do not appear to be protected from the effects of DSS-
induced colitis. Due to the absence of a clear distinguishable phenotype between the 
DSS treated IFNγR2Δ/Δ mice and DSS treated IFNγR2fl/fl mice no further 
experiments, utilising the conditional IFNγR2 knock-out mice, were performed. 
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4.3 DISCUSSION 
 
DSS-induced colitis is a well-established model of acute, innate-driven intestinal 
inflammation (Dieleman et al., 1994; Okayasu et al., 1990). Increasing the 
percentage of DSS administered in the drinking water of mice gives a dose-
dependent increase in colitis pathology. There is also some, slightly contradicting, 
data on the importance of water intake and thus the total DSS dose administered. 
Some experiments show it is the concentration of DSS administered, and not the total 
DSS dose consumed, that is the key factor in the severity of the colitis phenotype 
observed. Therefore, a minor change in fluid consumption, either between treatment 
groups or between different mice within a group, does not affect the severity of 
colitis observed (Egger et al., 2000). However, other experiments demonstrate a 
decrease in water consumption at high DSS concentrations and a correlation between 
total DSS dose (incorporating both water consumption and DSS concentration) and 
colitis (Vowinkel et al., 2004). Nevertheless, in the pilot study we performed, 
despite not monitoring water intake, a clear dose dependent increase in pathology 
was observed in wild-type mice treated with DSS in their drinking water. 
 
Previous studies have demonstrated that deletion of IFNγ results in protection against 
(Ito et al., 2006) or reduced severity (Nava et al., 2010; Xu et al., 2008) of DSS-
induced colitis. This is in stark contrast to our results, which suggest no protection 
against colitis and, if anything, a slight increased severity observed in IFNγR2Δ/Δ 
mice. However, in our experiments the IFNγR2fl/fl mice treated with DSS had no 
significant elevation in either intestinal or systemic levels of IFNγ. Therefore, the 
absence of a phenotype in IFNγR2Δ/Δ mice is expected. Conversely, in previous 
experiments a significant elevation of IFNγ levels in the colon is observed following 
DSS treatment (Ito et al., 2006; Nava et al., 2010). Several discrepancies in 
experimental protocol could underlie the differences observed between the different 
experiments including: background strain or gut flora of mice and the molecular 
weight of the DSS used for colitis induction. 
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4.3.1. Molecular weight of DSS could result in differences seen in the colitic 
phenotype of IFNγ deficient mice. 
It has been demonstrated that altering the molecular weight of DSS used for the 
induction of colitis in mice can impact both the severity and primary location of 
colitis observed. Mice given 5kD DSS develop a colitis predominantly observed in 
the caecum and upper colon, where as mice given 40kD DSS develop a colitis which 
is predominant in the lower colon and is more severe than the colitis induced by 5kD 
DSS (Kitajima et al., 2000). Ito et al. used DSS with a molecular weight of 5kDa, 
but neither Xu et al. nor Nava et al. state the molecular weight of the DSS used in 
their experiments. For our experiments we used DSS with a molecular weight of 36-
50kDa, and in keeping with observations of Kitajima et al., we detected the most 
severe inflammation in the lower colon. In the experiment performed by Ito et al., 
where total protection against DSS is observed in the absence of IFNγ, the 
histological alterations aren’t divided into segments of the colon; therefore it cannot 
be determined if the colitis predominated in the upper colon or the lower colon. 
Nevertheless, given the alterations in both severity and location previously reported, 
the lower molecular weight DSS may be driving inflammation through an altered 
mechanism which, in turn, could be driving the significant elevation of IFNγ seen in 
this model. 
 
4.3.2. Background strain of mice could result in differences in colitic 
phenotypes. 
It has been extensively documented that the background strain of mice is a key factor 
in determining the severity of colitis observed following DSS treatment. Mahler et 
al. analysed acute DSS-colitis in nine inbred strains and observed the pattern and 
severity of colitis. C3H/HeJ mice were most susceptible to colitis with a colonic 
ulceration frequency of 88%. In contrast, no ulcerations were observed DBA/2J 
mice. In this study by Mahler et al., both B6 and 129/Sv mice were highly 
susceptible to colitis, with severe inflammation observed in the colon. Interestingly, 
despite similar colonic pathology B6 mice had significantly increased inflammation 
in the caecum compared to 129/Sv mice (Mahler et al., 1998).  In previous 
experiments using IFNγ deficient mice, animals used were fully backcrossed onto a 
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B6 line (Ito et al., 2006; Nava et al., 2010; Xu et al., 2008). However, the mice we 
used for these experiments were on a mixed genetic background of B6 and 129/Sv. 
Although these two lines appear to have relatively similar inflammatory response to 
DSS (Mahler et al., 1998), it is important to also recognise that knowing the 
phenotype of parental strains doesn’t always define the range of responses in animals 
derived from their crossing. It has been demonstrated that epistatic interactions can 
occur between two strains resulting in a phenotype in offspring unlike the phenotype 
seen in either of the parental strains (Miner, 1997). This could explain the high 
sensitivity to the DSS-induced colitis seen in our IFNγR2fl/fl mice. These mice 
succumbed to severe colitis at low DSS concentrations when compared to the colitis 
observed B6 mice used in the pilot study. However, the genetic strain is unlikely to 
underlie the different phenotype of the IFNγR2 deficient mice in comparison to the 
IFNγ deficient mice of previous studies as both the IFNγR2Δ/Δ and IFNγR2fl/fl mice 
were on the same mixed background. 
 
4.3.3. Gut flora of mouse colonies could influence the colitic phenotype of IFNγ  
deficient mice. 
There is increasing evidence that normal enteric bacteria can play an important role 
in the intestinal inflammation see in both human IBD and in experimental colitis 
models. The association of enteric bacteria with inflammation in DSS-colitis is well 
described. Okayasu et al. reported alterations in the balance of enteric bacteria 
following acute DSS colitis, with increases in Bacteroides, Enterobacter and 
Clostridium but decreases in Eubacterium spp. and Enterococcus spp (Okayasu et 
al., 1990). 
 
It has recently been demonstrated in DSS-induced colitis that the inner mucus layer 
of the colon, which is normally devoid of bacteria, becomes penetrated with bacteria 
following DSS treatment. Moreover, this occurs prior to the observation of any 
intestinal inflammation (with 24 hours of DSS administration) and therefore could be 
one of the mechanisms through which DSS induces colitis (Johansson et al., 2010). 
This is supported through experiments demonstrating that treatment with some 
antibiotics can eliminate certain bacterial strains and therefore protect against colitis. 
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It is important, however, to note that some commensal bacteria have stronger pro-
inflammatory capabilities than others (Rath et al., 2001) and some can actually be 
protective. Indeed, it has recently been demonstrated that germfree IL-10 deficient 
mice are even more susceptible to DSS induced colitis that IL-10 deficient mice 
maintained on CRASF flora (Pils et al., 2010a). Thus, it is thought that some 
commensal bacteria can have a protective effect on DSS, with other experiments 
demonstrating commensal or probiotic bacteria e.g. Bifidobacterium can attenuate 
the severity of DSS induced colitis (Frick et al., 2007; Nanda Kumar et al., 2008). 
Taken together, this demonstrates that the balance of commensal bacteria found in 
mice is vitally important to the colitic phenotype. 
 
The mice in our animal facility are maintained with a Charles River altered 
Schaedler flora (CRASF) however, previous DSS experiments performed using 
IFNγ deficient mice did not report a defined flora. This is important as conventional 
mouse facilities can contain some pathogenic bacteria e.g. Helicobacteur hepaticus 
(Bohr et al., 2006) that is known to drive IFNγ-dependant intestinal inflammation in 
some mouse models of colitis e.g. IL-10 deficient mice (Kullberg et al., 1998). 
Therefore, different commensal gut flora can result in different levels of intestinal 
IFNγ following DSS treatment. This suggests that the increased IFNγ levels seen in 
studies by Ito et al. and others could be a result of an altered or more aggressive 
intestinal microbiota than maintained in our animal facility. Indeed, work with 
peptidoglycan recognition protein (PGRP) deficient mice identified an elevation in 
intestinal IFNγ levels, as a result of alterations in normal bacterial flora. These 
bacterial flora alterations led to an increased severity of DSS in these animals (Saha 
et al., 2010). Moreover, experiments by Saha et al. support the results we have 
generated as, wild-type mice treated with DSS display no increase in IFNγ levels or 
the IFNγ-responsive genes CXCL-9, -10, -11 or CCL-8. Moreover, although a role of 
IFNγ is implicated in PGRP deficient mice, blockade of IFNγ through neutralising 
antibodies does not protect the mice from colitis development but returns the severity 
of the disease to levels seen in control DSS-treated animals. 
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In conclusion, it appears that IFNγ is an important mediator in colitis when the colitis 
is driven by a skewed or excessively aggressive gut microbiota. Conversely, in DSS-
colitis induced in an animal unit with a strictly controlled gut microbiota there is no 
induction of IFNγ expression in the intestine and therefore, neutralisation of IFNγ or 
IFNγ signalling appears to be unimportant. 
 
 
4.3.4. Targeting of different genes for deletion could result in differences seen in 
the colitic phenotype of IFNγ  deficient mice. 
In previous experiments looking at the role of IFNγ in the induction of DSS colitis 
mice deficient in IFNγ have been used (Ito et al., 2006; Xu et al., 2008), whereas we 
have generated mice with a deficiency in IFNγR2. This may affect the phenotype 
seen in DSS-colitis as we have demonstrated that, as well as the abrogation of IFNγ 
signalling, the deletion of IFNγR2 results in a decreased sensitivity to IFNα. This 
could, in part, account for the trend towards increased sensitivity to DSS and 
elevated intestinal inflammation seen in the IFNγR2Δ/Δ mice as it has been 
demonstrated that mice deficient in the type I IFN receptor have an increased 
sensitivity to DSS. This is thought to be due to an anti-inflammatory action of 
IFNα/β on macrophages and a role of IFNα/β in protecting epithelial integrity 
(Katakura et al., 2005). Thus, by decreasing sensitivity to IFNα/β there could be a 
detrimental effect on epithelial integrity and macrophage actions. The decreased 
sensitivity of the IFNγR2Δ/Δ mice to IFNα/β needs to be further investigated, 
therefore the relevance of this mechanism needs further dissecting. 
 
4.3.5. Future experiments to investigate the contribution of IFNγ  in colitis 
To confirm that the gut flora of these mice is the key contributing factor to the 
altered phenotype of the IFNγR2Δ/Δ mice, compared to previously published results 
the experiment needs to be repeated in fully backcrossed mice housed both with the 
CRASF® flora and in a more conventional animal house. 
 
It has previously be demonstrated that the spontaneous colitis development observed 
in IL-10 deficient mice, maintained in conventional animal facilities, is associated 
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with increased levels of IFNγ production by CD4 T cells (Berg et al., 1996; Mahler 
& Leiter, 2002). Moreover, the enterocolitis development in these mice is 
preventable when mice are treated with anti-IL-12 or anti-IFNγ antibodies (Berg et 
al., 1996; Davidson et al., 2000). However, if treated once disease is established the 
anti-IFNγ antibodies are unable to reduce the severity of colitis (Berg et al., 1996). 
Therefore it will be interesting to cross the global and conditional IFNγR2 deficient 
mice to the IL-10 deficient background and to determine if IFNγR2 deficiency on the 
IL-10 deficient background protects against the development of colitis. If IFNγR2 
deficiency is protective it will be interesting to determine the key IFNγ responding 
cells in this setting using the conditional IFNγR2 deficient mice crossed to IL-10 
deficient mice. This will be particularly relevant, as clinically it has been 
demonstrated that IL-10 receptor deficient patients can develop severe, early-onset 
IBD (Glocker et al., 2009). 
 
These mice could also be used to investigate the IFNγ-driven intestinal inflammation 
seen in H. hepaticus. H. hepaticus infected IL-10 deficient mice are protected from 
colitis development when treated with anti-IFNγ antibodies (Kullberg et al., 1998). 
These experiments could be performed in our animal facility where, due to the 
maintenance of animals on the CRASF® flora, spontaneous colitis development 
doesn’t occur in IL-10 deficient mice (Pils et al., 2010a). 
 
4.4 CONCLUSION 
The results presented in this chapter demonstrate 
1. IFNγR2Δ/Δ mice are not resistant to DSS-induced colitis, under the conditions 
used in our experiments, and IFNγR2fl/fl mice do not show an up-regulation of 
IFNγ either locally or systemically following DSS treatment. 
2. IFNγR2Δ/Δ and IFNγR2fl/fl mice on a mixed B6 and 129/Sv background 
appeared to display increased sensitivity to DSS-induced colitis compared to 
the B6 mice used to titrate the initial DSS dose. 
3. Future experiments to investigate the role of IFNγR2 in colitis include 
crossing the complete and conditional IFNγR2 knock-out mice with IL-10 
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deficient animals and monitoring either spontaneous colitis development in a 
conventional animal facility or H. hepaticus driven intestinal inflammation. 
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CHAPTER FIVE 
 
Characterisation of the role of IFNγ  in 
Trichuris muris infection 
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5.1 INTRODUCTION 
 
It has already been established that IFNγ is an important mediator of susceptibility to 
T. muris, as antibody depletion of IFNγ can confer resistance to a normally 
susceptible mouse (Else et al., 1994) and mice deficient in IFNγ or IFN-γ receptor 1 
expel the parasite more rapidly than wild type animals (unpublished observation in 
review by (Grencis, 2001)). However, the cells that are important in responding to 
IFNγ and conferring susceptibility are unknown. 
 
Our conditional IFNγR2 system under the control of Cre-LoxP, as described in 
Chapter 3, enables us to investigate this mechanism in more detail. Given the 
importance of T cells in resistance to T. muris (Lee et al., 1983) and the prototypic 
role of IFNγ in Th1 skewed T cells, it is of interest to determine if the role of IFNγ is 
due to its actions on the T cell compartment. Alternatively, as there is a large 
accumulation of macrophages in the intestines of infected mice and, given the 
importance of IFNγ for macrophage activation, the action of IFNγ on macrophages 
may underlie the importance of IFNγ in susceptibility. The mice we have generated 
with the conditional inactivation of IFNγ on T cells and macrophages as described in 
Chapter 3 provides an elegant method for dissecting the role of IFNγ during T. muris 
infection. 
 
Aims 
Therefore, the aims are as follows: 
1. To verify if complete IFNγR2 deficient mice are resistant to a low dose 
Trichuris muris infection 
2. To determine if the absence of IFNγR2 on T cells and/or macrophages will 
mimic the resistant phenotype expected in the complete IFNγR2 knock-out 
mice 
3. Confirm the characterisation of IFNγ as a IgG2a switch inducing factor 
through the analysis of the antibody response in complete IFNγR2 deficient 
mice 
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4. To analyse the role of IFNγR2 in the differentiation of naïve T cells to Th1 or 
Th2 cells, during T. muris infection. 
 
5.2 RESULTS 
 
5.2.1 Lack of responsiveness to IFNγ  is sufficient to render a mouse resistant to 
T. muris 
 
To determine the importance of IFNγ signalling during the expulsion of T. muris, 
complete IFNγR2 knock-out mice (IFNγR2Δ/Δ) and control IFNγR2fl/fl mice 
(generated as described in Chapter 3) were infected with a low dose of T. muris and 
worm burden was assessed at day 35 p.i.. As anticipated, IFNγR2Δ/Δ mice were 
resistant to the infection having completely expelled their parasites, in contrast to 
IFNγR2fl/fl mice which were susceptible to infection, all harbouring adult worms (Fig 
5.1). This was not due to initial differences in infectivity, as at day 12 p.i. there were 
no differences between the two experimental groups (data not shown). 
 
Analysis of the antibody responses demonstrated the T. muris infected IFNγR2fl/fl 
mice mounted a mixed parasite-specific IgG1 and IgG2a/c response, consistent with 
the mixed Th1 / Th2 response expected in B6 mice (Fig 5.2). In contrast, the infected 
IFNγR2Δ/Δ mice mounted a slightly, but not significantly, stronger IgG1 response 
(Fig 5.2), with no detectable parasite specific IgG2a/c (Fig 5.2). This lack of IgG2a/c 
was expected as IFNγ has previously been described as an IgG2a/c switch inducing 
factor (Finkelman et al., 1988). Thus, the absence of an IgG2a/c response is not 
indicative of the absence of a Th1 response, but the inability for B cells to undergo 
class switching to IgG2a/c. 
 
Histological adaptations in crypt length were significantly different between the 
genotypes of infected mice, with infected IFNγR2fl/fl mice showing significant crypt 
hyperplasia at day 35 p.i. compared to naïve IFNγR2fl/fl mice. In contrast, infected 
IFNγR2Δ/Δ mice had a similar crypt length to naïve IFNγR2Δ/Δ mice (Fig 5.3). A 
significant goblet cell hyperplasia was also seen in infected IFNγR2fl/fl mice 
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compared to naïve IFNγR2fl/fl mice (Fig 5.4). Interestingly, although no goblet cell 
hyperplasia was observed in infected IFNγR2Δ/Δ mice compared to naïve IFNγR2Δ/Δ 
mice, uninfected IFNγR2Δ/Δ mice had significantly more goblet cells than uninfected 
IFNγR2fl/fl mice (Fig 5.4). As well as increased crypt length and goblet cells the 
infected IFNγR2fl/fl mice had a significant increase in CD3+ cells at d21 and d35 p.i. 
compared to naïve IFNγR2fl/fl mice. In contrast, infected IFNγR2Δ/Δ mice had a 
significant increase in CD3+ cells at d21 compared to naïve IFNγR2Δ/Δ mice, but this 
was no longer significant by d35 p.i. (Fig 5.5, 5.6). The influx of F4/80+ cells in 
IFNγR2fl/fl mice was slightly delayed in comparison to CD3+ cells, with no increase 
at d21 compared to naïve IFNγR2fl/fl mice but an elevation at d35 p.i., which was 
accompanied by an increase in Arg1+ cells. In the infected IFNγR2Δ/Δ mice a similar 
trend was observed in the F4/80+ cells as in the CD3+ cells, with a significant 
increase compared to the naïve IFNγR2Δ/Δ mice at d21 p.i. but a return to baseline 
levels by d35 p.i. (Fig 5.5, 5.6). 
 
Taken together, it can be seen that the deletion of IFNγR2 resulted in the abrogation 
of the parasite-specific IgG2a/c response, a trend towards elevated parasite-specific 
IgG1 titres and expulsion of the parasite. This is accompanied by an elevation in 
inflammatory cells at d21 p.i. which returns to levels comparable to naïve mice by 
d35 p.i.. 
 
5.2.2 Conditional inactivation of IFNγR2 on T cells or macrophages is 
insufficient to impart a resistant phenotype 
 
To determine the responding cells important in imparting the resistant phenotype to 
T. muris seen in complete IFNγR2 knock-out mice, T-cell deficient 
(IFNγR2fl/flCD4Cre+) and macrophage deficient (IFNγR2fl/flLysMCre+) mice, as 
described in Chapter 3, were infected with a low dose of T. muris and worm burden 
was assessed at day 35 p.i.. However, no significant differences in worm burden 
were seen in the conditional knock-out mice compared to the IFNγR2fl/fl control mice 
and all mice harboured chronic infections (Fig 5.7). 
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Histological alterations in crypt length were only statistically different in infected 
IFNγR2fl/flLysMCre+ mice, which displayed a marked crypt hyperplasia compared to 
naïve mice of the same genotype (Fig 5.8). However, the hyperplasia did not reach 
significance in comparison to IFNγR2fl/flLysMCre- T. muris infected mice. 
Moreover, there were no significant differences between infected and uninfected 
IFNγR2fl/flCD4Cre+ mice or between infected IFNγR2fl/flCD4Cre+ mice and infected 
IFNγR2fl/flCD4Cre- mice (Fig 5.8). 
 
As demonstrated previously, the infected IFNγR2Δ/Δ mice mounted a strong parasite-
specific IgG1 response, with no IgG2a/c response detected (Fig 5.2). In contrast, mice 
harbouring an IFNγR2 deficiency on either their T-cells or macrophages were 
capable of mounting a parasite-specific IgG2a/c response (Fig 5.9). Moreover, the 
infected IFNγR2fl/flLysMCre+ mice displayed a significant increase in parasite-
specific IgG2a/c compared to infected IFNγR2fl/flLysMCre- mice (Fig 5.9). This 
increase in IgG2a/c was not accompanied by a reciprocal decrease in IgG1, with no 
significant differences in antibody titre between infected LysM-Cre conditional 
mutant mice and infected IFNγR2fl/fl mice (Fig 5.9). 
 
Analysis of antigen-specific cytokine production following MLN re-stimulation 
demonstrated no significant changes in IFNγ, IL- 17A, IL-10, IL-4, IL-13, IL-6, TNF 
or MCP-1 following T. muris infection (Fig 5.10, 5.11). Large variability within both 
uninfected and infected groups hindered analysis and could be due, in part, to the 
mixed genetic background of the mice. Overall, as expected in a low dose infection, 
the mice mounted a predominantly Th1-mediated response with high levels of IFNγ 
detected and low or no IL-4 detected, except in the resistant IFNγR2Δ/Δ mice. In 
keeping with the levels of parasite-specific IgG2a/c, which is a marker of Th1 
responses, higher levels of IFNγ were seen in IFNγR2fl/flLysMCre+ mice compared to 
Cre- littermates, however, this was not statistically significant (Fig 5.10A). 
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Therefore, the ablation of the IFNγ response in T cells or macrophages, through the 
conditional inactivation of the IFNγR2 chain, is insufficient to mimic the resistant 
phenotype seen in the complete knock-out mice. 
 
5.2.3. Conditional inactivation of IFNγR2 on T cells and macrophages is 
insufficient to consistently impart a resistant phenotype 
 
To determine if there is redundancy in the IFNγ system the two conditional knockout 
lines were interbred to create a double conditional KO mouse (double KO, 
IFNγR2fl/flLysMCre+CD4Cre+) with the ablation of the IFNγ receptor on both T cells 
and macrophages. Initial experiments demonstrated the double conditional KO mice 
were capable of expelling a low dose infection. A trend towards a reduced worm 
burden in the T cell conditional knockout was also observed, although this did not 
reach significance (Fig 5.12). However, subsequent repeats of the experiment were 
unable to reproduce this phenotype with a significant increase in worms recovered 
from both the double conditional KO mice and the T cell specific knock-out from 
Experiments 2 and 3 compared to the worm burdens in Experiment 1 (Fig 5.12). 
Furthermore, in experiments 2 and 3 all mice were susceptible to the low dose 
infection with fecund adult worms present in the intestine. To determine if a subtler 
phenotype was being produced, in experiment 3 the length of the worms recovered 
from the gut at d35 p.i. were measured. However, no stunting was seen in the double 
conditional knockout mice. Nevertheless, there was a slight but significant stunting 
of worm growth in the IFNγR2fl/flLysMCre+ infected mice compared to the 
IFNγR2fl/fl infected mice (Fig 5.13). 
 
In the initial experiment, where the double conditional knockout mice were capable 
of expelling the parasite, the double KO mice displayed no histological changes 
compared to the IFNγR2fl/fl infected mice across all parameters measured (crypt 
length; CD3+ cell, F4/80+ cell and Arg1+ cell influx; Fig 5.14, 5.15). In contrast, 
there were significant differences in the antibody response with a decreased IgG2a/c 
response in both IFNγR2fl/flCD4Cre+ and IFNγR2fl/flCD4Cre+LysMCre+ infected 
mice compared to IFNγR2fl/fl infected mice (IFNγR2fl/flCD4Cre-LysMCre-) but no 
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changes in IgG1 response (Fig 5.17). Despite this decrease in IgG2a/c there was no 
corresponding decrease in IFNγ production following MLN re-stimulation (Fig 
5.19A), although there was a trend towards elevated IL-4 levels in the infected 
double KO mice and a significant increase in the infected IFNγR2fl/flCD4Cre+ mice 
compared to the infected IFNγR2fl/fl mice (Fig 5.19C). IL-13 cytokine levels 
mirrored the pattern of increased IL-4 cytokine production in the double KO and 
IFNγR2fl/flCD4Cre+ mice, although this did not reach significance in any of the 
groups (Fig 5.19C, D). Therefore, the resistance to T. muris infection in the double 
conditional knockout mice appears to be accompanied by a slight shift in the Th1-
Th2 balance compared to IFNγR2fl/fl mice, although this change was very subtle. 
 
To investigate the differences between the three experiments, in order to determine 
the mechanisms behind the different expulsion profiles, the histological adaptations 
in the intestine was examined. No significant differences in crypt length was 
observed between the genotypes within each experiment or across the across the 
experiments within each genotype (Fig 5.14). However, in the final experiment there 
appeared to be a significant increase in CD3+ cell influx in the intestine and a trend 
towards increased F4/80+ cell influx across all genotypes (Fig 5.15A,B). The validity 
of this data is uncertain as in the final experiment the tissue sections were fixed using 
a slightly difference method, therefore the elevation in positive cells could be a 
staining artefact. Nevertheless, the consistency of the Arg1+ cell numbers in 
comparison to the previous experiments (Fig 5.15C) and the elevated levels of MCP-
1 and TNF following MLN re-stimulation suggests that this may be a real result due 
to an increased inflammatory response (Fig 5.20B,C). 
 
Analysis of parasite specific IgG1 and IgG2a/c responses at day 35 p.i. demonstrated 
no significant differences between experiments in infected IFNγR2fl/fl and 
IFNγR2fl/flCD4Cre+ mice (Fig 5.17A,C; 5.18A,C). However, in the initial experiment 
the double conditional knock-out mice mounted a significantly increased IgG1 
response compared to experiments 2 and 3 (Fig 5.17B). This elevated Th2 response 
was accompanied by a decreased Th1 response with a diminished IgG2a/c response 
compared to the subsequent experiments (Fig 5.18B). Additionally, in the initial 
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experiment the macrophage specific knock-out mice mounted a significantly reduced 
IgG1 response compared to subsequent experiments (Fig 5.17C). Conversely to the 
double conditional knock-out, this reduction in IgG1 levels was not accompanied by 
a change in IgG2a/c levels, with no differences between the experiments (Fig 5.18C). 
 
On examination, the Ag-specific cytokine production following MLN re-stimulation 
demonstrated a similar trend to the antibody data. In the double conditional 
knockouts there was an increase in levels of the type 2 cytokines IL-4 and IL-13 in 
experiment 1 compared to the subsequent experiments (Fig 5.19C,D) with a 
concurrent decrease in IFNγ and IL-17A secretion (Fig 5.21A,B). However, these 
changes did not reach significance. Interestingly there appeared to be an increase in 
both IL-6 (Fig 5.20A) and TNF (Fig 5.20B) levels between the experiments with 
significantly higher levels of IL-6 seen in both experiments 2 and 3 when compared 
to the initial experiment and significantly higher levels of TNF in experiment 3 
across all of the genotypes. 
 
Therefore, the expulsion of the parasite seen in the double conditional knock-out 
mice in the initial experiment is associated with an increased Th2 response 
demonstrated by an elevation of antigen specific IgG1 and a trend towards increased 
IL-4 and IL-13 levels. This increased Th2 response is associated with a decreased 
Th1 response with lowered antigen specific IgG2a/c levels and a trend towards 
decreased IFNγ levels. However, the expulsion cannot be consistently repeated with 
subsequent experiments unable to replicate the resistant phenotype. 
 
The potential mechanisms behind the expulsion seen in the complete IFNγR2 
deficient mice and the discrepancies in the phenotype of the conditional knockout 
mice is dissected in the following discussion. 
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5.3 DISCUSSION 
 
Previous studies have demonstrated that mice harbouring the deletion of IFNγ or the 
receptor for IFNγ can expel a high dose T. muris infection more rapidly than control 
animals (unpublished observation in review by (Grencis, 2001)). The results of this 
chapter have extended this data to demonstrate that the deletion of IFNγ receptor 2 is 
sufficient to impart resistance to a low dose infection. 
 
As most cells express IFNγ receptors, and are therefore capable of responding to 
IFNγ, it can be very difficult to dissect the in vivo actions of the cytokine (Bach et 
al., 1997). Therefore, the conditional Cre-loxP system is extremely powerful in 
elucidating the mechanism through which resistance to T. muris is mediated. The 
analysis of the in vivo infection of conditional knock-out mice has demonstrated that 
the action of IFNγ, contrary to our hypotheses, is not dependent on T cells or 
macrophages, as CD4- and LysM- Cre conditional knockout mice remain susceptible 
to a low dose T. muris infection. However, there is some evidence that in certain 
circumstances the abrogation of IFNγ signalling in both T cells and macrophages is 
sufficient to reinstate the resistant phenotype seen in complete knock-out animals. 
 
5.3.1 The role of IFNγ-responsive cells in the generation of a Th1 response 
After infection with T. muris it is well documented that mouse strains either mount a 
Th1 response and become susceptible, with infections reaching chronicity; or they 
develop a Th2 response and expel their parasites. This T cell response is known to 
play a pivotal role in the mechanism of T. muris expulsion, as the depletion of CD4+ 
cells results in susceptibility to the parasite in normally resistant strains of mice 
(Koyama et al., 1995). Mice given a low dose infection, even if they are normally 
resistant to T. muris, will become susceptible (Wakelin, 1973). As susceptibility is 
accompanied by the inappropriate mounting of a Th1 response this model, of low-
dose T. muris infection, allows us to investigate the importance of IFNγ-
responsiveness in the generation of a Th1 response. 
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Previous experimental work has established that although IFNγ is not vital for the 
development of a Th1 response, it enhances responsiveness to IL-12 in naïve T cells 
thus increasing Th1 development (Wenner et al., 1996). Indeed, other experiments 
with IFNγR2 knock-out mice have shown a decreased Th1 polarisation, when IFNγ 
signalling is abrogated, due to a down-regulation of IL-12Rβ2 (Lu et al., 1998). 
However, in our model using a low dose T. muris infection to drive a Th1 response, 
we see no significant differences in IFNγ production between control mice and mice 
harbouring a complete knock-out of IFNγR2 when lymph node re-stimulations are 
analysed.  
 
A potential reason for the discrepancies in results is the different in vivo models used 
to investigate the Th1 polarisation. Lu et al immunised their mice with keyhole 
limpet hemocyanin (KLH) in FCA and analysed the immune responses following 
KLH re-stimulation of the draining lymph node cells at day 10 post immunisation. 
They observe a functional Th1 response in the IFNγR2Δ/Δ mice but it is significantly 
muted compared to the control mice. This experiment looks at a very early time point 
in the adaptive immune response and potentially the IFNγR2Δ/Δ mice take longer to 
mount a full Th1 response, so by day 35 post infection with T. muris we don’t see 
any significant differences between IFNγR2fl/fl and IFNγR2Δ/Δ mice. 
 
Moreover, experiments using the over-expression of a cytoplasmically-truncated 
dominant negative IFNγR1 on either T cells or macrophages demonstrated that 
macrophages made unresponsive to IFNγ fail to produce IL-12 and therefore a 
decrease in Th1 polarisation is observed. In contrast, mice in which T cells are 
unresponsive to IFNγ show normal Th1 polarisation (Dighe et al., 1995). However, 
our data suggests that both the IFNγR2fl/flLysMCre+ and IFNγR2fl/flCD4Cre+ mice 
are capable of mounting a Th1 response, with comparable levels of IFNγ produced, 
upon re-stimulation of lymph nodes with E/S antigen, as produced by IFNγR2fl/fl 
mice. Again, the different models used can explain the discrepancies in the data. The 
method of using the over-expression of a dominant negative receptor is a less 
specific method of gene inactivation. The high expression levels of the non-
endogenous mutant receptor can potentially have adverse effects, including the 
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mutation altering specificity for the original target or the physical-chemical 
properties of the receptor (Lagna & Hemmati-Brivanlou, 1998). Furthermore, the in 
vitro system used to analyse the generation of a Th1 response greatly simplifies the 
actions occurring in vivo, where the decreased IL-12 production from non-responsive 
macrophages could be compensated for by other cell types in the 
IFNγR2fl/flLysMCre+ mice; for instance dendritic cells. 
 
5.3.2. The role of IFNγ  responsive cells in mediating T. muris – induced 
intestinal inflammatory changes 
During T. muris infection an accumulation of lymphocytes is observed in the 
epithelium and lamina propria of the large intestine (Little et al., 2005). In resistant 
mice it has been demonstrated that inflammation is dominated by CD4+ 
intraepithelial lymphocytes and F4/80+ lamina propria leukocytes, which peaks at the 
time of worm expulsion. In contrast, susceptible mice have a peak of infiltrating cells 
during the chronic phase of the infection and the infiltrate is dominated by CD8+ 
intraepithelial lymphocytes and F4/80+ lamina propria leukocytes. Alongside the 
influx of inflammatory cells there are also changes in gut architecture with the 
generation of crypt hyperplasia, thought to be a hallmark of chronic infection (Artis 
et al., 1999).  
 
5.3.2.1. The role of IFNγ-responsive cells in mediating alterations in crypt 
length following T. muris infection. 
Intestinal epithelial cells undergo a continuous turnover and renewal with pluripotent 
stem cells at the base of crypts giving rise to daughter cells, which migrate luminally. 
As these enterocytes migrate they proliferate, differentiate and mature before 
undergoing programmed cell death and are extruded into the intestinal lumen 
(Potten, 1998). This process of epithelial cell turnover, in combination with the rate 
of epithelial cell proliferation, determines the length of crypts in the intestine. 
 
An elevation in the rate of epithelial cell turnover is an effector mechanism by which 
T. muris is expelled from the gut. In the Th2-dominated environment of a resistant 
mouse IL-13 induces an increase in the ‘epithelial escalator’, physically pushing the 
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parasites out of their niche environment (Cliffe et al., 2005). In contrast, in a Th1 
dominated environment IFNγ induces the chemokine CXCL-10 which has opposing 
actions to IL-13 and slows the rate of epithelial cell turnover (Cliffe et al., 2005). As 
well as altering epithelial turnover IFNγ can also increase crypt length by inducing 
epithelial hyper-proliferation (Artis et al., 1999). These two effects of IFNγ 
synergistically lead to an increase in crypt length and the niche environment in which 
T. muris resides. 
 
The histological data from the IFNγR2 complete knock-out mice demonstrates these 
mice do not undergo crypt hyperplasia during T. muris infection. This may be due to 
the expulsion of the parasite and recovery of the intestine to normal morphology, by 
day 35 p.i. when the analysis was performed. However, given the instrumental role 
of IFNγ in crypt hyperplasia, the deletion of the IFNγ receptor could be directly 
inhibiting epithelial hyper-proliferation and CXCL-10 induction. This would prevent 
crypt hyperplasia and decrease the epithelial niche in which the parasite resides, 
aiding parasite expulsion. 
 
Despite the well-established role IFNγ plays in crypt hyperplasia, whether IFNγ is 
acting directly on the epithelial cells or via another cell type to induce these actions 
is unknown. It has been proposed that the increased epithelial cell proliferation seen 
during T. muris infection could be due to IFNγ acting on macrophages and the 
induction of mediators like nitric oxide (Artis et al., 1999). Indeed, nitric oxide is a 
known mediator of IFNγ-induced intestinal epithelial hyper-permeability (Unno et 
al., 1995) as well as an inducer of epithelial cell apoptosis (Kagnoff & Eckmann, 
1997). However, we’ve demonstrated that in the IFNγR2fl/flLysMCre+ mice there is 
no decrease in crypt hyperplasia compared to IFNγR2fl/fl mice, suggesting that 
macrophages are not involved in the epithelial hyper-proliferation. Moreover, the 
lack of alterations in histological morphology in infected IFNγR2fl/flCD4Cre+ mice 
compared to infected IFNγR2fl/fl control mice suggests that T cells are also 
unimportant in these histological changes. 
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5.3.2.2. The role of IFNγ-responsive cells in the influx of CD3+ T lymphocytes 
into the intestine following T. muris infection 
The kinetics of lymphocyte influx into the intestine following T. muris infection has 
been demonstrated to be indicative of susceptibility to the parasite. Resistant mice 
show a peak in CD4+ intraepithelial lymphocytes around the time of worm expulsion 
and then a reversion to normal levels. However, in susceptible mice the number of 
intraepithelial lymphocytes increases more gradually than in resistant mice, as 
infection progresses, and remains high during the chronic phase of infection (Little et 
al., 2005). 
 
In our experiments there was an increase in CD3+ cells in both IFNγR2fl/fl and 
IFNγR2Δ/Δ mice by d21 p.i. however, in the IFNγR2Δ/Δ mice by day 35 p.i. this is no 
longer significant and appears to be returning to naïve levels. In contrast, IFNγR2fl/fl 
mice at day 35 p.i. still have a significant increase in CD3+ cells in the intestine 
compared to uninfected mice. This is consistent with previous data showing that, in 
susceptible mice, CD4+ cells remain high during chronic infection. In contrast, there 
were no significant differences in the number of CD3+ T cells present in the gut of 
infected IFNγR2fl/flCD4Cre+ mice compared to infected IFNγR2fl/fl control mice at 
d35 p.i.. As we looked at just the CD3+ population we could have missed more subtle 
changes in the CD4+, CD8+ and CD4-CD8- sub-populations found in the large 
intestine. Indeed, it has previously be reported that susceptible mice, despite having a 
more gradual influx of CD4+ cells, have more CD8+ cells in the intestine (Little et al., 
2005), therefore, there could be no significant changes in the overall CD3+ 
population. However, in the previous experiment high dose T. muris infections were 
given and the resistant and susceptible mice were on different genetic backgrounds 
(BALB/c and AKR respectively). The different genetic background may have 
confounding effects on the histological analysis as the mice display different levels 
of intraepithelial lymphocyte phenotypes in unchallenged mice, with significantly 
more CD8+ cells present in AKR mice (Little et al., 2005). Therefore, the differences 
in the influx of cells during in infection may be due to the strain differences and not 
the susceptibility to the parasite. To further clarify the importance of the influx of the 
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CD3+ subpopulations in mediating resistance to the parasite these populations should 
be characterised in the IFNγR2Δ/Δ (resistant) and IFNγR2fl/fl (susceptible) mice. 
 
5.3.2.2. The role of IFNγ-responsive cells in the influx of macrophages into the 
intestine following T. muris infection 
The role of macrophages in the expulsion of T. muris is not fully understood, 
however, it has been well documented that resistant mice have more macrophages in 
the intestine than susceptible mice (Little et al., 2005). Indeed, mice lacking the 
macrophage chemokine CCL2 have fewer macrophages in the gut lamina propria 
and fail to expel the parasite with an associated altered Th1/Th2 balance 
(deSchoolmeester et al., 2003). In light of this data it has been proposed that 
macrophages may be important in the mechanism of worm expulsion from the gut 
(Little et al., 2005).  
 
Work with other models of helminth parasites has determined that macrophages at 
the site of infection primarily display an alternatively-activated phenotype (Jenkins 
& Allen, 2010). The numbers of circulating alternatively activated macrophages 
(AAMs) increase during infection with Nippostrongylus brasiliensis and the AAMs 
are thought to be responsible for infection-associated alterations in small intestine 
smooth muscle. Indeed, expulsion of N. brasiliensis is impaired after depletion of 
macrophages or blocking of arginase (Zhao et al., 2008). Similarly, depletion of 
macrophages or blocking arginase activity in mice infected with Heligmosomoides 
bakeri (formerly Heligmosomoides polygyrus) increases parasitic burdens (Anthony 
et al., 2006). Previous research has therefore implicated a role for AAMs as effector 
cells in parasitic infections and AAMs are increasingly being recognised as an 
important arm of the Th2 immune response (Jenkins & Allen, 2010). Moreover, a 
striking number of mechanisms associated with alternatively activated macrophage 
responses to parasitic nematode infections have been identified, although these vary 
from parasite to parasite and between tissues (for review see (Horsnell & 
Brombacher, 2010)). 
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In keeping with the previous T. muris data, our IFNγR2Δ/Δ resistant mice have a 
significantly increased number of macrophages in the gut by day 21 p.i. which 
returns to naïve levels by day 35 p.i.. The IFNγR2fl/fl mice, on the other hand, do not 
display an increased number of macrophages in the intestine until day 35 p.i.. 
Moreover, in IFNγR2Δ/Δ mice we have demonstrated that macrophages produce 
significantly less nitric oxide and more arginase in vitro suggesting a skewing of the 
macrophages towards a alternatively activated phenotype. However, in vivo 
following T. muris infection there is no significant increase in the number of Arg1+ 
cells in the intestine of IFNγR2Δ/Δ or IFNγR2fl/flLysMCre+ mice compared to 
IFNγR2fl/fl mice. This is in contrast to other work with IFNγ knock-out mice, which 
display an enhanced generation of AAMs following pulmonary Cryptococcus 
neoformans infection (Arora et al., 2005). This discrepancy may be due to the model 
of infection used as in the low dose T. muris infection there is not a significant 
increase in levels of Th2 cytokines that drive the differentiation of AAMs. The 
elevation of macrophages seen during T. muris may not be as important as 
hypothesised as it has been recently demonstrated that expulsion of T. muris is 
unaffected by AAMs and arginase-1 is not essential for resistance to T. muris (R. 
Bowcutt, personal communication) and we have demonstrated efficient worm 
expulsion in IFNγR2Δ/Δ mice which do not develop classical macrophage effector 
functions. Moreover, it has recently been discovered that depletion of macrophages 
using CD11b-DTR mice during T. muris infection, does not alter worm expulsion but 
is important for regulating inflammation (M. Little, personal communication). 
 
An alternative explanation for the increase in macrophages seen at d21 p.i. in the 
intestines of IFNγR2Δ/Δ mice is that this is unrelated to resistance to T. muris but due 
to an altered myelopoiesis and chemokine expression (Kelchtermans et al., 2007; 
Matthys et al., 1999). It has previously been demonstrated that IFNγ is normally 
involved in the maintenance of myelopoiesis and the removal of IFNγ signalling 
results in an increase in macrophage production (Matthys et al., 1999). This 
synergises with an elevation in chemokine production e.g. MCP-1 following IFNγ 
deletion (Kelchtermans et al., 2007), resulting in an increased infiltration of 
monocytes into tissues. Although following MLN stimulation there did not appear to 
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be an increase in MCP-1, we cannot rule out an increase in MCP-1 in the intestinal 
tissue. 
 
5.3.3 Future directions to further investigate the role of IFNγ  responsive cells in 
T. muris infection  
 
The inconsistency in the IFNγR2fl/flCD4Cre+LysMCre+ phenotype, in contrast to the 
robustness of the complete knock-out phenotype, demonstrates that although the 
inability to respond to IFNγ in T cells and macrophages can, under some 
circumstances, boost the Th2 response sufficiently to enable to expulsion of the 
parasite, there is another important IFNγ responding cell type or types involved in 
susceptibility to the T. muris. 
 
The mechanism behind the differences seen between the three experiments with the 
double conditional knockout mice is unknown. All of the control mice had 
comparable worm burdens, the eggs were from the same batch and infections were 
performed at similar times suggesting that the level of infection or circadian 
interactions weren’t the cause of the inconsistency. Moreover, there were no 
differences in the age of the mice and although in all three experiments mice of a 
mixed sex were used no significant differences were seen between the sexes in any 
of the parameters analysed. The only confounding factor between the experiments 
was the time of year. Indeed, it has been demonstrated in other experiments that 
‘circannual rhythms’ can have an influence despite mice being housed temperature 
and light controlled environments (Loscher & Fiedler, 1996). The way mice are able 
detect seasonal changes despite the controlled environment is not known, but it has 
been proposed that the presence of an endogenous oscillator as part of a calendar 
system in combination with a seasonally varying environmental queue could be 
responsible. One environmental queue which as been hypothesised to be detectable 
by mice, despite maintenance in a controlled environmental, is the horizontal 
component of the geomagnetic field (Bartsch et al., 1994). The ability of changes in 
circannual rhythms to impact the susceptibility of mice to T. muris infection is 
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feasible, indeed, it has recently been demonstrated that circadian rhythms can alter 
susceptibility (S. Otto, personal communication). 
 
Nevertheless, there are clearly other cell types involved in the resistance seen in 
IFNγR2Δ/Δ mice. Potential candidates include other haemopoietic cells e.g. dendritic 
cells and B cells or non-haemopoietic cells e.g. epithelial intestinal cells. To clarify 
the potential involvement of these other cell types the following experiments, using 
the versatility of the Cre-loxP system, could be performed. 
 
5.3.3.1 Generation of an IFNγR2fl/fl x Vav-Cre mouse would allow the role of 
IFNγ-responsive cells in the haemopoietic system during T. muris infection to be 
elucidated 
 
Vav-Cre mice have been generated which drive recombination between loxP sites in 
the majority of haematopoietic cells and endothelial cells but in very few other 
somatic cells (Georgiades et al., 2002). Crossing the IFNγR2fl/fl mice to Vav-Cre 
mice will allow the determination of whether the additional cells responsible for the 
resistant phenotype observed in IFNγR2Δ/Δ mice are part of the haemopoietic system. 
If this is the case, further experiments could then be performed to dissect which 
components of the haemopoietic system are most important. Two potential 
candidates are the dendritic cells and the B cells. 
 
5.3.3.1.1. Generation of an IFNγR2fl/fl x CD11c-Cre mouse would allow the role 
of IFNγ-responsive dendritic cells during T. muris infection to be elucidated. 
 
Dendritic cells (DCs) are the most important professional antigen-presenting cells, 
with the ability to prime naïve T cells. Immature DCs reside in peripheral tissue 
where they act as sentinels, capturing and processing antigens. Upon activation DCs 
migrate to secondary lymphoid organs where they prime antigen-specific naïve T 
cells (Moser & Murphy, 2000). 
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The importance of dendritic cell responses in the outcome of T. muris infection has 
been demonstrated through experiments showing that the kinetics and magnitude of 
the dendritic cell response are strikingly different between resistant and susceptible 
animals (Cruickshank et al., 2009). Dendritic cells in mice susceptible to T. muris do 
not appear to become fully mature in contrast to dendritic cells in resistant mice, 
which display increased MHC class II, CCR7 and other maturation markers. 
Moreover, as the influx of dendritic cells occurs several days prior to the generation 
of an adaptive immune response, they may be key in facilitating the skewing of the 
immune response (Cruickshank et al., 2009). 
 
It has also been demonstrated that IFNγ is an important mediator in the maturation of 
dendritic cells. Using IFNγR2 knock-out mice it has been shown that IFNγ is 
important for the up-regulation of the co-stimulatory molecules CD54 and CD86. It 
is also important for the secretion of the pro-inflammatory cytokines IL-1β and IL-
12p70. Furthermore, IFNγR2-deficient DCs have a decreased ability to stimulate 
alloreactive T cells and drive Th1 differentiation (Pan et al., 2004). Therefore, the 
dendritic cell may be an important target for IFNγ responsiveness and could be, at 
least in part, responsible for the discrepancy seen between the double conditional and 
complete knock-out phenotype. 
 
5.3.3.1.2. Generation of an IFNγR2fl/fl x CD19-Cre mouse would allow the role 
of IFNγ-responsive B cells during T. muris infection to be elucidated. 
 
B cells upon activation will become either a memory cell or a plasma cell capable of 
producing a large amount of antibody. In germinal centres mature B cells can 
undergo class switching - changing from the production of IgM and IgD to other 
isotypes such as IgG and IgE (for review see (Bonilla & Oettgen, 2010)). Class 
switching is partly determined by the cytokine milieu e.g. IL-4 promotes class 
switching to IgE and IgG1 whereas IFNγ promotes class switching to IgG2a. In 
addition, IFNγ antagonises the effects of class switching induced by IL-4 (Hasbold et 
al., 1999). In keeping with this, it has been established that the abrogation of IFNγ 
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signalling results in inhibition of IgG2a secretion and the enhancement of IgG1 and 
IgE secretion by B cells (Finkelman et al., 1988).  
 
The investigation of IFNγR2fl/fl x CD19-Cre mice would allow the role of IgG2a 
antibodies during T. muris infection to be analysed. It has previously been proposed 
that IgG2a may act as a blocking antibody to prevent IgG1-mediated effector 
mechanisms. Therefore, the deletion of IFNγR2 on B cells may not only increase 
IgG1 levels through the removal of IFNγ antagonism of IL-4-induced IgG1 class 
switch but also increase the efficacy of IgG1 by the removal of functional 
antagonism. Parasite-specific IgG1 is known to be important to T. muris infection 
outcome as the transfer of parasite-specific IgG1, purified from the serum of resistant 
NIH mice, can prevent worm establishment in  µMT mice (Blackwell & Else, 2001). 
Although anti-parasitic IgG1 responses are an attractive candidate for effector 
mechanisms against T. muris a clear role for antibody has not been demonstrate 
during primary infections (Blackwell & Else, 2002).  This suggests that IFNγ 
responsive B cells are unlikely to be the cause of discrepancy between the double 
conditional knock-out mice and the complete knock-out mice, but the IFNγR2fl/fl x 
CD19-Cre mice present an elegant method of confirming the role of IgG2a in 
primary and secondary T. muris infections. 
 
5.3.3.1.2 Generation of an IFNγR2fl/fl x Villin-Cre mouse would allow the role of 
IFNγ-responsive intestinal epithelial cells during T. muris infection to be 
elucidated. 
 
Another cell type, which could be an important target for IFNγ in susceptibility to T. 
muris, is the intestinal epithelial cell. Epithelial cells have recently be recognised to 
play a more important role that once acknowledged in directing immune responses as 
demonstrated by the presence of the ‘epimmunome’ – a collection of molecules 
secreted by epithelial cells and epithelial cell surface molecules which are capable of 
directing the actions of immune cells (Swamy et al., 2010).  
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T. muris resides within the epithelial cells throughout its lifetime, as following egg 
hatching L1 larvae invade the epithelial cells, moving through the epithelium in a 
syncytical tunnel. Indeed, in T. muris it is known that intestinal epithelial cells play a 
vital role in resistance to the parasite as the intestinal epithelial cell-specific deletion 
of IκB kinase (IKK)-β results in the development of susceptibility to a high dose 
infection (Zaph et al., 2007). This susceptibility is associated with the failure to 
mount a Th2 response and the alteration of dendritic cell conditioning, suggesting 
that epithelial cells may be able to alter the dendritic cell response. 
 
In addition to the role of epithelial cells in shaping the immune response following 
infection with T. muris, it has been demonstrated that epithelial cells play an 
important role in the effector response required for parasite expulsion. It is known 
that the epithelial escalator is important in the expulsion of the parasite and that this 
is controlled through IL-13 which enhances movement up the crypt and IFNγ-
induced CXCL10 which slows movement of cells up the crypt (Cliffe et al., 2005). 
We have demonstrated that macrophages and T cells are unlikely to be the important 
source of CXCL10 in the gut as, although mucosal T cells are capable of producing 
CXCL10 (Singh et al., 2008), IFNγR2fl/flCD4Cre+ and IFNγR2fl/flLysMCre+ infected 
mice display similar crypt hyperplasia to IFNγR2fl/fl mice. It is known that gut 
epithelial cells are capable of responding directly to IFNγ (Baumgart et al., 1998) 
and producing CXCL10 (Kawaguchi et al., 2009) so, could be the vital source of 
CXCL10 during infection. Furthermore, epithelial hyper-proliferation enhances crypt 
hyperplasia and has been shown to be dependant on IFNγ (Artis et al., 1999). 
Recently it has been demonstrated that IFNγ acts directly on epithelial cells to 
regulate intestinal epithelial homeostasis via β-catenin signalling pathways and can 
increase epithelial proliferation (Nava et al., 2010). Given the importance of the 
epithelial escalator in parasite expulsion and the potential of IFNγ responding 
intestinal epithelial cells to alter crypt length, it would be of interest to determine if 
the intestinal epithelial specific deletion of IFNγR2 is sufficient to confer resistance. 
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5.4 CONCLUSION 
 
The results presented in this chapter demonstrate that: 
1. Complete deletion of IFNγ results in the generation of a mouse resistant to T. 
muris infection. 
2. T cells and macrophages play a role in the resistance to T. muris but there are 
other cell types that are also important. 
3. Complete, T cell specific or macrophage specific deletion of IFNγR2 does 
not impede the development of a Th1 response following T. muris infection. 
4. Complete deletion of IFNγR2 stops B cells being able to class switch to 
produce IgG2a/c antibodies. 
5. The generation of further conditional knock-out mice will allow more 
detailed dissection of the role IFNγ plays during T. muris infection. 
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6.1 INTRODUCTION 
Experimental autoimmune encephalomyelitis (EAE) is currently the most commonly 
used animal model for the study of multiple sclerosis. The role of IFNγ in the 
pathogenesis of CNS inflammation in both MS and EAE has been controversial with 
data pointing to both a detrimental and protective function. 
 
For many years the IFNγ-secreting Th1 cells were believed to be the pathogenic 
population central EAE. However, following the initial experiment by Billiau and 
colleagues, which produced the unexpected result that treatment of mice with 
neutralising monoclonal antibodies against IFNγ enhanced the severity of EAE 
(Billiau et al., 1988), the role of IFNγ during EAE has remained fairly controversial. 
Further experiments using mutant mice confirmed the studies with neutralising 
antibodies as IFNγR1 deficient mice on a 129/Sv background developed EAE with 
high morbidity and mortality compared to wild type mice (Willenborg et al., 1996). 
Multiple studies have now been performed using both IFNγR1 and IFNγ deficient 
mice, in both acute EAE and adoptively transferred EAE, all of which demonstrate 
an increased susceptibility and more severe symptoms in the mutant mice (Chu et al., 
2000; Ferber et al., 1996; Krakowski & Owens, 1996; Willenborg et al., 1999). More 
recent studies have suggested that IFNγ deficiency results in a shift from classical 
EAE symptoms – with ascending paralysis and inflammation in the spinal cord to a 
non-classical or atypical EAE with axial rotatory movement, disequilibrium, and 
ataxia (Wensky et al., 2005).  
 
Atypical EAE in IFNγ deficient mice has been demonstrated to result in a large 
eosinophil accumulation in the brainstem and cerebellum. It was hypothesised that 
the eosinophilia could be responsible for the atypical symptoms (Wensky et al., 
2005), however, further work has demonstrated that mice backcrossed onto an IL-5 
deficient background still display atypical symptoms but there is an absence of 
eosinophilia (Wensky et al., 2005). Therefore, the location of inflammation rather 
than the make up of the inflammatory cell infiltrate is thought to determine the EAE 
phenotype, however, it is still to be elucidated what the mechanisms are behind these 
alterations. Several reasons have been proposed for the atypical symptoms observed 
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in IFNγ or IFNγR1 deficient mice including a decreased chemokine expression or 
altered lineage commitment of cells i.e. IFNγ has been shown to inhibit Th17 
development in vitro through the down-regulation of the IL-23 receptor (Harrington 
et al., 2005). 
 
It has been demonstrated that the generation of an atypical pathology in IFNγ or 
IFNγR1 deficient mice is associated with the influx of inflammatory cells into the 
cerebellum and brain stem (Wensky et al., 2005) rather than the spinal cord as seen 
in classical EAE. This has also been demonstrated in the adoptive transfer model of 
EAE as the transfer of wild-type T cells into wild-type mice results in spinal cord 
inflammation; but the transfer of wild-type cells into IFNγR1 deficient mice results 
in brain inflammation. Interestingly, the transfer of IFNγ deficient T cells into wild-
type mice also results in brain, rather than spinal cord, inflammation and an atypical 
phenotype (Lees et al., 2008). Given these results it has been proposed that IFNγ 
signalling in the spinal cord is required for inflammation but IFNγ signalling in the 
brain inhibits inflammation (Lees et al., 2008). This is not fully understood as, in 
contrast to this hypothesis, it has been shown that IFNγ has several pro-inflammatory 
actions in the CNS including activation of resident microglia and infiltrating 
macrophage cells, induction of MHC class II and co-stimulatory molecule expression 
in astrocytes (Nikcevich et al., 1997), all culminating in increased tissue injury 
(Goverman, 2009; Krakowski & Owens, 1996). Indeed, IFNγ expression in the 
mature CNS under the control of an oligodendrocyte specific promoter resulted in 
the development of demyeliniation, gliosis and inflammation (Horwitz et al., 1997). 
In light of this data an alternative hypothesis has been suggested which proposes that 
it is an altered influx of cells which is important for the different phenotypes 
observed and that IFNγ is important in inhibiting the influx of T cells into the brain. 
Indeed, IFNγ deficient mice displaying atypical symptoms have no detectable CNS 
expression of the chemokines CXCL9 and CXCL10 (Lees et al., 2008). Moreover, it 
has been shown that the receptor for these chemokines, CXCR3, plays an important 
role in retaining T cells in the perivasculature space of the cerebellum and therefore, 
preventing atypical disease development (Muller et al., 2007). 
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An alternative proposed mechanism for the altered location of inflammatory cells is 
the CD4 T cell subset developed in the mice. Recent experiments have demonstrated 
the T cells specific for different epitopes of MOG preferentially induce inflammation 
in different areas e.g. MOG97-114 preferentially induces brain inflammation and an 
atypical phenotype whereas MOG35-55 and MOG79-90 preferentially induces spinal 
cord inflammation and a classical phenotype. In this system T cells infiltrated the 
brain and spinal cord meninges at a comparable rate for all three epitopes but brain 
inflammation was only observed in mice where the number of Th17 cells was equal 
or higher to the number of Th1 cells in the brain meninges. This observation lead to 
the proposal that the balance of Th17 and Th1 cells, in the infiltrating population, is 
the crucial factor in determining inflammatory cell infiltration in the brain. As it has 
been shown that inhibition of IFNγ can increase IL-17 producing cells (Harrington et 
al., 2005), in IFNγ deficient mice an increased ratio of Th17 cells to Th1 cells could 
be the cause of the atypical phenotype seen in the mutant mice. However, 
experiments performed at the University of Zurich demonstrate that the cause of the 
preferential influx into the cerebellum and brain stem is not due to an increase in IL-
17 expressing cells, as IL-17, IFNγ double deficient animals still develop an atypical 
disease (V. Toveski, personal communication). 
 
It is apparent that, despite multiple groups establishing an altered site of 
inflammation influx in IFNγ deficient animals with atypical EAE, more research is 
necessary to understand the mechanisms underlying this process. Through a 
collaboration with Professor Burkhard Becher at the University of Zurich we were 
able to investigate, for the first time, the role of IFNγR2 during EAE. Mice from our 
facility at the University of Manchester were shipped to the animal facility at the 
University of Zurich, and the EAE experiments were performed in Zurich. Future 
work utilising the conditional inactivation of the gene through the Cre-LoxP system 
may finally clarify the role of IFNγ in this model. 
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6.2 EXPERIMENTAL SETUP 
The experiments were performed according to the scheme shown in Fig 6.1. Briefly, 
for the initial experimental (Experiment 1) mice were shipped from the Biological 
Services Unit at the University of Manchester to the experimental animal facility at 
the University of Zurich. These mice were then left to acclimatise for 1 week prior to 
immunisation with MOG-CFA and pertussis toxin on day 0 (for details see Section 
2.2.3). Mice were subjected to a second dose of pertussis toxin on day 2 p.i.. Mice 
were monitored daily for clinical symptoms and from day 7 p.i. were weighed daily 
until the termination of the experiment at day 21 p.i.. B6 mice, bred and maintained 
at the University of Zurich experimental animal facility, were immunised 
simultaneously and used as controls. 
 
Minor alterations were made to the experimental procedure prior to the start of the 
subsequent experiment (experiment 2) (see Fig 6.1). The primary change was an 
Fig 6.1 Scheme illustrating the experimental setup followed for EAE experiments. In 
Experiment 1 mice were shipped from Manchester to Zurich seven days prior to immunisation 
and autopsied on day 21 post immunisation. In Experiment 2 mice had a two week 
acclimitisation period with used bedding from other cages prior to immunisation. Mice were 
subsequently autopsied at day 24 post immunisation 
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increase in the acclimatisation time following the shipping of animals to Zurich, 
from one week to two weeks. During this period the mice were exposed to dirty 
bedding from mice, which had been reared at the University of Zurich experimental 
animal facility. For this experiment bodyweight was measured from day 0 and the 
experiment was continued until day 24 p.i.. 
 
6.3 RESULTS 
 
6.3.1. Induction of EAE in IFNγR2fl/fl and IFNγR2Δ/Δ mice 
Experiment 1: EAE disease penetrance was poor with 3/9 IFNγR2Δ/Δ mice and 1/9 
IFNγR2fl/fl mice displaying clinical symptoms by day 21 p.i. (Fig 6.2B). 
Furthermore, mice which did display clinical symptoms only had a mild phenotype 
e.g. the sole IFNγR2fl/fl mouse which displayed clinical symptoms only suffered from 
tail paralysis with no involvement of the hind or fore limbs (Fig 6.2B). Furthermore, 
neither group appeared to undergo a significant weight loss (Fig 6.2A). There was a 
greater increase in weight d11-13p.i. in the IFNγR2Δ/Δ mice in comparison to 
IFNγR2fl/fl mice, however this was not maintained for the duration of the experiment 
(Fig 6.2A). 
 
In both IFNγR2fl/fl and IFNγR2Δ/Δ mice severe ulceration at the point of MOG-CFA 
immunisation was observed (Fig 6.3). It has previously been recognised that the 
subcutaneous immunisation of CFA-containing adjuvants can cause ulceration 
(Broderson, 1989). However, the penetrance and severity of ulceration in the mice 
was more severe than normally observed in mice at the University of Zurich (B. 
Becher, personal communication). Moreover, B6 control mice had good EAE 
penetrance and no ulcerations at the injection site (data not shown). Therefore, one 
hypothesis was that a difference between animal units could be the cause of the low 
penetrance and ulceration. As one of the main differences in the mouse colonies at 
the University of Manchester and the University of Zurich is the gut flora the mice 
are maintained on, the experiment was repeated but upon arrival at the University of 
Zurich mice were house in cages with dirty bedding. The mice were then left to  
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acclimatise for two weeks, being maintained in cages that contained dirty bedding 
from other cages within the animal unit (see Fig 6.1). 
 
6.3.2. Clinical symptoms of EAE in IFNγR2fl/fl and IFNγR2Δ/Δ mice 
Experiment 2: Following acclimatisation, mice were immunised and clinical 
symptoms and bodyweight monitored daily (Fig 6.4A). No ulcerations at the site of 
immunisation were observed in any mice throughout the experiment. In IFNγR2fl/fl 
mice an EAE penetrance of 7/9 was observed with a decreased bodyweight evident 
from day 13 p.i., corresponding with the onset clinical symptoms (Fig 6.4A,B). 
Weight loss continued for approximately 4 days accompanied by worsening of 
clinical symptoms. These clinical symptoms were of a classical EAE phenotype 
evident initially through loss of tone in the tail and proceeding with complete tail 
paralysis followed by hind limb paralysis in most mice. At day 17 p.i. bodyweight 
began to increase, returning to baseline, and clinical symptoms decreased with 
recovery of hind limb and then tail function (Fig 6.4A,B). At the end of the 
experiment (day 24 p.i.) the mice had almost fully recovered with a slight paralysis 
of the tip of the tail the only evidence of any EAE in the mice (Fig 6.4B). 
 
IFNγR2Δ/Δ mice also displayed good EAE penetrance with 6/9 mice displaying 
symptoms. Weight loss began at a similar time to the IFNγR2fl/fl mice - 
approximately day 13 p.i., with a corresponding onset of clinical symptoms (Fig 
6.4A,B). However, in contrast to the IFNγR2fl/fl mice, the clinical symptoms 
observed in 5/6 IFNγR2Δ/Δ mice were not the classical symptoms of EAE but an 
alternative or atypical symptoms. These symptoms generally started with an axial 
rotatory movement upon tail suspension, bringing the fore-limb of one side up to the 
hind limb of the same side. This was followed by evidence of a head tilt that 
proceeded to tilting of both the head and body. These symptoms increased until the 
mice were unable to walk in a straight line, and instead started to travel in circles, 
with evidence of vertigo. In some cases the onset of symptoms in IFNγR2Δ/Δ mice 
was sudden, with no evidence of any EAE phenotype one day prior to the 
observation of severe symptoms and vertigo. Moreover, the IFNγR2Δ/Δ mice were 
unable to recover from these symptoms before the termination of the experiment on 
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day 24 p.i. and, correspondingly, had no recovery in bodyweight (Fig 6.4A). One 
IFNγR2Δ/Δ mouse developed classical EAE symptoms, however, unlike the 
IFNγR2fl/fl mice it had not recovered by the end of the experiment and still displayed 
complete hind limb paralysis. Moreover, there was evidence of both the classical 
paralysis and atypical symptoms with asymmetric axial rotation upon tail suspension 
observed, a sign of preliminary atypical disease. 
 
Due to the poor penetrance of EAE in the initial experiment all subsequent data 
refers to analysis performed in mice in experiment two. 
 
6.3.3. Histological alterations during EAE in IFNγR2fl/fl and IFNγR2Δ/Δ mice 
To determine the cause of the EAE symptoms, inflammation in the spinal cord and 
cerebellum was analysed in the IFNγR2Δ/Δ and IFNγR2fl/fl mice. Analysis of H&E 
stained longitudinal sections of the spinal cord demonstrated inflammation in both 
the IFNγR2Δ/Δ and IFNγR2fl/fl mice displaying EAE symptoms, with a trend towards 
increased inflammation in the IFNγR2fl/fl mice (Fig 6.5A,B). No correlation between 
EAE symptoms and spinal cord inflammation was seen in IFNγR2Δ/Δ mice although, 
the IFNγR2Δ/Δ mice which developed classical EAE symptoms had more severe 
inflammation in the spinal cord than the other IFNγR2Δ/Δ mice (Fig 6.5B,C). In 
contrast, a clear correlation between spinal cord inflammation and classical EAE 
symptoms was observed in IFNγR2fl/fl mice (Fig 6.5D). 
 
Analysis of H&E stained brain sections demonstrated the presence of inflammation, 
but in order to get a clearer picture of the inflammatory changes occurring further 
staining was performed by immunohistochemistry for CD45 and ionised calcium 
binding adaptor molecule -1 (IBA-1) positive cells. In the cerebellum a significant 
increase in CD45 positive cells was observed in the IFNγR2Δ/Δ mice compared to the 
IFNγR2fl/fl mice (Fig 6.6A). This became highly significant (p=0.0004) when the 
mice that didn’t develop EAE were excluded from the analysis. In contrast to the 
spinal cord analysis, the CD45 influx in the IFNγR2Δ/Δ mice showed a correlation 
with maximum EAE score (Fig 6.6B) whereas, in the IFNγR2fl/fl mice there was no 
correlation between EAE score and CD45-positive cell infiltrate (Fig 6.6C). It needs  
Chapter Six: Experimental autoimmune encephalomyelitis 
 
 - 186 - 
Chapter Six: Experimental autoimmune encephalomyelitis 
 
 - 187 - 
Chapter Six: Experimental autoimmune encephalomyelitis 
 
 - 188 - 
to be noted that the number of CD45 cells stained may be an under-representation of 
the number of CD45 cells in the brain as the brains were left in paraformaldehyde for 
2 weeks prior to tissue processing. 
 
To get a better understanding of the events occurring in the brain, sections were 
analysed for microglial activation. Microglia were visualised through staining with 
an IBA-1 antibody (Imai et al., 1996) and the different activation states were 
analysed (see Section 2.3.5. for a description of the microglia scoring criteria). 
Again, due to fixation problems the staining was not as strong as typically seen and, 
therefore, only microglia in activation states 2-4 and not resting microglia were 
visualised as these states express higher levels of IBA-1 (Ito et al., 2001). Despite the 
increased inflammatory infiltrate into the cerebellum, IFNγR2Δ/Δ mice had lower 
levels of microglia activation in the cerebellum compared to IFNγR2fl/fl mice (Fig 
6.7A). The clearest difference between the IFNγR2Δ/Δ and IFNγR2fl/fl mice was 
apparent in the cerebral cortex, as IFNγR2Δ/Δ mice had significantly less activated 
microglia in this area compared to other areas of the brain. Moreover, in this area, the 
IFNγR2Δ/Δ mice had significantly less, state 2 and total, activated microglia compared 
to IFNγR2fl/fl mice (Fig 6.7C,E).  
 
This histological data supports previously demonstrated findings that atypical 
symptoms correlate with inflammation in the brain whereas typical or classical EAE 
symptoms correlate with inflammation in the spinal cord (Wensky et al., 2005). 
 
6.3.4. FACS analysis of infiltrating cells in the brain during EAE in IFNγR2fl/fl 
and IFNγR2Δ/Δ mice 
 
FACS analysis was performed on four IFNγR2Δ/Δ mice and two IFNγR2fl/fl mice, of 
the IFNγR2Δ/Δ mice one mouse displayed classical and not atypical EAE symptoms. 
Matching the histological analysis, there was an increased percentage of CD45 
positive cells in IFNγR2Δ/Δ mice compared to IFNγR2fl/fl animals (Fig 6.8A). 
Moreover, within this CD45 positive population there appeared to be an trend 
towards an increase in 1A8 positive cells (primarily neutrophils), but only in the 
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IFNγR2Δ/Δ mice displaying atypical symptoms (Fig 6.8B). There was also a trend 
towards an increased CD4 positive population in the IFNγR2Δ/Δ mice, independently 
of the EAE phenotype observed (Fig 6.8C). 
 
In summary, we have demonstrated that differences in animal unit conditions may 
have altered the penetrance of EAE and susceptibility of mice to ulceration. 
Moreover, the IFNγR2Δ/Δ mice appear to develop a severe, atypical disease with no 
recover that is accompanied by inflammation in the cerebellum. In contrast, the 
IFNγR2fl/fl mice develop a classical EAE disease course with almost complete 
recovery and spinal cord inflammation. Interestingly, despite the increased brain 
inflammation, lower levels of microglial activation is observed in the brains of 
IFNγR2Δ/Δ mice compared to IFNγR2fl/fl mice. These differences in the context of the 
existing literature will be analysed in the following discussion. 
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6.4 DISCUSSION 
The data contained within this chapter demonstrates that complete IFNγR2 deficient 
mice develop severe, atypical EAE symptoms from which they are unable to recover. 
To our knowledge, this is the first time that the IFNγR2 chain deficiency has been 
analysed in EAE and, as expected, these mice display the same phenotype as 
previously described in IFNγR1 deficient mice (Wensky et al., 2005). The 
mechanism behind the altered EAE phenotype observed in IFNγ or IFNγR deficient 
mice is still unclear. We, and others, have shown an association between spinal cord 
inflammation and classical EAE symptoms, and inflammation in the cerebellum with 
atypical EAE symptoms (Wensky et al., 2005). We have also demonstrated 
alterations in microglial activation in IFNγR2 deficient mice, the implications of this 
observation, future experiments and an examination of some of the problems and 
limitations of this model are discussed in the remainder of this chapter. 
 
6.4.1. Microglial activation during EAE in IFNγR2Δ/Δ and IFNγR2fl/fl mice 
Microglia are the key innate immune cells of the brain (Kofler & Wiley, 2010) and 
exhibit dynamic cell processes that appear to sample their microenvironment with 
projecting and retracting protrusions (Nimmerjahn et al., 2005). These microglia also 
have similar functions to tissue macrophages including phagocytosis, antigen 
presentation and cytokine production (see review by (Gehrmann et al., 1995)). 
 
It is thought that microglial activation during EAE contributes to pathology through 
antigen presentation and pro-inflammatory cytokine secretion. Previously, it has 
been demonstrated that during a relapsing-remitting model of EAE a correlation was 
observed between loss of neuronal synapses and microglial activation (Rasmussen et 
al., 2007). This study proposed that microglia extend their processes around the cell 
bodies of neighbouring neurons resulting in the loss of synaptic proteins and these 
microglia sustain the inflammation seen in the chronic phase of EAE. This 
hypothesis is supported by similar findings in primary progressive MS patients, 
where activated microglia are seen in association with inflammatory areas in the 
white matter of the brain (Kutzelnigg et al., 2005). As well as loss of neuronal 
synapses, it is thought microglia can also play a role in demyelination and 
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phagocytosis of the degraded myelin (Bauer et al., 1994). Furthermore, microglial 
cells can promote inflammation through the secretion of molecules like TWEAK 
(TNF like weak inducer of apoposis), and it has been demonstrated in the brains of 
MS patients that TWEAK-expressing microglial cells are associated with myelin 
loss, neuronal damage and vascular abnormalities in cortical lesions (Serafini et al., 
2008). 
 
However, despite the evidence of a pathogenic role of microglia during EAE there is 
also evidence that microglial cells maybe beneficial. These beneficial effects occur 
through several mechanisms including: clearing away myelin debris and apoptotic 
cells, the release of protective cytokines, the recruitment of oligodendrocyte 
precursors and the stimulation of neurogenesis (for review see (Napoli & Neumann, 
2010)). Therefore, the current hypothesis is that during EAE microglial cells can 
perform both neuro-destructive and neuro-protective functions, and that a switch of 
function from destructive to protective could be vital in preventing chronic 
demyelination and axonal loss. 
 
In has been demonstrated in vitro that IFNγ can activate microglia and these 
activated microglia are capable of antigen presentation to CD4 T cells (Frei et al., 
1987). Therefore, it is not surprising that in IFNγR2Δ/Δ mice with EAE, despite an 
increased inflammatory infiltrate into the cerebellum, there is a decrease in microglia 
activation in comparison to IFNγR2fl/fl mice. It will be interesting to determine the 
importance of this decreased microglial activation using the IFNγR2fl/flLysMCre+ 
mice. Furthermore, it has been demonstrated that, similarly to macrophages, 
microglia may be sub-divided into different activation states – classical activation 
requiring IFNγ and alternative activation which is independent of IFNγ (Kofler et al., 
2010). Therefore, it will be of interest to analyse the microglial phenotypes in the 
IFNγR2Δ/Δ mice and determine if this has an influence on whether these microglia are 
neuro-protective or neuro-destructive during EAE. 
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6.4.2. Future directions to further investigate the role of IFNγ  responsive cells 
during EAE. 
A lot of research has been performed trying to define the role of IFNγ during EAE 
and in recent years this has focused on defining the physiological mechanisms by 
which IFNγ signalling alters the localisation of inflammation. However, as far as we 
know, this has only utilised mutant mice that are deficient in IFNγ or IFNγR1 in all 
cells. The existing T cell deficient IFNγR2fl/flCD4Cre+ and macrophage/granulocyte 
deficient IFNγR2fl/flLysMCre+ mice as well as mice which are currently being bred at 
the University of Zurich, by members of Prof Becher’s laboratory, will allow the 
more precise analysis of the role of IFNγ responsive cells. The new lines being bred 
for these experiments include IFNγR2fl/flNestin-Cre+ with the deletion of IFNγR2 in 
all macroglia and neurons (Tronche et al., 1999) and IFNγR2fl/flCNP-Cre+ resulting 
in the deletion of IFNγR2 in oligodendrocytes (an unpublished Cre line). 
 
The data presented in this chapter demonstrates a correlation between the location of 
inflammation and EAE phenotype. Future experiments will also analyse more 
parameters including chemokine expression, make up of inflammatory cell infiltrate 
and microglial phenotype. The make up of inflammatory cells will also be 
determined to confirm the previous reports that it is the area of inflammation, not the 
make-up of the inflammatory infiltrate, that plays critical key role in determining the 
clinical phenotype observed in the mutant mice (Wensky et al., 2005). Finally the 
microglia phenotype will be analysed in an attempt to shed some light on the 
contradictory roles of these cells that is currently reported during EAE. 
 
6.4.2.1. IFNγR2fl/flCD4Cre+ mice will allow the role of IFNγ-responsive T cells 
during EAE to be elucidated 
T cells are well established as being vital for the pathogensis of EAE (see review by 
(Gutcher & Becher, 2007) for an overview of the importance of T cell polarisation 
during EAE). However, the importance of IFNγ acting on T cells has not been 
elucidated. The inactivation of IFNγR2 on T cells during EAE may result in an 
altered T cell polarisation, with a decrease in Th1 polarisation and a shift towards 
increased Th17 polarisation (Harrington et al., 2005). This increased Th17 
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population has previously been proposed to be the cause of the atypical phenotype 
seen in IFNγ deficient animals. Although, IL-17, IFNγ double deficient mice still 
display an atypical phenotype (V. Toceski, personal communication) the importance 
of the Th17 population is still undetermined and the analysis of the 
IFNγR2fl/flCD4Cre+ mice will allow further clarity in this manner. 
 
A second mechanism of action for IFNγ-activated T cells has also been proposed 
during EAE. This proposal stemmed from observations that IFNγ deficient mice 
have an elevation in T cell proliferation, due to the removal of the dampening of T 
cell responses normally provided by IFNγ signalling (Dalton et al., 1993). This 
elevated T cell proliferation has been proposed to be a factor in the high morbidity 
seen in IFNγ deficient animals with EAE. Therefore, the T cell specific IFNγR2 
knock out mice will be interesting to investigate to determine if an altered T cell 
proliferation or polarisation is observed and, if this is capable of altering the EAE 
disease course 
 
6.4.2.2. IFNγR2fl/flLysMCre+ mice will allow the role of IFNγ-responsive 
macrophages/microglia and granulocytes during EAE to be elucidated 
Macrophages and microglia are important inflammatory cells in the brain with 
evidence of upregulation of MHC class II and co-stimulatory molecules during EAE 
and MS (Martin et al., 1992; Windhagen et al., 1995). Importantly, these changes are 
thought to be due to IFNγ signalling and generate cells capable of stimulating T cell 
responses (Martin et al., 1992). Additionally, activated macrophages / microglia are 
major sources of inflammatory mediators including TNF (Renno et al., 1995) and 
NO (Tran et al., 1997). These inflammatory mediators are capable of causing 
oligodendrocyte death which is proposed to be important in the formation of MS 
lesions (Merrill et al., 1993). As IFNγ stimulated microglia activate multiple 
inflammatory pathways IFNγR2fl/flLysMCre+ mice may have a different phenotype 
to global IFNγ deficient mice with a less severe EAE phenotype.  
 
IFNγ deficient mice have been shown to have decreased CXCL9 and CXCL10 
expression during EAE, and this has been hypothesised to result in increased 
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trafficking of cells away from the perivascular space and into the parenchyma (Carter 
et al., 2007). This altered chemokine expression has proposed to be important in the 
altered location of inflammation resulting in the atypical phenotype observed in these 
mice (Lees et al., 2008). Macrophages / microglia could be key mediators of this 
effect as they are able to upregulate expression of CXCL9 and CXCL10 following in 
vitro stimulation with IFNγ and appear to be the only source of CXCL9 in the brains 
of mice with EAE (Carter et al., 2007). Therefore, microglia could be involved in the 
atypical phenotype observed in IFNγ deficient mice. 
 
6.4.2.3. Generation of IFNγR2fl/flNestin-Cre+ mice will allow the role of IFNγ-
responsive neuronal and glial cells during EAE to be elucidated 
The importance of IFNγ-responsive brain resident cells in EAE is apparent through 
data that demonstrates a correlation between CNS IFNγ concentration and EAE 
severity (Renno et al 1995, Merrill et al 1992, Kennedy et al 1992, Owens et al 
1994).  This is supported by adoptive transfer studies that have shown somatic cells 
are important for the atypical phenotype seen in IFNγR1 deficient mice, as the 
transfer of wild-type cells into IFNγR1 deficient animals results in atypical disease 
(V. Toveski, personal communication). There are several brain somatic cells, which 
are potential candidates for these IFNγ-driven actions, including neuronal cells and 
glial cells e.g. astrocytes or oligodendrocytes. 
 
The role of neurons in CNS inflammation is increasingly being recognised as being 
more important than previously acknowledged. It has recently been demonstrated 
that IFNγ may be important in the homeostasis of synaptic circuitry. This has been 
hypothesised to involve the stimulation of MHC class I expression on neurons, and 
there is some data showing the absence of IFNγ can result in neuronal death 
(Victorio et al., 2010). This suggests that the deletion of IFNγR2 on neurons may be 
involved of the increased severity EAE seen in IFNγR2 deficient animals.  
 
Glial cells have also been implicated in EAE, indeed astrocytes which have 
traditionally been seen as supplementary cells of the nervous system, have been 
discovered to play a more important role. They are currently thought to be important 
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in the structural architecture of the brain, its communication pathways, activation and 
plasticity (for review see (Nedergaard et al., 2003)). During EAE astrocyte gliosis, 
with astrocyte hyperplasia and hypertrophy, has been reported (Pham et al., 2009). 
Nevertheless, the role of astrocytes during MS and EAE is not fully understood. It is 
proposed that reactive astrocytes may be beneficial following demyelination but 
subsequently or in the presence of ‘inactive’ astrocytes they may inhibit 
remyelination (for a review of all the different effects of astrocytes in MS and animal 
models see (Williams et al., 2007)). 
 
Although astrocytes do not constitutively express MHC class II molecules, 
expression is up-regulated during active EAE. Importantly, in vitro incubation with 
IFNγ also results in MHC class II upregulation and generates astrocytes capable of 
priming naïve antigen-specific T cells (Nikcevich et al., 1997). IFNγ can also induce 
astrocyte proliferation and increase the extent of trauma-initiated gliosis (Yong et al., 
1991). Furthermore, astrocytes have been shown to be capable of upregulating 
CXCL10 following stimulation with IFNγ and CXCL10 expression is seen in 
astrocytes surrounding inflammatory EAE lesions (Carter et al., 2007). Therefore, 
astrocyes, either independenatly or in conjuction with microglia (as discussed in 
section 6.3.2.2), may play a key role in directing the location of the inflammatory 
infiltrate and aiding T cell activation. 
 
Oligodendrocytes are the other key macroglial cell thought to be important in EAE. 
Indeed, the loss of oligodendrocytes is a hallmark of MS and EAE and is associated 
with neuronal dysfunction and damage resulting in the clinical manifestations of 
disease. It has been demonstrated in vitro that upon exposure to IFNγ a decrease in 
the number of viable oligodendrocytes is observed (Vartanian et al., 1995). This has 
subsequently be determined to be due to the combined anti-miotic and pro-apoptotic 
effects of IFNγ on oligodendrocyte precursors (Horiuchi et al., 2006). This data 
suggests that the deletion of IFNγR2 on oligodendrocytes may result in a protective 
effect, which could be hidden in the complete IFNγR2 deficient animals by the 
effects IFNγ has on other cell types. The generation of IFNγR2fl/flCNP-Cre+ mice 
would allow the importance of IFNγ signalling in oligodendrocytes in vivo to be 
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elucidated and determination if IFNγ can result in oligodendrocyte loss in vivo and, if 
so, what implication this has for the development of EAE.  
 
6.4.3. Reasons for the poor penetrance and severe ulceration seen in initial EAE 
studies. 
It has been well established that ulceration and the skin lesions are recognised side 
effects of injection with complete freund’s adjuvant (CFA) (Broderson, 1989). In 
mice, following subcutaneous immunisation, these lesions have been demonstrated 
to be associated with moderate to severe pathological changes including granuloma 
formation, diffuse inflammation and fibrosis (Leenaars et al., 1995; Leenaars et al., 
1998). In these experiments there was also evidence of acute pain including 
bodyweight loss and piloerection during the first few days post injection. Therefore, 
the ulceration observed in our initial experiment consistent with previously reported 
experiments in the literature, although we did not observe any evidence of acute 
pain. We hypothesised that the high levels of inflammation observed in the skin of 
immunised mice with ulcerations could be directing the inflammatory response away 
from the brain and spinal cord and this could be responsible for the low EAE 
penetrance. However, previous data from EAE induced in rats suggests this is 
unlikely to be the cause of the low EAE penetrance, as they observed a correlation 
between skin ulceration and EAE severity (Levine & Wenk, 1961). 
 
An alternative hypothesis is that the high susceptibility to skin ulceration and the low 
penetrance of EAE are both a result of the different gut flora present in the animal 
units at the University of Manchester and the University of Zurich. Indeed, it has 
been demonstrated that gut flora is able to influence inflammatory responses in the 
skin as the administration of Lactobacilli, a gram positive bacteria commonly used in 
human probiotics, can decrease the severity of contact hypersensitivity (Chapat et al., 
2004). Moreover, as discussed in chapter four of this thesis, the mice at the 
University of Manchester are maintained on CRASF® flora. This limited gut flora 
with reduced exposure to pathogens may result in an immune system that is 
hypersensitive to bacterial challenge. Therefore, following CFA exposure an 
enhanced immune response could be mounted driving the severe ulcerations apparent 
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in the immunised mice. Furthermore, there is clear evidence that the gut flora can 
significantly alter the penetrance of EAE as, treatment of mice with antibiotics has 
been demonstrated to alter the gut flora of mice and suppress the induction of EAE 
(Yokote et al., 2008). 
 
This hypothesis, indicating a role of gut flora, is supported by our data demonstrating 
that subsequent to the longer acclimatisation period, with dirty bedding from other 
mice normally housed at the University of Zurich, immunised mice have no evidence 
of ulceration and a good disease induction. However, as we did not analyse the 
caecal contents from these mice we are unable to determine if there had been any 
alterations in gut flora or if the increased penetrance was due to another change in 
experimental conditions. 
 
6.4.4. Limitations of murine EAE as a model of MS 
The use of murine models of EAE and the availability of genetically modified mice 
has provided a lot of insight into the mechanisms involved in the pathogenesis of 
EAE but, nevertheless, these models also have their shortcomings (for overview see 
review by (Gold et al., 2006)). 
 
In contrast to the primary demyelination seen in MS most murine models of EAE 
have lesions characterised by massive tissue injury with both axonal and neuronal 
damage. Moreover, in EAE models the tissue damage is accomplished primarily by 
T cells and activated macrophages and, in contrast to MS, the role of demyelinating 
auto-antibodies is less important (see review by (Gold et al., 2006)). Furthermore, 
the CD4+ T cell dominance seen in EAE is not reflected in MS where is there an 
predominance of CD8+ T cells in lesions (see (Friese & Fugger, 2005) for review). 
Therefore, there is a need for more CD8+ T cell based models.  
 
A clear feature in MS is the large heterogeneity in pathological features that vary 
between patients and disease stage. The only way to mimic this complexity in EAE 
models is through the use of a large spectrum of models in different species by 
different sensitisation techniques (see (Gold et al., 2006) for a review of different 
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models and the appropriateness of each model in mimicking different MS 
pathologies). Nevertheless, with these limitations kept in mind EAE has, and 
continues to, provide an important insight into the mechanisms of damage during 
MS. 
 
6.5 CONCLUSION 
The results presented in this chapter demonstrate that: 
1. Complete deletion of IFNγR2 results in an atypical EAE phenotype 
2. Atypical EAE appears to be accompanied by an inflammation predominately 
located in the cerebellum whereas in classical EAE inflammation 
predominates in the spinal cord 
3. Penetrance of EAE and frequency of ulceration following Freund’s adjuvant 
use may be altered by conditions in animal facilities 
4. IFNγR2 deficiency decreases microglial activation in the brain 
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7.1 SUMMARY 
 
In this thesis, the generation and characterisation of a complete IFNγR2 deficient 
mouse, as well as a conditional macrophage/granulocyte- and T cell-specific mouse 
mutant has been described. The initial generation of mice with a conditional IFNγR2 
allele was performed by A. Fleige (Fleige, 2006) at the Helmholtz Institute for 
Infection Research, Braunschweig. Subsequent deletion of the neomycin resistance 
cassette and breeding homozygous floxed and delta alleles was described at the start 
of this thesis. Characterisation of IFNγR2fl/fl and IFNγR2Δ/Δ mice demonstrated the 
IFNγR2fl/fl mice have a functional IFNγR2 whereas the IFNγR2Δ/Δ mice have no 
functional IFNγR2, as expected. Subsequent in vitro characterisation of the complete 
IFNγR2 mouse mutant demonstrates decreased STAT1 phosphorylation, following 
IFNα stimulation, compared to control mice and a skewing of the macrophage 
phenotype towards alternative activation. IFNγR2fl/flCD4Cre+ and 
IFNγR2fl/flLysMCre+ mice have been successfully generated and the deletion of 
IFNγR2 confirmed to occur in a cell-type specific manner. 
 
The complete mutant mouse was tested in three models in vivo – DSS-induced 
colitis, Trichuris muris infection and EAE. Acute DSS-induced colitis is a model of 
the innate immune system as it can occur independently of cells of adaptive 
immunity (Dieleman et al., 1994). Despite previous reports demonstrating IFNγ 
deficient mice are protected from DSS-colitis (Ito et al., 2006; Xu et al., 2008) our 
data demonstrates IFNγR2 deficient mice display an equal or more severe colitis than 
control mice. We hypothesise that this discrepancy is due to differences in the gut 
microbiota between the different experiments, and the limited CRASF® flora in our 
mice does not drive the IFNγ response seen in the other experiments. 
 
Trichuris muris is a well-established model of intestinal nematode infection, where 
expulsion of the parasite is dependent on the generation of a Th2 response. The 
complete IFNγR2 mutant was resistant to T. muris with all infected mice capable of 
expelling a low dose infection before the worms reached fecundity. In contrast, the 
control mice all harboured fecund worms in the intestine at day 35 post infection. 
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Infection of IFNγR2fl/fl mice drove a strong IgG1 and IgG2a/c response, however 
IFNγR2 deficient mice were unable to produce IgG2a/c antibodies. This is in keeping 
with previous reports describing IFNγ as a IgG2a switch factor (Finkelman et al., 
1988). Nevertheless, the mutant mice were capable of mounting a Th1 response 
evident through IFNγ production following lymph node re-stimulation. This needs to 
be further investigated to determine if there is a decreased polarisation of naïve T 
cells to a Th1 phenotype as observed in other IFNγ mutant mice (Lu et al., 1998). 
 
To further investigate the mechanism of action behind the resistant phenotype 
observed in complete IFNγR2 deficient mice, conditional mutant mice were infected 
with T. muris. Contrary to our hypotheses neither the T cell-specific mutant nor the 
macrophage/granulocyte-specific mutant duplicated the resistant phenotype observed 
in the complete knock-out mice, with both conditional knock-out mutants remaining 
susceptible to the parasitic infection. Analysis of double conditional, T cell- and 
macrophage/granulocyte- specific, IFNγR2 mutant mice produced inconsistent 
results with initial experiments suggesting that, in combination, these deficiencies are 
sufficient to duplicate the resistant phenotype observed in the complete mutant mice. 
However, subsequent experiments with the double conditional knockout mice found 
that they were susceptible to infection with fecund adults present at day 35 post 
infection. Therefore, whilst abrogation of IFNγ signalling in T cells and macrophages 
in combination can, under some circumstances, mimic the phenotype of the complete 
IFNγR2 deficient mice the lack of robustness suggests there must be other important 
IFNγ responsive cells. Further work will be performed to investigate the other 
potential candidates through crosses to new Cre lines including the hemapoietic cell 
specific Vav-Cre (Georgiades et al., 2002), dendritic cell specific CD11c-Cre (Caton 
et al., 2007), B cell specific CD19-Cre (Rickert et al., 1997) and the intestinal 
epithelial cell specific Villin-Cre (el Marjou et al., 2004).  
 
The third in vivo model that we used to analyse IFNγR2 mutant mice was EAE. The 
mechanism of action and the involvement of IFNγ in EAE has, for a long time, been 
a matter of uncertainty. EAE was initially described as a Th1 driven disease and, as 
with many other putative Th1-diseases, upon the discovery of the Th17 subset was 
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reinvestigated and determined to be a Th17 driven disease. The current dogma is that 
the pathogenic cells in EAE can not be solely attributed to Th1 or Th17 cells but both 
subsets may play a role (for a review of the changing dogma see (Goverman, 2009)). 
Nevertheless, the role of IFNγ still remains uncertain with IFNγ deficient mice 
displaying more severe EAE (Willenborg et al., 1996), suggesting a protective role 
of IFNγ; but other experiments demonstrating IFNγ expression in the CNS causes 
inflammation and tissue injury (Nikcevich et al., 1997). The conditional IFNγR2 
mouse mutant is an elegant method of dissecting the role of IFNγ signalling during 
EAE in different cell types. As this work was performed at the University of Zurich, 
through the collaboration with Prof. Burkhard Becher, I was only able to perform 
two experimental runs and members of his group will now continue this work. 
 
Initial EAE induction was unsuccessful with very low disease penetrance and high 
levels of ulceration at the site of immunisation. It was hypothesised this could be due 
to differences in gut microbiota present at the University of Manchester and 
University of Zürch animal facilities. In an attempt to circumvent this discrepancy, 
prior to the initiation of the subsequent experiment, mice were left to acclimatise for 
a longer period and were exposed to the used bedding of mice normally housed at the 
University of Zürich animal facility. This subsequent experiment had successful 
EAE induction with good penetrance, although this cannot be conclusively attributed 
to an alteration in gut flora as no caecal analysis was performed. The complete 
IFNγR2 mutant mice demonstrated an atypical phenotype, with no signs of recovery. 
In contrast, the IFNγR2fl/fl control mice displayed classical EAE symptoms with 
almost complete recovery prior to the termination of the experiment. The severity of 
the atypical EAE symptoms correlated with the severity of inflammation in the 
cerebellum whereas the severity of the classical EAE symptoms correlated with the 
severity of the spinal cord inflammation. These results are consistent with the 
literature, and therefore further experiments analysing the existing conditional 
mutant mice, as well as new crosses to various brain-specific Cre lines will hopefully 
allow the elucidation of the actions of IFNγ to finally be achieved. 
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7.2 AREAS OF FURTHER INVESTIGATION 
The work presented in this thesis demonstrates the successful targeting of the 
IFNγR2 allele, initiated by A. Fleige, and the generation of conditionally targeted T 
cell and macrophage/granulocyte mutant mice. The work has began to clearly dissect 
the mechanisms through which IFNγ acts but there are still unanswered questions 
that were beyond the scope of this thesis including the potential interaction of 
IFNγR2 and IFNγ signalling components with other signalling pathways, the 
importance of the T. muris derived IFNγ-homologue and it’s mechanism of action 
and the role of IFNγ signalling in other models of parasitic infection. Our data has 
also demonstrated the importance of gut flora in multiple models of disease and this 
future work and the current literature surrounding these areas will be discussed in the 
remainder of this discussion. 
 
7.2.1 The successful generation of a conditional IFNγR2 allele and further work 
using the complete IFNγR2 mutant mice 
The first complete IFNγR deficient mouse was generated by Aguet and colleagues in 
1993 and targeted IFNγR1 (Huang et al., 1993) with the generation of a complete 
IFNγR2 deficient mouse subsequently performed by Rothman and colleagues (Lu et 
al., 1998). The phenotypes observed in these mice include no overt abnormalities, 
normal development, impaired STAT1 phosphorylation to IFNγ stimulation and 
deficiencies in IgG2a class switching and were all duplicated in the IFNγR2Δ/Δ mice 
generated as part of this thesis. Furthermore, these deficiencies, observed in the 
IFNγR2Δ/Δ mice, were not seen in the IFNγR2fl/fl mice. Therefore, we conclude that 
the conditional allele has been successfully targeted and the complete mutant 
behaves as expected. Further analysis of the IFNγ complete mutant mouse resulted in 
the several key observations including an interaction with the IFNα signalling 
pathway, the importance of which is still not fully understood. 
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7.2.1.1. The importance of determining interactions in signalling pathways when 
using mutant mice. 
The IFNγ signalling pathway has been widely investigated and initial research 
focused on the Jak-STAT pathway as the mediator of signal transduction, but 
recently it has become apparent that other pathways can act in parallel to the Jak-
STAT pathway to regulate the effects of IFNγ signalling (for review of the different 
pathways and how the interact see (Gough et al., 2008)). Despite this wealth of 
literature, on the multiple signalling pathways downstream of the IFNγ receptor, far 
less is known about the ability of IFNγ receptors to interact with other receptors. 
Takaoka and colleagues have demonstrated that the IFNγ and IFNα receptor chains 
cluster together in lipid rafts and there is cross talk between these pathways (Takaoka 
et al., 2000). The results presented in this thesis support this observation, with a 
decreased response to IFNα signalling in cells lacking IFNγR2. The proposed 
mechanism of action for this crosstalk is that IFNαR1 facilitates the assembly of 
IFNγ-activated transcription factors, through an interaction between the two non 
ligand-binding components: IFNαR1 and IFNγR2 (Takaoka et al., 2000). It is not 
known if a similar interaction between non-ligand binding chains also occurs with 
other members of the class II cytokine receptor family or other cytokine receptors. 
The class II cytokine receptor family contains the IFN type I (IFNαR1/2), IFN type 
II (IFNγR1/2) and IFN type III (the IFNλR1) receptors as well as the receptors for 
the IL-10 family and Factor VII/VIIa (Langer et al., 2004). Further investigations 
will aim to investigate potential interactions between these signalling cascades. It 
will also be of interest to determine the functional impact of any associations under 
physiological conditions. 
 
The cross-talk seen in the IFN pathways may also be important in other cytokine 
receptor families. It will be important to determine in other mice with cytokine 
receptor deficiencies if there is a deficiency in the expression or signalling of other 
receptors, due to an altered interaction of proteins at the membrane or other cellular 
locations. 
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7.2.1.2. Importance and mechanism of action of the negative regulator SOCS1 
in IFNγ  signalling 
Negative regulators play an important role in the control of signalling cascades and 
are known to be capable of suppressing multiple signalling pathways. An important 
group of negative regulators are the Suppressor of cytokine signalling (SOCS) 
proteins: a family of 8 intracellular proteins which can be induced by cytokine 
signalling and act to regulate the magnitude and duration of responses through a 
classical negative feedback loop. As well as this feedback loop SOCS proteins are 
also capable of participating in ‘cross-talk’ and regulate the signalling downstream of 
other cytokines  (for an overview of SOCS regulation of the Jak-STAT pathway see 
(Croker et al., 2008)). 
 
SOCS1 is the key SOCS molecule important in the IFNγ signalling pathway and acts 
through two key mechanisms (i) binding to the phosphorylation loop of Jak 2 to 
prevent the access of substrates to the catalytic pocket (Yasukawa et al., 1999) and 
(ii) binding to tyrosine 441 on IFNγR1 blocking the access of STAT1 to the IFNγR1 
chain (Qing et al., 2005; Starr et al., 2009). The importance of this negative feedback 
loop is highlighted through the analysis of SOCS-1 deficient mice, these mice die 
between 2 and 3 weeks of age due to a complex multi-organ disease that can be 
prevented by the administration of anti-IFNγ antibodies (Alexander et al., 1999). 
Preliminary data in this thesis suggests that in unchallenged mice the level of SOCS1 
present in the intestine of IFNγR2Δ/Δ mice is approximately seven fold the level in 
IFNγR2fl/fl mice. It will be interesting to determine if this effect is seen in all organs 
or if it is specific to the colon and if the data demonstrating changes in SOCS1 
message are replicated when the protein levels are analysed. Moreover, the reason 
for this increase in SOCS1 message is unknown as, although IL-6 and GM-CSF are 
also capable of inducing SOCS1 proteins IL-6 does not appear to be up-regulated in 
the serum of IFNγR2Δ/Δ mice. Although we did not measure GM-CSF levels, 
previous reports have shown GM-CSF elevated in IFNγ deficient mice following 
infection but this not evident early in infection which suggests there is no elevation 
of GM-CSF in unchallenged mice (Allendoerfer & Deepe, 1997). As well as pro-
inflammatory cytokines STAT proteins, primarily STAT1, can also induce SOCS1 
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expression, however, we see no evidence of STAT1 phosphorylation from un-
stimulated cells of either IFNγR2Δ/Δ or IFNγR2fl/fl mice. Therefore, the mechanism 
for this elevation in SOCS1 needs to be further investigated and it will also be 
interesting to determine if there is an increase in other negative regulators of IFNγ 
signalling. 
 
As SOCS proteins can act not only as negative regulators but can also participate in 
cross talk it will be important to determine if there are any implications of the high 
SOCS1 levels to other signalling pathways e.g. SOCS1 can also impact on the NFκB 
pathway by facilitating the degradation of p65 (Ryo et al., 2003), and alter the JNK 
and p38 pathways through the degradation of ASK1 (He et al., 2006). 
 
SOCS1 also has an important role in colitis and can function as an anti-oncogene 
with SOCS1 methylation observed in colorectal cancer (Lin et al., 2004). This 
observation has been duplicated in mice as both SOCS1/TCRα double deficient mice 
and SOCS1 deficient TG mice, where SOCS1 expression has been restored on T and 
B cells, develop colitis and colorectal cancer in an IFNγ dependant manner (Chinen 
et al., 2006; Hanada et al., 2006). Crossing the IFNγR2 mouse mutant with SOCS1 
deficient mice will allow the key IFNγ responding cells that are important for the 
effects of SOCS1 deficiency to be determined, which may provide further insight 
into the anti-oncogenic functions of SOCS1. 
 
7.2.2 The successful generation of a conditional IFNγR2 mutant mice and 
further work using the existing lines 
 
We have demonstrated the successful generation of T cell- specific, 
granulocyte/macrophage- specific and a double T cell-, granulocyte/macrophage- 
specific conditional IFNγR2 deficient mouse mutants. Currently we have only tested 
the conditional mutant mice in T. muris infection, however there are multiple other 
models of infection, which these mice could provide further insight into. These 
include other models of parasitic infection e.g. Toxoplasma gondii to determine if 
IFNγ acts through a similar mechanism during other parasite infections. 
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7.2.2.1 The role of IFNγ during parasitic infection 
Work presented within this thesis demonstrates that responsiveness to IFNγ is vital 
for the survival of the parasite, and complete deletion of IFNγR2 results in resistance 
to infection. Moreover, we have determined that is achieved, in part, through the 
actions of IFNγ on both T cells and macrophages/granulocytes. Further work on 
these conditional mouse mutants needs to be performed to better understand the 
magnitude and kinetics of the different T helper subset responses during infection. 
Although we have demonstrated no clear change in the Th1 or Th17 response at day 
35 post infection, it will be interesting to look at earlier time points to determine in 
there is a skewing during the peak of the immune response away from Th1 
phenotype and towards a Th17 or Th2 phenotype. 
 
Another avenue of interest is the T. muris derived IFNγ homologue. This homologue 
has been demonstrated to share cross reactive epitopes to IFNγ and is capable of 
binding to the IFNγ receptor and inducing similar changes to those seen following 
IFNγ stimulation (Grencis & Entwistle, 1997). It has been proposed that the 
production of this IFNγ homologue by the parasite might be a mechanism through 
which the parasite is able to interfere with the host response and increase its own 
survival potential. Previous experiments have demonstrated the ability of the IFNγ 
homologue to bind to the IFNγR1 chain and upregulate Ly-6G (Grencis & Entwistle, 
1997). It isn’t known if this homologue signals through the same method as IFNγ 
with the need of the IFNγR2 chain, therefore future work will investigate the 
capacity of this IFNγ homologue to induce changes in IFNγR2Δ/Δ mice. It will also be 
interesting to determine if, in naïve and IFNγR2 deficient cells, this parasite derived 
molecule is capable of driving other IFNγ actions including skewing the macrophage 
phenotype towards a classically activated state and driving naïve T cells to 
preferentially differentiate into Th1 cells. 
 
7.2.2.2. The role of IFNγ  during Toxoplasma gondii infection 
It will be interesting to examine the role of other IFNγ in other parasitic infections 
and future work will look at Toxoplasma gondii (T. gondii) infection. T. gondii is an 
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intracellular protozoan parasite which has proposed to be the ‘most successful 
parasite’ as it is found worldwide and is capable of infecting all warm-bloodied 
animals including humans (for an overview see (Innes, 2010)). T. gondii has a 
complex life cycle involving different developmental stages: the rapidly replicating 
tachyzoite, the slower growing bradyzoites and sporozoites within oocysts. The 
oocyst stage only occurs in the intestine of its definitive host – the feline and the 
oocysts are shed in the cat’s feaces where they can sporulate and become infectious. 
Infection can also occur through the ingestion of bradyzoite tissue cysts. Infection is 
characterised by an acute phase when the rapidly dividing tachyzoite form of the 
parasite disseminates throughout the body. If the immune system is unable to control 
this stage of the infection extensive tissue damage can be done by the parasite. The 
later parasite stage, in contrast, is largely asymptomatic with the dormant bradyzoite 
form of the parasite residing in cysts in the host tissue particularly in the brain (for 
overview of the lifecycle see (Dubey, 1998)). 
 
The importance of IFNγ during T. gondii infection is already well established as 
mice treated with anti-IFNγ antibodies and IFNγ deficient mice rapidly succumb 
even to avirulent strains of the parasite (Scharton-Kersten et al., 1996; Suzuki et al., 
1988). As well as an important role in the acute phase of disease IFNγ has also been 
demonstrated to be important during the chronic phase of the disease and are 
involved in the maintenance of intact cysts and the prevention of toxoplasmic 
encephalitis (Suzuki et al., 1989). Recent experiments using MIIG (“macrophages 
insensitive to IFNγ”) mice have demonstrated that macrophages are one of the key 
responding cells during acute IFNγ infection as MIIG mice succumb to infection in a 
similar manner to IFNγ deficient mice. However, bone marrow chimera studies have 
demonstrated that IFNγ-responsive non-haemopoietic cells are also vital for 
protection again T. gondii mortality as reconstitution of IFNγR1 deficient mice with 
wild-type bone marrow is not sufficient to confer protection (Yap & Sher, 1999). 
The somatic cell(s) responsible for this phenotype are unknown but the conditional 
IFNγR2 mice present a good system for dissecting the importance of different 
somatic cells. 
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It will also be interesting to determine the key responding cells in chronic T. gondii 
infection given the importance of IFNγ in preventing Toxoplasma encephalitis 
(Suzuki et al., 1989). Several brain resident cells have been demonstrated to respond 
to IFNγ to regulate toxoplasmosis, including astrocytes through the induction IGTP 
(Halonen et al., 2001) and microglia through an action involving TNF (Chao et al., 
1993). Similarly to results from acute infections bone marrow chimera studies have 
demonstrated that IFNγR expression on non-haemopoietic as well as bone marrow-
derived cells is essential for host survival in the chronic phase (Yap & Sher, 1999). 
One potential bone marrow derived candidate for driving host survival in both the 
chronic and the acute phases is the T cell. It has been demonstrated that IFNγ plays 
an important role in the apoptosis of activated T cells during infection and that the 
level of apoptosis in the acute stages of infection in mice correlates with a hosts 
genetic susceptibility to T. gondii infection (Begum-Haque et al., 2009; Gavrilescu & 
Denkers, 2001). Indeed, some preliminary results, from our laboratory, suggests that 
IFNγR2fl/flCD4Cre+ display an increased sensitivity to the prugniaud strain of T. 
gondii compared to IFNγR2fl/flCD4Cre- animals. This needs to be further investigated 
but, if confirmed, demonstrates that importance of both T cells and macrophages in 
controlling acute infection and that, unlike in T. muris infection, these cells have 
non-redundant roles. 
 
T. gondii provides a well characterised, pathologically important model of parasitic 
infection in which IFNγ is known to play an important role. Recent work by Lykens 
and colleagues have demonstrated the importance of IFNγ responsive macrophages 
in controlling mortality in the acute stages of disease. However, little is known about 
the role of other cell types, especially somatic cells, which have been shown to be 
important through bone marrow chimera studies. Therefore, the conditional IFNγR2 
mouse mutant provides a valuable tool to dissect the role of different cells during 
infection. 
 
7.2.2.3. The importance of IL-10 in IFNγR2 deficient mice 
As well as the generation of further IFNγR2 conditional mutant mice it will be 
interesting to cross these conditional mice onto an IL-10 deficient background. This 
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strategy has previously been used with the gp130 conditional mutant mice and has 
revealed important information on the role of gp130 signalling in regulating 
inflammatory processes (Fasnacht et al., 2009). IL-10 is a cytokine with anti-
inflammatory properties that arise primarily through it’s ability to inhibit 
macrophage and dendritic cell function (for IL-10 overview see review by (Moore et 
al., 2001)). IL-10 deficient mice have been well characterised and develop 
spontaneous colitis when house in conventional animal facilities (Kuhn et al., 1993). 
If these mice are associated with a Charles River Altered Schaedler Flora, as found 
in our animal facility, IL-10 deficient mice remain free from colitis (Stehr et al., 
2009). Colitis can be induced in these mice through treatment with DSS and the IL-
10 deficient mice develop a more severe colitis than wildtype control mice (Pils et 
al., 2010a). Under these circumstances IL-10 deficient mice, but not wildtype mice, 
show an elevation in levels of serum IFNγ and the IFNγ-induced protein IP-10 (Pils 
et al., 2010a). The generation of IFNγR2 conditional mutant mice on an IL-10 
deficient background will allow the analysis of IFNγ during induced acute intestinal 
inflammation by removing the IL-10 that normally serves to counterbalance the 
inflammatory signals given from the gut flora. Furthermore, it has previously been 
shown that IFNγ is a key mediator of the spontaneous colitis observed 
conventionally housed IL-10 deficient mice, as treatment with anti-IFNγ monoclonal 
antibodies can prevent colitis development (Rennick et al., 1997). It will be 
interesting to determine if IFNγ is also responsible for the increased colitis evident in 
the IL-10 deficient DSS-treated mice and, if so, which are the key responding cell 
types. 
 
7.2.3 The importance of gut microflora in experimental design 
The intestinal microflora plays an important role in host physiology and has been 
demonstrated to play important metabolic, trophic and protective functions (for 
review see (Guarner & Malagelada, 2003)). The major metabolic role of gut 
microflora is the fermentation of non-digestible dietary substances. However, as well 
as this metabolic role gut microflora has also been demonstrated, primarily through 
the use of germ-free mice, to be important in a wide range of other processes. Indeed, 
germ free mice have been documented to suffer from a wide range of abnormalities 
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including altered bile acid and bilirubin metabolism; low heart, lung and liver 
weights; low cardiac output; enlarged caecum and thin intestinal wall; decreased rate 
of enterocyte replacement and slow peristalsis; lowered body temperature and small 
lymph nodes compared to mice housed in a conventional environment (for overview 
see (Tannock, 2001)). 
 
The data contained within this thesis has highlighted the importance of gut 
microflora in multiple mouse models, not just those confined to the analysis of 
intestinal inflammation. With increasing collaborations and importation of mice from 
other institutes it is vital that the role of gut flora in susceptibility to different disease 
models is not ignored. We now know that genetic background (Esworthy et al., 
2010) and genetic mutations e.g. peptidoglycan recognition protein deficiencies 
(Saha et al., 2010) as well as differences between animal facilities can alter the gut 
microflora. These differences in gut microflora can in turn alter the phenotype of 
mice in various different diseases including models that do not focus on intestinal 
inflammation like EAE (Ochoa-Reparaz et al., 2009; Yokote et al., 2008). This all 
demonstrates the importance of gut flora and the need for this influence to be 
properly recognised, and taken into account, when designing and analysing 
experiments.  
 
7.3 CONCLUSION 
In conclusion, the work in this thesis has demonstrated the successful generation and 
characterisation of an IFNγR2 mouse mutant, work that was initiated by Anna Fleige 
during her PhD (Fleige, 2006). This mouse mutant has allowed the important IFNγ-
responsive cells during T. muris infection to be dissected and has demonstrated that 
both T cells and macrophages/granulocytes are importance in mediating 
susceptibility to this parasite. Nevertheless, there are other important cell types also 
involved and the generation of further conditional mutant mice will allow further 
understanding of the mechanism of action of IFNγ. This thesis has also highlighted 
the importance of gut microflora in different experimental models with the poor EAE 
penetrance seen in the initial study and the lack of protection in DSS thought to be 
attributable to differences in gut flora. Finally the complete IFNγ deficient mouse 
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displays an atypical EAE phenotype and further work analysing different conditional 
mutant mice with our collaborators at the University of Zurich will allow a clearer 
understanding of the, currently controversial, role of IFNγ in EAE and MS. This 
mouse mutant is an extremely powerful tool that will allow a deeper understanding 
of the role of the pleiotropic cytokine IFNγ in many different models. 
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APPENDIX A 
 
Tail Lysis Buffer: 50mM KCl, 10mM Tris, 2.5mM MgCl2, 0.1mg/ml gelatine, 0.4% 
w/v NP40, 0.4% w/v Tween 20 (all Sigma-Aldrich) 
 
Western Blot Running buffer: 25mM Tris (Sigma-Aldrich), 0.192M glycine (BDH), 
0.1% w/v SDS (BDH) 
 
TBS: 25mM Tris, 0.125M NaCl pH 8.0 (all Sigma-Aldrich) 
 
TBS-Tween: TBS, 1% v/v Tween-20 (Sigma-Aldrich) 
 
Ponceau-S stain: 0.1% Ponceau S, 5% v/v acetic acid (all Sigma-Aldrich) 
 
Western blot gels: 
 Resolving Gel (10%) Stacking Gel 
1M Tris (Sigma-Aldrich) pH8.8 4.5ml - 
1M Tris (Sigma-Aldirch) pH6.8 - 0.5ml 
Protogel (30% acrylamide; National 
Diagnostics) 
4ml 680µl 
10% SDS (BDH) 120µl 40µl 
TEMED (Sigma-Aldrich) 12µl 4µl 
Water 3.34ml 2.74ml 
10% ammonium persulfate (Sigma-
Adrich)* 
160µl 80µl 
 
Strip Buffer: 60mM Tris (Sigma-Aldrich), 2% w/v SDS (BDH) pH 6.8. 0.7% β-
mercaptoethanol (Sigma-Aldrich) added prior to use 
 
API buffer: 300mM Tris (Sigma-Aldrich), 20% v/v Methanol (BDH) 
 
APII buffer: 25mM Tris (Sigma-Aldrich), 20% v/v Methanol (BDH) 
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CP buffer: 40mM β-aminocaproic acid (Sigma-Aldrich), 0.01% w/v SDS (BDH), 
20% v/v Methanol (BDH) 
 
Laemelli buffer 5x: 32mM Tris (Sigma-Aldrich), 5% SDS (BDH), 25% Glycerol 
(Sigma-Aldrich), 0.5% β-mercaptoethanol (Sigma-Aldrich), 0.2mg/ml bromophenol 
blue (Sigma-Aldrich) 
 
Western blot blocking buffer: 4% low-fat milk (Marvel) in TBS-Tween 
 
Complete DMEM: Dulbecco's modified Eagle's medium (DMEM; PAA) containing 
10% v/v fetal calf serum (PAA) , 2 mM L-glutamine (PAA), 100 units/ml penicillin 
and 100 µg/ml streptomycin (PAA) 
 
Complete RPMI: RPMI-1640 media (PAA) containing 10% v/v fetal calf serum 
(PAA), 2 mM L-glutamine (PAA), 100 units/ml penicillin and 100 µg/ml 
streptomycin (PAA) 
 
FACS buffer: PBS, 2% FCS (PAA), 0.05% sodium azite (Sigma-Aldrich) 
 
FACS staining buffer: PBS, 2% FCS (PAA), 1% rat serum (eBioscience), 0.05% 
sodium azite (Sigma-Aldrich) 
 
Carbonate bicarbonate buffer: 15mM Na2CO3 (Sigma-Aldrich), 35mM NaHCO3  
(Sigma-Aldrich), pH 9.6 
 
ELISA blocking buffer: 3% w/v BSA  (Sigma-Aldrich) in 100ml PBS 
 
PBS: 3.2mM Na2HPO4, 0.5mM KH2PO4, 1.3mM KCl, 135mM NaCl, pH7.4 (all 
Sigma-Aldrich) 
 
PBS-T: PBS, 0.05% v/v Tween 20 (Sigma-Aldrich) 
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MACS buffer: PBS, pH 7.2, 0.5% BSA (Sigma-Aldrich), 2 mM EDTA (Sigma-
Aldrich) 
 
Citrate buffer: 10mM sodium citrate (Sigma-Aldrich), 0.05% Tween 20 (Sigma-
Aldrich) pH 6.0 
 
Adapted NBF fixative: 4% v/v formaldehyde (BDH), 0.154M NaCl (Sigma-Aldrich), 
2% v/v glacial acetic acid (BDH), 1.37µM hexadecyl trimethyl-ammonium bromide 
(Sigma-Aldrich). 
